"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtAU_IN","meanArtPer_AU_IN_FIRST","meanArtPer_AU_IN_LAST","meanArtPer_AU_IN_CORR","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","InternCoauthorship","AffCoauthorship","meanCitationTrend","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"IRCCS_DEBELLIS",2000,17,6.88235294117647,2,0.5,0.529411764705882,0.117647058823529,0,0.117647058823529,0,5,6,0,6,0.29,0.35,0,0.35,73.24,1.61556838086271,0.294117647058824,0.588235294117647,NA,0.290483510746295,0.170940170940171,0.166666666666667,0,"GIOACCHINO LEANDRO;ALFREDO DI LEO;V. D’ONOFRIO;VALENTINI AM;FRANCESCO DI MARIO;F. PEZZOLLA;CARUSO ML;I. DEMMA;MICHELE LINSALATA;ALBERTO R. OSELLA;VITO GUERRA;ALDO CAVALLINI;MARISA CHILOIRO;MARIA LUCIA CARUSO;ALBERTO PILOTTO;GAETANO IAQUINTO;MARIO RASSU;PALMA AURELIA IACOVAZZI;D. MADIA;PIERO PORCELLI","5;5;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","ALFREDO DI LEO;VALENTINI AM;CARUSO ML;GIOACCHINO LEANDRO;MARIA LUCIA CARUSO;ANNA MARIA VALENTINI;MARISA CHILOIRO;MICHELE LINSALATA;PIERO PORCELLI;MASSIMO DE CARNE;GIOVANNI A. FAVA;ALDO CAVALLINI;F. PEZZOLLA;I. DEMMA;ALBERTO R. OSELLA;VITO GUERRA;G DARCONZA;CATERINA MESSA;MARIA PRICCI;GIUSEPPE RIEZZO","0.93;0.64;0.64;0.6;0.6;0.5;0.39;0.38;0.33;0.33;0.33;0.31;0.29;0.29;0.27;0.27;0.25;0.25;0.25;0.25","GIOACCHINO LEANDRO;VALENTINI AM;F. PEZZOLLA;CARUSO ML;I. DEMMA;MICHELE LINSALATA;ALBERTO R. OSELLA;VITO GUERRA;ALDO CAVALLINI;MARIA LUCIA CARUSO;PIERO PORCELLI;CATERINA MESSA;M. CORREALE;M PIRRELLI;BRIAN I. CARR;ANNA MARIA VALENTINI;ROSA ANGELA CARDONE;DOMENICA LORUSSO;GIUSEPPE RIEZZO;FRANCESCO RUSSO","5;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","VALENTINI AM;CARUSO ML;GIOACCHINO LEANDRO;MARIA LUCIA CARUSO;ANNA MARIA VALENTINI;MICHELE LINSALATA;PIERO PORCELLI;ALDO CAVALLINI;F. PEZZOLLA;I. DEMMA;ALBERTO R. OSELLA;VITO GUERRA;CATERINA MESSA;GIUSEPPE RIEZZO;FRANCESCO RUSSO;GUERRA;BRIAN I. CARR;ROSA ANGELA CARDONE;MARIA NOTARNICOLA;M PIRRELLI","0.64;0.64;0.6;0.6;0.5;0.38;0.33;0.31;0.29;0.29;0.27;0.27;0.25;0.25;0.25;0.25;0.17;0.17;0.17;0.14","BRIAN I. CARR;JAMES H. OLIVER;JAMES V. FERRIS;MARK S. PETERSON;R L BARON;S. L. KATYAL;GIOACCHINO LEANDRO;ALFREDO DI LEO;A. COLANTONI;DAVID H. VAN THIEL;JAMES M. HARIG;LOIS FRIEDLANDER;NICOLA DE MARIA;RAMAZAN İDILMAN;ALBERTO PILOTTO;FRANCESCO DI MARIO;MARILISA FRANCESCHI;MARIO RASSU;GIOVANNI A. FAVA;MASSIMO DE CARNE","697;697;697;697;697;697;253;118;106;106;106;106;106;106;101;101;90;90;81;81","BRIAN I. CARR;GIOACCHINO LEANDRO;PIERO PORCELLI;ALBERTO R. OSELLA;VITO GUERRA;CARUSO ML;VALENTINI AM;ALDO CAVALLINI;F. PEZZOLLA;MICHELE LINSALATA;DOMENICA LORUSSO;M. CORREALE;MARIA LUCIA CARUSO;CATERINA MESSA;FRANCESCO RUSSO;I. DEMMA;MARIA NOTARNICOLA;ROSA ANGELA CARDONE;M PIRRELLI;RAFFAELE ARMENTANO","697;253;81;75;75;60;60;56;53;39;36;24;24;23;23;17;17;17;14;14","GIOACCHINO LEANDRO;ALBERTO R. OSELLA;ALDO CAVALLINI;CARUSO ML;F. PEZZOLLA;MICHELE LINSALATA;VALENTINI AM;VITO GUERRA;ANNA MARIA VALENTINI;BRIAN I. CARR;CATERINA MESSA;DOMENICA LORUSSO;FRANCESCO RUSSO;GUERRA;I. DEMMA;M PIRRELLI;M. CORREALE;MARIA LUCIA CARUSO;MARIA NOTARNICOLA;PIERO PORCELLI","5;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ENGINEERING;PSYCHOLOGY","17;12;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;GENETICS;PATHOLOGY;CANCER RESEARCH;BIOCHEMISTRY;IMMUNOLOGY;MICROBIOLOGY;VIROLOGY;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;SURGERY;ANESTHESIA;CLINICAL PSYCHOLOGY;ECOLOGY;ENDOCRINOLOGY;OBSTETRICS;ONCOLOGY;PALEONTOLOGY;PSYCHIATRY;PSYCHOTHERAPIST;RADIOLOGY;TRANSPORT ENGINEERING","14;8;5;5;4;3;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARCINOMA;GENE;HELICOBACTER PYLORI;HEPATOCELLULAR CARCINOMA;ANTIBIOTICS;ANTIBODY;CELL;CELL GROWTH;POPULATION;STOMACH;VIRUS;ADENOMA;ANTIGEN;APOPTOSIS;BOTULINUM TOXIN;CELL CULTURE;CIRRHOSIS;COHORT;COHORT STUDY;DISEASE;DNA;DYSPHAGIA;ENZYME;EPIDEMIOLOGY;ESOPHAGUS;ESTROGEN;FECES;GLYCOPROTEIN;GRADING (ENGINEERING);HEPATITIS;HEPATITIS C;HUMAN PAPILLOMAVIRUS;IMMUNOHISTOCHEMISTRY;LESION;LUNG;LYMPH;MALIGNANCY;MALIGNANT TRANSFORMATION;MENTAL HEALTH;NOSOLOGY;ODDS RATIO;POLYAMINE;PREGNANCY;PUBLIC TRANSPORT;RECEPTOR;RISK FACTOR;SEX ORGAN;STAGE (STRATIGRAPHY);TRANSIT TIME","9;4;4;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARCINOGENESIS;COLORECTAL CANCER;GASTRITIS;AMOXICILLIN;METRONIDAZOLE;MUTATION;ACHALASIA;ADENOCARCINOMA;ANTIBIOTIC RESISTANCE;BREAST CANCER;CERVICAL CANCER;CHRONIC HEPATITIS;CLARITHROMYCIN;CONDYLOMA ACUMINATUM;EPIDERMAL GROWTH FACTOR;ESOPHAGEAL DILATATION;GASTRECTOMY;GASTRIC EMPTYING;GASTRIC MUCOSA;GENOTYPE;GROWTH FACTOR;HCCS;HEAT SHOCK PROTEIN;HELICOBACTER;HEPATITIS A VIRUS;HEPATITIS C VIRUS;IMMUNOASSAY;IMMUNOSTAINING;LANSOPRAZOLE;METASTASIS;MONOCLONAL ANTIBODY;P53 PROTEIN;POLYMERASE CHAIN REACTION;PROGRAMMED CELL DEATH;PROSTATE;REFLUX;SEROLOGY;SOMATIZATION;SPERMIDINE;SPERMINE;TRANSIT (SATELLITE);VIRULENCE;WESTERN BLOT","3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE MUTATION;BILE REFLUX;BILLROTH I;BILLROTH II;CAGA;CERVICAL INTRAEPITHELIAL NEOPLASIA;ESTROGEN RECEPTOR;HEPACIVIRUS;INTRAEPITHELIAL NEOPLASIA;RAPID UREASE TEST;SPIRILLACEAE;TINIDAZOLE;TUMOR SUPPRESSOR GENE","2;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;CARCINOMA, HEPATOCELLULAR;COLORECTAL NEOPLASMS;LIVER NEOPLASMS;ADENOCARCINOMA;AGED;HELICOBACTER INFECTIONS;HELICOBACTER PYLORI;AGED, 80 AND OVER;DUODENAL ULCER;LIVER CIRRHOSIS;STOMACH NEOPLASMS;TUMOR SUPPRESSOR PROTEIN P53;GASTRITIS;ALPHA-FETOPROTEINS;AMOXICILLIN","16;14;14;12;11;11;11;10;9;9;8;7;6;6;6;6;6;5;4;4","HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;POLYAMINES AND BIOGENIC AMINES IN BIOLOGY AND HEALTH;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;INTEROCEPTION AND SOMATIC SYMPTOMS;LIPID METABOLISM IN CANCER PATHOGENESIS;MECHANISMS OF ESTROGEN RECEPTOR SIGNALING;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;ROLE OF GALECTINS IN IMMUNITY AND DISEASE","3;2;2;2;2;1;1;1;1;1;1","HEPATOCELLULAR CARCINOMA;ANTIBIOTIC RESISTANCE;APOPTOSIS;BILE REFLUX;BILLROTH I;BILLROTH II;CAGA;CAGA PROTEIN;CANCER;CANCER GENOMICS;CANCER METABOLISM;CANCER THERAPY;CELL CYCLE;COLORECTAL CANCER;CONDYLOMA ACUMINATUM;DIAGNOSTIC CRITERIA;ERYTHROCYTE;ESOPHAGEAL DILATATION;ESTROGEN;GRADING (ENGINEERING)","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HEPATOCELLULAR CARCINOMA;COLORECTAL CANCER;GASTRIC CANCER;HELICOBACTER PYLORI;ACHALASIC PATIENTS;ACTIVE DUODENAL;ANO-GENITAL LESIONS;ANTIBODY RESPONSE;ASSESSING SOMATIZATION;BILLROTH II;BOTULINUM TOXIN;CANCER CELL;CANCER DEVELOPMENT;CANCER PATIENTS;CELL DEATH;CELL LINE;CELLS EXFOLIATED;CHRONIC HEPATITIS;CLINICOPATHOLOGICAL CORRELATION;COHORT STUDY;COLONIC EPITHELIAL;COLORECTAL CARCINOGENESIS;DISORDERS INTEGRATION;DNA EXTRACTED;DOUBLE-BLIND MULTICENTRE;DUODENAL ULCER;DUODENOGASTRIC REFLUX;EPIDERMAL GROWTH;EPITHELIAL CELLS;ERYTHROCYTE POLYAMINES","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LES PRESSURE;SYMPTOM SCORE;ACHALASIC PATIENTS;CHEST PAIN;LIVER-RELATED MORTALITY;MIN RADIONUCLIDE;MONTHS RANGE;RADIONUCLIDE RETENTION;ACETYLCHOLINE RELEASE;ADVERSE EFFECTS;ALTERNATIVE TREATMENT;ATTRACTIVE TREATMENT;BACKGROUND HEPATITIS;BOTULINUM TOXIN;BOTX DECREASED;BOTX INJECTION;BOTX LASTED;BOTX RESULTED;BOTX TREATMENT;CHRONIC LIVER;CLINICAL REMISSION;CLINICAL SCORE;DISEASES CONTRIBUTE;DYSPHAGIA REGURGITATION;ELDERLY PATIENTS;ESOPHAGEAL INJECTION;ESOPHAGEAL MANOMETER;ESOPHAGEAL RADIONUCLIDE;ESOPHAGEAL SPHINCTER;FOLLOW-UP PERIOD","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",2,0.12,7.5,3.25,0,0,0,0,4,0,1,3.25,0,0,0,0,0,0,0,0,0,0,0,16.25,16.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2001,26,7.46153846153846,3.23076923076923,0.30952380952381,0.538461538461538,0.384615384615385,0.0769230769230769,0.192307692307692,0,12,8,3,3,0.46,0.31,0.12,0.12,39.96,0.874576802258117,0.153846153846154,0.615384615384615,NA,0.375094138126867,0.416666666666667,0.314655172413793,0,"ALFREDO DI LEO;MARISA CHILOIRO;GIUSEPPE RIEZZO;NICOLA LAFORGIA;O MONTAGNA;C. TRIPALDI;MATTIA GENTILE;A MAUTONE;VITO GUERRA;FLAVIA INDRIO;GIOACCHINO LEANDRO;P. FIORENTE;EMILIO JIRILLO;ALDO CAVALLINI;FRANCESCO RUSSO;L. CARADONNA;MASSIMO DE CARNE;CATERINA MESSA;A GENTILE;A. FRANCAVILLA","7;7;7;4;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2","ALFREDO DI LEO;MARISA CHILOIRO;GIUSEPPE RIEZZO;MASSIMO DE CARNE;ALDO CAVALLINI;NICOLA LAFORGIA;O MONTAGNA;C. TRIPALDI;A MAUTONE;FLAVIA INDRIO;VITO GUERRA;PIERO PORCELLI;GIOACCHINO LEANDRO;FRANCESCO RUSSO;MATTIA GENTILE;MARIA NOTARNICOLA;EMILIO JIRILLO;L. CARADONNA;P. FIORENTE;ONOFRIO G. MANGHISI","1.07;0.98;0.98;0.67;0.6;0.57;0.57;0.57;0.57;0.57;0.53;0.5;0.49;0.49;0.45;0.38;0.32;0.32;0.32;0.29","ALFREDO DI LEO;MARISA CHILOIRO;GIUSEPPE RIEZZO;NICOLA LAFORGIA;O MONTAGNA;C. TRIPALDI;MATTIA GENTILE;A MAUTONE;VITO GUERRA;FLAVIA INDRIO;GIOACCHINO LEANDRO;P. FIORENTE;EMILIO JIRILLO;ALDO CAVALLINI;FRANCESCO RUSSO;L. CARADONNA;MASSIMO DE CARNE;CATERINA MESSA;A. FRANCAVILLA;FILOMENA CARIOLA","7;7;7;4;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2","ALFREDO DI LEO;MARISA CHILOIRO;GIUSEPPE RIEZZO;MASSIMO DE CARNE;ALDO CAVALLINI;NICOLA LAFORGIA;O MONTAGNA;C. TRIPALDI;A MAUTONE;FLAVIA INDRIO;VITO GUERRA;PIERO PORCELLI;GIOACCHINO LEANDRO;FRANCESCO RUSSO;MATTIA GENTILE;MARIA NOTARNICOLA;EMILIO JIRILLO;L. CARADONNA;P. FIORENTE;ONOFRIO G. MANGHISI","1.07;0.98;0.98;0.67;0.6;0.57;0.57;0.57;0.57;0.57;0.53;0.5;0.49;0.49;0.45;0.38;0.32;0.32;0.32;0.29","GIUSEPPE RIEZZO;MARISA CHILOIRO;CATERINA CLEMENTE;MASSIMO DE CARNE;ALFREDO DI LEO;E PICCIOLI;G DARCONZA;GIOACCHINO LEANDRO;MARIA LUCIA CARUSO;MATTIA GENTILE;EMILIANO GIOSTRA;FRANCESCO NEGRO;LAURA RUBBIA-BRANDT;LAURENT SPAHR;PIERRE‐JEAN G. MALÉ;RAFAEL QUADRI;VITO GUERRA;ANNA MARIA VALENTINI;E. ALTOMARE;FRANCESCO SUSCA","312;312;261;225;219;176;176;172;146;145;133;133;133;133;133;133;109;100;100;100","GIUSEPPE RIEZZO;MARISA CHILOIRO;E PICCIOLI;MASSIMO DE CARNE;ALFREDO DI LEO;GIOACCHINO LEANDRO;MATTIA GENTILE;MARIA LUCIA CARUSO;VITO GUERRA;ANNA MARIA VALENTINI;M PIRRELLI;EMILIO JIRILLO;FRANCESCO RUSSO;CATERINA MESSA;CATERINA CLEMENTE;LUCIA BUONADONNA;L. AMATI;L. CARADONNA;ALBERTO R. OSELLA;A. FRANCAVILLA","312;292;176;176;167;159;145;140;103;100;100;97;97;90;85;85;84;84;83;82","GIUSEPPE RIEZZO;MARISA CHILOIRO;ALFREDO DI LEO;MATTIA GENTILE;FRANCESCO RUSSO;P. FIORENTE;VITO GUERRA;EMILIO JIRILLO;MARIA LUCIA CARUSO;A. FRANCAVILLA;ALBERTO R. OSELLA;ALDO CAVALLINI;CATERINA CLEMENTE;CATERINA MESSA;FILOMENA CARIOLA;GIOACCHINO LEANDRO;L. AMATI;L. CARADONNA;MARIA NOTARNICOLA;ANNA MARIA VALENTINI","7;6;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;ART;ECONOMICS;ENGINEERING;MATHEMATICS;PSYCHOLOGY;SOCIOLOGY","23;16;3;2;1;1;1;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;PATHOLOGY;CANCER RESEARCH;VIROLOGY;ANATOMY;ART HISTORY;ASTROBIOLOGY;CIVIL ENGINEERING;CLINICAL PSYCHOLOGY;DEMOGRAPHY;ENVIRONMENTAL HEALTH;GENERAL SURGERY;GEOMETRY;GERONTOLOGY;INTENSIVE CARE MEDICINE;MACROECONOMICS;MICROBIOLOGY;PEDIATRICS;PHARMACOLOGY;PSYCHIATRY;QUANTUM MECHANICS;STATISTICS;SURGERY","21;15;11;9;5;5;5;4;3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;VIRUS;CANCER;CIRRHOSIS;HELICOBACTER PYLORI;RECEPTOR;STOMACH;CARCINOMA;HEPATITIS C;HEPATOLOGY;PARENTERAL NUTRITION;PREGNANCY;CISAPRIDE;DISEASE;ENZYME;HYDROLYSIS;IMMUNOHISTOCHEMISTRY;INTERFERON;MOTILITY;ODDS RATIO;RANDOMIZED CONTROLLED TRIAL;SECRETION;VOMITING","7;7;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","HEPATITIS C VIRUS;GASTRIC EMPTYING;COLORECTAL CANCER;ALPHA INTERFERON;ENTERAL ADMINISTRATION;GASTRIN;GENOTYPE;GESTATIONAL AGE;HYDROLYSATE;ACETYLCYSTEINE;ALLELE;ALPHA-FETOPROTEIN;BREAST CANCER;CD20;CHOLECYSTOKININ;CHROMOSOME;CHRONIC HEPATITIS;CONSTRUCT VALIDITY;EXON;FATTY LIVER;GASTRITIS;GESTATION;GLUTATHIONE;HELICOBACTER;HELICOBACTER INFECTIONS;HELICOBACTER PYLORI INFECTION;HEPATIC FIBROSIS;HEPATITIS B VIRUS;HUM;IMMUNOSTAINING;IMMUNOTHERAPY;INFLAMMATORY BOWEL DISEASE;INTERLEUKIN;LIPID PEROXIDATION;LIPOPROTEIN;LIVER BIOPSY;LIVER CANCER;MESSENGER RNA;MICRONUCLEUS TEST;MOOD DISORDERS;MUTATION;NUCLEIC ACID SEQUENCE;NUCLEOTIDE;NUTRITIONAL EPIDEMIOLOGY;OPIOID;PEPSIN;PEPTIDE SEQUENCE;PHENOTYPE;PHYLOGENETIC TREE;PHYLOGENETICS;POLYMERASE CHAIN REACTION;PROINFLAMMATORY CYTOKINE;ROTAVIRUS;SEQUENCE ANALYSIS;SIMIAN;SISTER CHROMATID EXCHANGE;SOMATIZATION;TORONTO ALEXITHYMIA SCALE;TRANSPLANT SURGERY;TUMOR MARKER","5;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","(+)-NALOXONE;ADENOMATOUS POLYPOSIS COLI;ALPHA (FINANCE);CHRONIC GASTRITIS;DNA MISMATCH REPAIR;DUCTAL CARCINOMA;FAMILIAL ADENOMATOUS POLYPOSIS;FLAVIVIRIDAE;HEPACIVIRUS;INTERFERON ALFA;LDL RECEPTOR;MICROSATELLITE;MISSENSE MUTATION;RIBAVIRIN;SINGLE-STRAND CONFORMATION POLYMORPHISM;SISTER CHROMATIDS;TBARS;TUMOR ASSOCIATED ANTIGEN","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;HEPATITIS C, CHRONIC;ADULT;MALE;MIDDLE AGED;AGED;HELICOBACTER INFECTIONS;COLORECTAL NEOPLASMS;HELICOBACTER PYLORI;LIVER CIRRHOSIS;DYSPEPSIA;HEPACIVIRUS;RNA, VIRAL;;GASTRIC EMPTYING;INTERFERON-ALPHA;LYMPHOCYTES;POLYMERASE CHAIN REACTION;ADENOCARCINOMA","20;17;16;15;15;14;10;10;9;9;8;7;7;7;5;5;5;5;5;4","HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;HEPATITIS C INFECTION AND TREATMENT;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;MORTALITY AND SEQUELAE OF PRETERM BIRTH;ROLE OF NEUROPEPTIDES IN PHYSIOLOGY AND DISEASE;DEVELOPMENT AND APPLICATIONS OF RADIOPHARMACEUTICALS;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;INTEROCEPTION AND SOMATIC SYMPTOMS;LIPID METABOLISM IN CANCER PATHOGENESIS;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;PHARMACOLOGICAL EFFECTS OF LICORICE ROOTS;PROVISION AND ASSESSMENT OF NUTRITION SUPPORT THERAPY;ROLE OF GALECTINS IN IMMUNITY AND DISEASE;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES","4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1","HEPATITIS C;PRETERM INFANTS;CISAPRIDE;ENTERAL ADMINISTRATION;HELICOBACTER PYLORI;TREATMENT;ADENOMATOUS POLYPOSIS COLI;ALEXITHYMIA;ALPHA (FINANCE);ALPHA-FETOPROTEIN;BREASTFEEDING DURATION;CANCER;CANCER RISK;CHRONIC GASTRITIS;CLINICAL SIGNIFICANCE;COHEN'S KAPPA;COMBINATION THERAPY;CONCORDANCE;DEPRESSION (ECONOMICS);DIET QUALITY","3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ELECTRICAL ACTIVITY;GASTRIC ELECTRICAL;GASTRIC EMPTYING;CHRONIC HEPATITIS;CONTROLLED STUDY;FED STANDARD;FEEDING INTOLERANCE;GASTRIC MOTILITY;HYDROLYSATE FORMULAS;NEWBORNS FED;PRETERM NEWBORNS;RANDOMIZED CONTROLLED;AIGO STUDY;ALPHA INTERFERON;ALT VALUES;ANTI-MELANOMA MONOCLONAL;ANTIBACTERIAL ACTIVITY;APC MUTATIONS;ASSESSING DIETARY;ASYMPTOMATIC SUBJECTS;BOWEL DISEASE;BREAST CANCER;BYIHELICOBACTER PYLORI;CANCER BIOPSIES;CANCER STUDIES;CARCINOMA PATIENTS;CHOLECYSTOKININ ANTAGONISTS;CHROMATID EXCHANGE;CHROMOSOME LOSS;CIRCULATING CYTOKINES","3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","STRAIN RV;AMINO ACID;CANINE STRAINS;HCV RNA;GASTRIC EMPTYING;ADENOMATOUS POLYPS;ALANINE AMINOTRANSFERASE;CD POSITIVE;COMBINATION THERAPY;DISTINCTIVE HISTOPATHOLOGICAL;GASTROINTESTINAL MOTILITY;HEILMANNII GASTRITIS;HYDROLYZED FORMULA;POSITIVE CELLS;PRETERM NEWBORNS;PYLORI GASTRITIS;SERIAL SECTIONS;SIMIAN STRAIN;STRAIN RRV;ACID IDENTITY;ACID SEQUENCE;ACID SUBSTITUTIONS;ACID VARIATIONS;ADDITION STRAIN;ADDITIONAL SERIAL;ADENOMATOUS NA;ADENOMATOUS POLYPOSIS;ADVERSE EFFECTS;AGGREGATEMUCOSAL LYMPHOCYTE;AGGREGATES CHRONIC","5;4;4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1",3,0.12,3,15.5,0,0,0,0,15.5,0,0,15.5,0,0,0,0,0,0,0,0,0,0,0,17,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2002,30,7.5,1.9,0.526315789473684,0.3,0.3,0.133333333333333,0.1,0,9,8,3,7,0.3,0.27,0.1,0.23,48.83,0.885163580517179,0.2,0.766666666666667,NA,0.400000478520249,0.434343434343434,0.421296296296296,0.333333333333333,"MATTIA GENTILE;GIOACCHINO LEANDRO;ALFREDO DI LEO;EMILIO JIRILLO;PAOLO VOLPE;ANGELA TAFARO;VITO GUERRA;MARIA ALTAMURA;ANGELO ANDRIULLI;ANNAMARIA PRATELLI;LETIZIA PASSANTINO;M.C. VALENZANO;ANTONIO GASBARRINI;NICOLA DECARO;P. FIORENTE;ANNA MARIA VALENTINI;MICHELE LINSALATA;VITO MARTELLA;ANGELA BUONADONNA;G CARUSO","8;7;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MATTIA GENTILE;GIOACCHINO LEANDRO;PAOLO VOLPE;ALFREDO DI LEO;EMILIO JIRILLO;M. MARASINI;VITO GUERRA;PIERO PORCELLI;GREGORY J. MEYER;MARIA GABRIELLA CARUSO;G CARUSO;MARIA LUCIA CARUSO;ANGELA TAFARO;MARIA ALTAMURA;MARIA NOTARNICOLA;LETIZIA PASSANTINO;GIUSEPPE PASSANTINO;MICHELE LINSALATA;M.C. VALENZANO;P. FIORENTE","1.33;0.91;0.87;0.8;0.64;0.58;0.53;0.5;0.5;0.42;0.39;0.39;0.39;0.39;0.36;0.31;0.31;0.29;0.27;0.27","MATTIA GENTILE;GIOACCHINO LEANDRO;ALFREDO DI LEO;EMILIO JIRILLO;ANGELA TAFARO;VITO GUERRA;M.C. VALENZANO;P. FIORENTE;ANNA MARIA VALENTINI;MICHELE LINSALATA;ANGELA BUONADONNA;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;MARIA LUCIA CARUSO;ANTONIO DI CARLO;PIERO PORCELLI;G. PIETRO;CATERINA MESSA;M PIRRELLI;A. FRANCAVILLA","8;7;5;5;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1","MATTIA GENTILE;GIOACCHINO LEANDRO;ALFREDO DI LEO;EMILIO JIRILLO;VITO GUERRA;PIERO PORCELLI;GREGORY J. MEYER;MARIA GABRIELLA CARUSO;MARIA LUCIA CARUSO;ANGELA TAFARO;MARIA NOTARNICOLA;MICHELE LINSALATA;M.C. VALENZANO;P. FIORENTE;ANGELA BUONADONNA;ANTONIO DI CARLO;ANNA MARIA VALENTINI;BRIAN I. CARR;ALDO CAVALLINI;FRANCESCO PEZZOLLA","1.33;0.91;0.8;0.64;0.53;0.5;0.5;0.42;0.39;0.39;0.36;0.29;0.27;0.27;0.27;0.27;0.25;0.25;0.25;0.25","GIOACCHINO LEANDRO;B. COCO;FERRUCCIO BONINO;FILIPPO OLIVERI;JULIANA MONTI GORIN;MAURIZIA ROSSANA BRUNETTO;P. COLOMBATTO;MATTIA GENTILE;PAOLO VOLPE;EMILIO JIRILLO;A. D’ARIENZO;A. PRADA;D. VALPIANI;FERNANDO RIZZELLO;FRANCESCO MANGUSO;G. DI MATTEO;G. N. CASTIGLIONE;GUIDO VAROLI;MASSIMO CAMPIERI;PAOLO GIONCHETTI","664;334;334;334;334;334;334;252;170;157;130;130;130;130;130;130;130;130;130;130","GIOACCHINO LEANDRO;MATTIA GENTILE;G. DI MATTEO;ANGELA TAFARO;BRIAN I. CARR;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;GREGORY J. MEYER;PIERO PORCELLI;VITO GUERRA;ANGELA BUONADONNA;ANTONIO DI CARLO;M.C. VALENZANO;P. NANNA;BENEDETTA D’ATTOMA;ALDO CAVALLINI;ALFREDO DI LEO;P. FIORENTE;MARIA LUCIA CARUSO;EMILIO JIRILLO","664;223;130;106;95;80;54;52;52;46;45;45;45;45;43;37;37;35;34;32","GIOACCHINO LEANDRO;MATTIA GENTILE;MARIA LUCIA CARUSO;ANGELA TAFARO;ANNA MARIA VALENTINI;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;VITO GUERRA;A. FRANCAVILLA;ALDO CAVALLINI;ALFREDO DI LEO;ANGELA BUONADONNA;ANTONIO DI CARLO;BENEDETTA D’ATTOMA;BRIAN I. CARR;CATERINA MESSA;EMILIO JIRILLO;ERNESTO PICCIGALLO;ETTORE CAROPPO;FRANCESCO PEZZOLLA","7;6;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ART;COMPUTER SCIENCE;PSYCHOLOGY","23;16;8;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;BIOCHEMISTRY;GENETICS;PATHOLOGY;IMMUNOLOGY;ENDOCRINOLOGY;ANATOMY;CANCER RESEARCH;ONCOLOGY;RADIOLOGY;SURGERY;CARDIOLOGY;FISHERY;MICROBIOLOGY;MOLECULAR BIOLOGY;PEDIATRICS;VIROLOGY;ANESTHESIA;BIOINFORMATICS;CLINICAL PSYCHOLOGY;DEVELOPMENTAL PSYCHOLOGY;ECOLOGY;LITERATURE;ORGANIC CHEMISTRY;PROGRAMMING LANGUAGE;PSYCHIATRY;SOCIAL PSYCHOLOGY;UROLOGY;ZOOLOGY","21;13;9;9;9;8;5;3;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","GENE;VIRUS;CANCER;CIRRHOSIS;DISEASE;INTERFERON;PREGNANCY;CARCINOMA;ENZYME;IN VITRO;PHAGOCYTOSIS;AORTA;APOPTOSIS;BILE ACID;BIOPSY;CELL GROWTH;FISH <ACTINOPTERYGII>;HEPATITIS B;HEPATOCELLULAR CARCINOMA;HEPATOLOGY;MEMBRANE;POLYAMINE;RECEPTOR;REGIMEN","7;6;5;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","CHRONIC HEPATITIS;COLORECTAL CANCER;FETUS;ALPHA INTERFERON;AORTIC ARCH;CHROMOSOME;RAINBOW TROUT;REFLUX;SALMO;SPERMINE;TROUT;ACHALASIA;ADENOCARCINOMA;AGAROSE GEL ELECTROPHORESIS;ALAGILLE SYNDROME;ALLELE;BASAL (MEDICINE);BRAN;CALICIVIRUS;CAPSID;CELL CYCLE;CHROMOSOMAL TRANSLOCATION;COELIAC DISEASE;COLORECTAL SURGERY;CONSTRUCT VALIDITY;CORPUS CALLOSUM AGENESIS;CYTOTOXICITY;DEOXYCHOLIC ACID;EPIGASTRIC PAIN;FELINE CALICIVIRUS;GASTRIC ACID;GASTRIC MUCOSA;GENOTYPE;GERMLINE;GLUTEN FREE;HEART DEFECT;HEPATITIS B VIRUS;HEPATITIS C VIRUS;HEPATOCYTE;IMMUNOSTAINING;INFERTILITY;INNATE IMMUNE SYSTEM;INTENTION-TO-TREAT ANALYSIS;ION TRANSPORTER;LIPOPROTEIN;LIVER TRANSPLANTATION;MUTATION;NEURAL CREST;PANCREATIC CANCER;PANCREATICODUODENECTOMY;PARVOVIRUS;PHENOTYPE;PHOSPHOLIPID;PHYLOGENETIC TREE;PLACEBO;PROGRAMMED CELL DEATH;PROLIFERATING CELL NUCLEAR ANTIGEN;PUTRESCINE;REDUCTASE;RESPIRATORY DISEASE;SEQUENCE ANALYSIS;SPERMIDINE;TAUROCHOLIC ACID;TEST VALIDITY;TORONTO ALEXITHYMIA SCALE;ULCERATIVE COLITIS;UMBILICAL VEIN;UNFOLDED PROTEIN RESPONSE;VIRAL DISEASE;WNT SIGNALING PATHWAY","3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;INTERRUPTED AORTIC ARCH;KARYOTYPE;ADENOMATOUS POLYPOSIS COLI;AZOOSPERMIA;BECLOMETASONE DIPROPIONATE;BETA-CATENIN;BILIARY ATRESIA;BREAKPOINT;CALICIVIRIDAE;CENTROMERE;COLORECTAL ADENOMA;CYTOGENETICS;CYTOLYSIS;DNA FRAGMENTATION;DNA MISMATCH REPAIR;DUCTUS VENOSUS;ESOPHAGEAL SPHINCTER;ESOPHAGITIS;FAMILIAL ADENOMATOUS POLYPOSIS;FULMINANT HEPATIC FAILURE;GERD;GERMLINE MUTATION;HBSAG;HEARTBURN;HIATAL HERNIA;INTERFERON ALFA;LAMIVUDINE;LDL RECEPTOR;MICROSATELLITE;PANCREATIC TUMOR;PHOSPHATIDYLSERINE;REFLUX ESOPHAGITIS;RIBAVIRIN;SINGLE UMBILICAL ARTERY;TAUROURSODEOXYCHOLIC ACID;TRANSEPITHELIAL POTENTIAL DIFFERENCE","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ADULT;MALE;AGED;COLONIC NEOPLASMS;MIDDLE AGED;ABNORMALITIES, MULTIPLE;ANTIVIRAL AGENTS;AGED, 80 AND OVER;ANIMALS;CARCINOMA, HEPATOCELLULAR;DOG DISEASES;FETAL DISEASES;HEPATITIS B, CHRONIC;LIVER CIRRHOSIS;LIVER NEOPLASMS;TREATMENT OUTCOME;APOPTOSIS;BILE ACIDS AND SALTS","23;22;17;17;9;9;9;7;7;6;6;6;6;6;6;6;6;6;5;5","DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATITIS B INFECTION AND TREATMENT;IMMUNOLOGICAL RESPONSES IN AQUATIC ORGANISMS;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;POLYAMINES AND BIOGENIC AMINES IN BIOLOGY AND HEALTH;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;ETIOLOGY AND MANAGEMENT OF ABDOMINAL WALL DEFECTS;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;GENE THERAPY TECHNIQUES AND APPLICATIONS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;LIPID METABOLISM IN CANCER PATHOGENESIS;LIVER TRANSPLANTATION AND GRAFT SURVIVAL ANALYSIS;PANCREATIC CANCER RESEARCH AND TREATMENT","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","TREATMENT;FISH IMMUNOLOGY;HEPATITIS B;HEPATOCELLULAR CARCINOMA;INTERRUPTED AORTIC ARCH;LIVER BIOPSY;POLYAMINE;POLYAMINES;REGIMEN;ADENOMATOUS POLYPOSIS COLI;AGAROSE GEL ELECTROPHORESIS;AGENESIS;ALAGILLE SYNDROME;BASAL (MEDICINE);BECLOMETASONE DIPROPIONATE;BETA-CATENIN;BILE ACIDS;BLOOD COUNT;BLOOD TEST;BREAKPOINT","4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CHRONIC HEPATITIS;ANTI-HBE POSITIVE;AORTIC ARCH;CYTOGENETIC CHARACTERIZATION;FISH IMMUNOLOGY;HEPATOCELLULAR CARCINOMA;POSITIVE CHRONIC;PRENATAL DIAGNOSIS;RAINBOW TROUT;ACHALASIA PATIENTS;ACID REDUCES;ACTIVE ULCERATIVE;AGS CELL;ALBICANSIBY ERYTHROCYTES;ALPHA-INTERFERON TREATED;ALTERNATE CENTROMERE;ARCH TYPE;AZOOSPERMIC MALE;BECLOMETASONE DIPROPIONATE;BETA-CATENIN PROTEINS;BETA-ESTRADIOL ADMINISTRATION;BILE SALTS;BOTULINUM TOXIN;BOWEL SYNDROME;BRAN DIET;CALICIVIRUS ISOLATED;CANINE PARVOVIRUS;CAPSID PROTEIN;CELL LINE;CELL PROLIFERATION","3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACTIVE ULCERATIVE;ULCERATIVE COLITIS;YA TRANSLOCATIONS;ORAL ASA;TRANSLOCATION CHROMOSOME;ABNORMAL EMBRYOS;ACTIVITY INDEX;ACUTE ASSIGNMENT;ADAPTED EMOTIONAL;ADAPTIVE RESOURCES;ADDITION SEX;ADVERSE EVENTS;AFFECT ADAPTIVE;ALEXITHYMIA SCALE;ALEXITHYMIC SUBJECTS;ALLOWED ACUTE;ANALYSIS ALLOWED;ANALYSIS FANTASY;ASA GDAY;AZF GENE;AZOOSPERMIC PATIENT;BACKGROUND Y-AUTOSOME;BDP MGDAY;BECLOMETASONE DIPROPIONATE;BOWEL DISEASE;CELLS FISH;CENTROMERE DYZ;CHROMOSOMALLY ABNORMAL;CHROMOSOME CONFIRMING;CHROMOSOME MOLECULAR","3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",4,0.13,8.5,3,0,0,0,1,1,0,1.5,5.25,0,0,1,0,3,0,0,1,0,0,0,68,68,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2003,32,7.78125,2.65625,0.376470588235294,0.3125,0.375,0.125,0.1875,1,14,10,3,3,0.44,0.31,0.09,0.09,57.75,1.09110692338705,0.28125,0.84375,NA,0.427513431422695,0.222222222222222,0.425396825396825,0.25,"MATTIA GENTILE;GIOACCHINO LEANDRO;MARIA LUCIA CARUSO;ALFREDO DI LEO;VITO GUERRA;PALMA AURELIA IACOVAZZI;GIOVANNI MISCIAGNA;M. CORREALE;ANNA MARIA VALENTINI;ANDREA MARZULLO;VITO MARTELLA;G CARUSO;CANIO BUONAVOGLIA;FRANCESCO RUSSO;PAOLO VOLPE;FRANCESCO SPORTELLI;P.B. BERLOCO;M. CRISTINA DIGILIO;ANGELO ANDRIULLI;ANNAMARIA PRATELLI","9;8;6;5;5;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","GIOACCHINO LEANDRO;MATTIA GENTILE;GIANCARLO PARISI;MARIA LUCIA CARUSO;VITO GUERRA;ALFREDO DI LEO;PAOLO VOLPE;PALMA AURELIA IACOVAZZI;M. CORREALE;GIOVANNI MISCIAGNA;D. PALADINI;ANNA MARIA VALENTINI;FRANCESCO SPORTELLI;JO L. FREUDENHEIM;ANNA MARIA CISTERNINO;ONOFRIO G. MANGHISI;FRANCESCO RUSSO;S. ELBA;GIAMPIETRO DE MICHELE;ANGELO ANDRIULLI","1.13;1.11;1.09;0.8;0.79;0.62;0.56;0.5;0.5;0.46;0.45;0.44;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.31","MATTIA GENTILE;GIOACCHINO LEANDRO;MARIA LUCIA CARUSO;ALFREDO DI LEO;VITO GUERRA;PALMA AURELIA IACOVAZZI;GIOVANNI MISCIAGNA;M. CORREALE;ANNA MARIA VALENTINI;FRANCESCO RUSSO;FRANCESCO SPORTELLI;P.B. BERLOCO;LUCIA BONADONNA;P. FIORENTE;ANNA MARIA CISTERNINO;ONOFRIO G. MANGHISI;GIANCARLO PARISI;S. ELBA;GIAMPIETRO DE MICHELE;PIERO PORCELLI","9;8;6;5;5;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1","GIOACCHINO LEANDRO;MATTIA GENTILE;GIANCARLO PARISI;MARIA LUCIA CARUSO;VITO GUERRA;ALFREDO DI LEO;PALMA AURELIA IACOVAZZI;M. CORREALE;GIOVANNI MISCIAGNA;ANNA MARIA VALENTINI;FRANCESCO SPORTELLI;ANNA MARIA CISTERNINO;ONOFRIO G. MANGHISI;FRANCESCO RUSSO;S. ELBA;GIAMPIETRO DE MICHELE;P. FIORENTE;P.B. BERLOCO;M PIRRELLI;RAFFAELE ARMENTANO","1.13;1.11;1.09;0.8;0.79;0.62;0.5;0.5;0.46;0.44;0.33;0.33;0.33;0.33;0.33;0.33;0.31;0.22;0.2;0.2","GIOACCHINO LEANDRO;AURELIO SONZOGNI;GUIDO COLLOREDO;MARIA GUIDO;MATTIA GENTILE;CANIO BUONAVOGLIA;VITO MARTELLA;ALFREDO DI LEO;ALESSANDRA CAVALLI;ANNAMARIA PRATELLI;GABRIELLA ELIA;GRAZIA GRECO;MARIA TEMPESTA;NICOLA DECARO;VITO GUERRA;P. FIORENTE;FRANCESCO RUSSO;ANTONELLA TINELLI;DOMENICO BUONAVOGLIA;FRANCESCO CIRONE","1117;856;856;856;318;197;197;174;154;154;154;154;154;154;130;121;120;105;105;105","GIOACCHINO LEANDRO;MATTIA GENTILE;P. FIORENTE;ALFREDO DI LEO;FRANCESCO RUSSO;VITO GUERRA;GIOVANNI MISCIAGNA;MARIA LUCIA CARUSO;ANNA MARIA CISTERNINO;GIAMPIETRO DE MICHELE;ANTONIA LUCIA BUONADONNA;CATERINA MESSA;MICHELE CORREALE;VITO GIANNUZZI;ANNA MARIA VALENTINI;P.B. BERLOCO;M. CORREALE;A. FRANCAVILLA;ONOFRIO G. MANGHISI;S. ELBA","1117;318;121;120;120;114;95;88;73;73;71;67;67;67;56;53;46;43;35;35","MATTIA GENTILE;GIOACCHINO LEANDRO;MARIA LUCIA CARUSO;VITO GUERRA;ALFREDO DI LEO;ANNA MARIA VALENTINI;FRANCESCO RUSSO;GIOVANNI MISCIAGNA;M. CORREALE;ANNA MARIA CISTERNINO;GIAMPIETRO DE MICHELE;LUCIA BONADONNA;ONOFRIO G. MANGHISI;P. FIORENTE;P.B. BERLOCO;PALMA AURELIA IACOVAZZI;S. ELBA;A. FRANCAVILLA;ANTONIA LUCIA BUONADONNA;CATERINA MESSA","9;8;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;GEOLOGY;HISTORY","31;17;3;2;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;PATHOLOGY;GENETICS;BIOCHEMISTRY;ENDOCRINOLOGY;RADIOLOGY;MICROBIOLOGY;VIROLOGY;ANATOMY;CANCER RESEARCH;CARDIOLOGY;CELL BIOLOGY;ECOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;INTENSIVE CARE MEDICINE;PSYCHIATRY;SURGERY;ZOOLOGY","25;14;11;10;6;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2","GENE;DISEASE;HELICOBACTER PYLORI;CANCER;PREGNANCY;HEPATOCELLULAR CARCINOMA;INSULIN;VIRUS;ABNORMALITY;ADENOMA;ANTIBIOTICS;CARCINOMA;DIABETES MELLITUS;DIGEORGE SYNDROME;DOSE;ENZYME;HEPATITIS;HEPATOBLASTOMA;HEPATOLOGY;MITOCHONDRION;PATHOLOGICAL;POPULATION;RENAL CELL CARCINOMA;SEROTYPE;SURVIVAL RATE","7;6;6;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BREATH TEST;COLORECTAL CANCER;FETUS;CHROMOSOME;CLARITHROMYCIN;FRUCTOSAMINE;GESTATIONAL AGE;HELICOBACTER PYLORI INFECTION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);ROTAVIRUS;2019-20 CORONAVIRUS OUTBREAK;ACUTE DIARRHEA;ACUTE HEPATITIS;ADENOCARCINOMA;AMOXICILLIN;ANTRUM;AORTIC ARCH;BASAL (MEDICINE);CARCINOGENESIS;CELL CYCLE;CHROMOSOMAL TRANSLOCATION;CHRONIC HEPATITIS;COLOSTRUM;CONGENITAL MALFORMATIONS;CYTOCHROME C OXIDASE;CYTOSOL;ENDOTHELIN 1;ENDOTHELIN RECEPTOR;EPIGASTRIC PAIN;GASTRIC CONTENT;GASTRIC MUCOSA;GASTRITIS;GENETIC DIVERSITY;GENOTYPE;GLUTATHIONE;GLYCATION;HEPATECTOMY;HUMAN CHORIONIC GONADOTROPIN;INFERTILITY;LANSOPRAZOLE;LIVER BIOPSY;LIVER REGENERATION;METHIONINE;METRONIDAZOLE;MUTATION;MYIASIS;OCTREOTIDE;ORGANIC DISEASE;ORNITHINE DECARBOXYLASE;PHYLOGENETIC TREE;PHYLOGENETICS;PLACEBO;POSTPRANDIAL;RABEPRAZOLE;SMALL INTESTINAL BACTERIAL OVERGROWTH;SPERM MOTILITY;SUBARACHNOID SPACE;SUBFAMILY;TOLERABILITY;TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION;TUMOR MARKER;TYPE 2 DIABETES;VIRULENCE;WNT SIGNALING PATHWAY","3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COMPARATIVE GENOMIC HYBRIDIZATION;CORONAVIRUS DISEASE 2019 (COVID-19);REOVIRIDAE;ATROPHIC GASTRITIS;AZOOSPERMIA;BETA-CATENIN;CAGA;CATENIN;COLONOSCOPY;COLORECTAL ADENOMA;CYTOCHROME B;GLYCATED HEMOGLOBIN;MALE INFERTILITY;ONCOGENE;RAPID UREASE TEST;SEMEN ANALYSIS;SINGLE-STRAND CONFORMATION POLYMORPHISM;TINIDAZOLE;UREA BREATH TEST;VENTRICULOMEGALY","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;HELICOBACTER INFECTIONS;ADULT;AGED;COLORECTAL NEOPLASMS;DYSPEPSIA;HEART DEFECTS, CONGENITAL;HELICOBACTER PYLORI;TUMOR SUPPRESSOR PROTEIN P53;;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;POLYMERASE CHAIN REACTION;DIARRHEA;ABNORMALITIES, MULTIPLE;ANIMALS;BACTERIAL PROTEINS","22;18;15;13;12;11;10;10;8;8;8;8;7;7;7;7;6;5;5;5","HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;ROLE OF GALECTINS IN IMMUNITY AND DISEASE;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;EFFECTS OF KETOGENIC DIET ON HEALTH;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;FORENSIC ENTOMOLOGY AND DECOMPOSITION SCIENCE;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;IMPACT OF FRUCTOSE ON METABOLIC HEALTH;INFANT CRYING AND COLIC STUDIES;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;MALE REPRODUCTIVE HEALTH;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;ROLE OF NITRIC OXIDE IN HEALTH AND DISEASE;THERAPEUTIC APPLICATIONS OF CLAY MINERALS IN HEALTH","5;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;ABNORMALITY;COMPARATIVE GENOMIC HYBRIDIZATION;CONGENITAL HEART DEFECTS;DIGEORGE SYNDROME;DOSE;ERADICATION THERAPY;FRUCTOSAMINE;FRUCTOSE;GENOTYPING;GLUCOSE METABOLISM;HEPATOBLASTOMA;TREATMENT;2019-20 CORONAVIRUS OUTBREAK;ACUTE DIARRHEA;ACUTE HEPATITIS;ATROPHIC GASTRITIS;BACTERIAL COMMUNITY SUCCESSION;BACTERIAL OVERGROWTH;BASAL (MEDICINE)","3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","HELICOBACTER PYLORI;ERADICATION THERAPY;HCC PATIENTS;KMAC-BP SERUM;LEVELS CORRELATED;MULTICENTRIC STUDY;NEOPLASTIC DISEASE;PATIENTS PRELIMINARY;POOR PROGNOSIS;PRELIMINARY RESULTS;SERUM LEVELS;VP VP;ABSENT PULMONARY;ACUTE HEPATITIS;ADDITIONAL ULTRASOUND;ANTIPROTEASIC DRUGS;AORTIC ARCH;ARCH IMPACT;ARTERIAL CHEMOEMBOLIZATION;BACTERIAL OVERGROWTH;BIOPSY SIZE;BORDERLINE VENTRICULOMEGALY;BOWEL SYNDROME;BREAST MILK;BREATH TEST;BUFFALO ROTAVIRUS;C-METHIONINE BREATH;CANCER PROGRESSION;CANINE CORONAVIRUS;CAUSING OBLIGATE","3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SUBARACHNOID SPACES;SERUM LEVELS;ACID IDENTITY;AMINO ACID;BORDERLINE VENTRICULOMEGALY;STRAIN ELMO;BENIGN EXTERNAL;CCOV STRAINS;EXTERNAL HYDROCEPHALUS;HEPATOCELLULAR CARCINOMA;LYMPHO-EPITHELIAL LESIONS;MILD ENLARGEMENT;REFERENCE CCOV;ROTAVIRUS STRAIN;ROTAVIRUS STRAINS;THERAPEUTIC OUTCOME;VENTRICULAR DILATATION;VP GENE;VP SPECIFICITY;ABNORMAL SIGNAL;ACCOUNT AGE;ACUTE DIARRHEA;ADDITIONAL EVIDENCE;AFP LEVELS;AFP SERUM;AGE SEX;ANALOGOUS CCOVS;ANALYSIS BASED;ANATOMY SCAN;ANDOR CARDIAC","5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1",6,0.19,5.38,2,0,0,0,0,1,0,1.5,2,1,0,1,0,0,0,0,1,0,0,0,57.75,57.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2004,25,7.68,2.12,0.471698113207547,0.44,0.4,0.16,0.32,3,13,10,0,2,0.52,0.4,0,0.08,54.36,1.1552779153869,0.28,0.8,NA,0.477027192790587,0.304761904761905,0.340909090909091,0.285714285714286,"GIOACCHINO LEANDRO;PIERO PORCELLI;ENZO IERARDI;ALFREDO DI LEO;A. FRANCAVILLA;MATTIA GENTILE;P.B. BERLOCO;FRANCESCO RUSSO;MASSIMO DE CARNE;ALESSANDRA MANGIA;ANGELO ANDRIULLI;ORLANDO TODARELLO;MICHELE LINSALATA;ANGELA BUONADONNA;M. BARONE;G CARUSO;VITO GUERRA;LAURA RUBBIA‐BRANDT;D. PALADINI;PAOLO VOLPE","6;4;4;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2","PIERO PORCELLI;RAFFAELE COZZOLONGO;GIOACCHINO LEANDRO;MASSIMO DE CARNE;ORLANDO TODARELLO;MATTIA GENTILE;ALFREDO DI LEO;A. FRANCAVILLA;ENZO IERARDI;FRANCESCO RUSSO;P. MARINO;PASQUALE MAIELLARO;VITO GUERRA;MICHELE LINSALATA;P.B. BERLOCO;G CARUSO;D. PALADINI;PAOLO VOLPE;M. MARASINI;ANGELA BUONADONNA","2.5;1.33;0.59;0.5;0.5;0.44;0.44;0.43;0.39;0.34;0.33;0.33;0.29;0.28;0.27;0.27;0.27;0.27;0.27;0.21","GIOACCHINO LEANDRO;PIERO PORCELLI;ALFREDO DI LEO;A. FRANCAVILLA;MATTIA GENTILE;P.B. BERLOCO;FRANCESCO RUSSO;MASSIMO DE CARNE;MICHELE LINSALATA;ANGELA BUONADONNA;VITO GUERRA;RAFFAELE COZZOLONGO;MASSIMO MANNO;P. MARINO;FILOMENA CARIOLA;MASSIMO BERTOLI;A. L. PIEPOLI;DOMENICO CARONE;BRIAN I. CARR;PAOLO EMANUELE LEVI-SETTI","6;4;4;4;4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1","PIERO PORCELLI;RAFFAELE COZZOLONGO;GIOACCHINO LEANDRO;MASSIMO DE CARNE;MATTIA GENTILE;ALFREDO DI LEO;A. FRANCAVILLA;FRANCESCO RUSSO;P. MARINO;PASQUALE MAIELLARO;VITO GUERRA;MICHELE LINSALATA;P.B. BERLOCO;ANGELA BUONADONNA;BRIAN I. CARR;MASSIMO MANNO;MASSIMO BERTOLI;DOMENICO CARONE;PAOLO EMANUELE LEVI-SETTI;MARIA GABRIELLA CARUSO","2.5;1.33;0.59;0.5;0.44;0.44;0.43;0.34;0.33;0.33;0.29;0.28;0.27;0.21;0.2;0.17;0.17;0.17;0.17;0.17","GIOACCHINO LEANDRO;LAURA RUBBIA‐BRANDT;ANTONINA SMEDILE;ANTONIO CARLOTTO;EMILIANO GIOSTRA;F. NEGRO;L. BOZZOLA;MALÈ PJ;PAOLO FABRIS;S. PAGANIN;MATTIA GENTILE;ENZO IERARDI;ALFREDO DI LEO;FRANCESCO RUSSO;A. FRANCAVILLA;P.B. BERLOCO;A MUZZI;A. HADENGUE;BEAT HELBLING;J. J. GONVERS","557;457;291;291;291;291;291;291;291;291;254;237;229;219;218;213;166;166;166;166","GIOACCHINO LEANDRO;MATTIA GENTILE;PIERO PORCELLI;FRANCESCO RUSSO;P.B. BERLOCO;MASSIMO DE CARNE;MICHELE LINSALATA;A. FRANCAVILLA;GIOVANNI DI MATTEO;ANGELA BUONADONNA;VITO GUERRA;P. MARINO;PASQUALE MAIELLARO;RAFFAELE COZZOLONGO;A. L. PIEPOLI;DOMENICA LORUSSO;F. PEZZOLLA;I. DEMMA;M.A. MASELLI;MICHELE CARUSO","557;254;144;128;122;107;107;96;91;89;52;40;40;40;36;36;36;36;36;36","GIOACCHINO LEANDRO;MATTIA GENTILE;PIERO PORCELLI;A. FRANCAVILLA;ANGELA BUONADONNA;FRANCESCO RUSSO;MASSIMO DE CARNE;MICHELE LINSALATA;P.B. BERLOCO;RAFFAELE COZZOLONGO;VITO GUERRA;A. L. PIEPOLI;ADOLFO ALLEGRA;ALFREDO DI LEO;ANNA MARIA VALENTINI;ANTONIO DI CARLO;BRIAN I. CARR;DOMENICA LORUSSO;DOMENICO CARONE;F. PEZZOLLA","6;4;4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY","23;13;2;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;GENETICS;BIOCHEMISTRY;IMMUNOLOGY;PSYCHIATRY;SURGERY;ENDOCRINOLOGY;CLINICAL PSYCHOLOGY;MICROBIOLOGY;MOLECULAR BIOLOGY;BIOTECHNOLOGY;CANCER RESEARCH;CARDIOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;OBSTETRICS;VIROLOGY;ARTIFICIAL INTELLIGENCE;BOTANY;CELL BIOLOGY;GYNECOLOGY;NURSING;PATHOLOGY;PEDIATRICS;PHARMACOLOGY;RADIOLOGY","18;10;7;6;5;5;5;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","GENE;ALEXITHYMIA;HELICOBACTER PYLORI;HEPATITIS C;PREGNANCY;VIRUS;ANXIETY;DISEASE;FIBROSIS;AMINO ACID;ANTIBIOTICS;CANCER;CONFIDENCE INTERVAL;ENZYME;IN VIVO;IRRITABLE BOWEL SYNDROME;POLYAMINE;POPULATION;RECEPTOR;STEATOSIS","5;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2","FETUS;MUTATION;SOMATIZATION;ARGININE;CHRONIC HEPATITIS;COLORECTAL CANCER;FATTY LIVER;GESTATIONAL AGE;ORNITHINE DECARBOXYLASE;ALPHA INTERFERON;AMOXICILLIN;AORTIC ARCH;BACTEREMIA;BIOSYNTHESIS;BLOOD CULTURE;CARBACHOL;CARCINOGENESIS;CHROMOSOME;CLARITHROMYCIN;DNA SYNTHESIS;ESOPHAGOGASTRODUODENOSCOPY;FUNGEMIA;GASTRIC MUCOSA;GENE DUPLICATION;GENOTYPE;GERMLINE;HELICOBACTER INFECTIONS;HELICOBACTER PYLORI INFECTION;HEPATECTOMY;HEPATITIS C VIRUS;HUMAN CYTOMEGALOVIRUS;INFERTILITY;INFLAMMATORY BOWEL DISEASE;INSULIN RESISTANCE;LACTIC ACID;LIVER BIOPSY;LIVER REGENERATION;LOW DOSE ASPIRIN;MAPK/ERK PATHWAY;METRONIDAZOLE;MULTICENTER STUDY;NOCICEPTION;PEPTIC;PHENOTYPE;PHOSPHATASE;PUTRESCINE;RABEPRAZOLE;SIGMOID COLON;SPERMIDINE;SPERMINE;TAUROCHOLIC ACID;TELANGIECTASES;TETRALOGY OF FALLOT;TORONTO ALEXITHYMIA SCALE;VIRAL DISEASE;VIRULENCE","3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","RIBAVIRIN;ORNITHINE;PRENATAL DIAGNOSIS;ADENOMATOUS POLYPOSIS COLI;ARGININE DEIMINASE;CAGA;CAMPYLOBACTER FETUS;COLORECTAL ADENOMA;DOUBLE AORTIC ARCH;GANCICLOVIR;GENE MUTATION;GERMLINE MUTATION;HERPESVIRIDAE;KARYOTYPE;LACTOBACILLUS PLANTARUM;MISSENSE MUTATION;NEOPLASTIC TRANSFORMATION;OPPORTUNISTIC INFECTION;POINT MUTATION;PROBAND;SINGLE-STRAND CONFORMATION POLYMORPHISM;TINIDAZOLE;VISCERAL PAIN","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;HEPATITIS C, CHRONIC;MIDDLE AGED;HELICOBACTER INFECTIONS;AGED;RIBAVIRIN;GASTROINTESTINAL DISEASES;HELICOBACTER PYLORI;PEPTIC ULCER;ANTIVIRAL AGENTS;COLORECTAL NEOPLASMS;DNA;INTERFERON-ALPHA;LIVER;OMEPRAZOLE;PSYCHOPHYSIOLOGIC DISORDERS;BENZIMIDAZOLES","19;18;16;15;14;14;13;11;8;7;7;7;6;6;6;6;6;6;6;5","HEPATITIS C INFECTION AND TREATMENT;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;INTEROCEPTION AND SOMATIC SYMPTOMS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;POLYAMINES AND BIOGENIC AMINES IN BIOLOGY AND HEALTH;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GLOBAL TRENDS IN INFERTILITY AND REPRODUCTIVE TECHNOLOGIES;MECHANISMS AND TREATMENT OF LIVER FIBROSIS;MECHANISMS OF MULTIDRUG RESISTANCE IN CANCER;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;ROLE OF NEUROPEPTIDES IN PHYSIOLOGY AND DISEASE","4;3;3;2;2;2;1;1;1;1;1;1;1;1;1","TREATMENT;HEPATITIS C;HEPATIC STEATOSIS;INTESTINAL PERMEABILITY;POLYAMINE;PRENATAL DIAGNOSIS;ADENOMATOUS POLYPOSIS COLI;ALANINE AMINOTRANSFERASE;ALCOHOL ABUSE;ALEXITHYMIA;ANTIVIRAL THERAPY;ARGININE DEIMINASE;BACTEREMIA;BILE ACIDS;BIOPSYCHOSOCIAL MODEL;BLOOD CULTURE;CAGA;CAMPYLOBACTER FETUS;CAPSULE;CHOLANGIOCYTE","4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CHRONIC HEPATITIS;FUNCTIONAL GASTROINTESTINAL;GASTROINTESTINAL DISORDERS;ABSENT PULMONARY;ADENOMATOUS POLYPOSIS;AFFECTS CHRONIC;ALANINE AMINOTRANSFERASE;ANTAGONIST SR;ANTICANCER COMPOUND;AORTIC ARCH;ARTIFICIAL NEURAL;BILE-DUCT CELL;BILE-DUCT LIGATION;BOWEL SYNDROME;CAMPYLOBACTER FETUS;CAPSULE-ENDOSCOPIC STUDY;CELL PROLIFERATIVE;CHARACTERISTICS ASSOCIATIONS;CLINICAL CYTOGENETIC;CLINICAL USEFULNESS;COLON EFFECT;COLONIC SMOOTH;COLORECTAL ADENOMAS;COLORECTAL CARCINOMA;COMBINATION THERAPY;CONTROLLED OPENLABELLED;COUPLES QUALITY;DE NOVO;DECARBOXYLASE ACTIVITY;DELGGA GERMLINE","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CHRONIC HEPATITIS;FERTILIZATION ATTEMPTS;MALE POPULATION;VITRO FERTILIZATION;HOMA SCORE;AORTIC ARCH;AGE EDUCATION;ALCOHOL ABUSE;INSULIN RESISTANCE;LIMITATIONS DUE;MG BD;PATIENTS INFECTED;PREVIOUS SURGERY;ROLE LIMITATIONS;DNA SYNTHESIS;REGRESSION ANALYSIS;DOUBLE AORTIC;GENOTYPE INFECTED;GENOTYPE NON-;HCV RNA;LIVER STEATOSIS;RNA LEVEL;AD HOC;ANDROLOGICAL SURGERY;ATTEMPTS ASSOCIATIONS;ATTEMPTS PRODUCE;BIALLELIC GERMLINE;BODY PAIN;BP SF;CLINICAL SOCIO","14;9;9;9;8;7;6;6;6;6;6;6;6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3",2,0.08,17.81,4,0,0,0,2,0,0,1,4,0,0,1,1,1,0,0,1,0,0,0,36.5,36.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2005,30,7.06666666666667,2.76666666666667,0.36144578313253,0.466666666666667,0.633333333333333,0.0333333333333333,0.133333333333333,0,13,4,5,8,0.43,0.13,0.17,0.27,35.53,0.671152830547897,0.2,0.666666666666667,NA,0.403441525798876,0.224358974358974,0.310810810810811,0,"GIOACCHINO LEANDRO;GIUSEPPE D’AMATO;MARIA NOTARNICOLA;ETTORE CAROPPO;MARIA GABRIELLA CARUSO;DOMENICO CARONE;LUCA MARIA SCHONÄUER;G VIZZIELLO;MATTIA GENTILE;ALDO CAVALLINI;FRANCESCO RUSSO;SEVERINO MONTEMURRO;PIERO PORCELLI;CATERINA MESSA;ANGELO ANDRIULLI;FRANCESCO DI MARIO;FILOMENA CARIOLA;GIULIA MARTINA CAVESTRO;MICHELE LINSALATA;C. TERRIBILE","5;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","MARIA NOTARNICOLA;GIOACCHINO LEANDRO;GIUSEPPE D’AMATO;MARIA GABRIELLA CARUSO;ALDO CAVALLINI;ETTORE CAROPPO;C. TERRIBILE;P. MARIÑO;ROMINA GIANNINI;ANGELO ANDRIULLI;FRANCESCO RUSSO;PIERO PORCELLI;DOMENICO CARONE;LUCA MARIA SCHONÄUER;G VIZZIELLO;CATERINA CLEMENTE;MARIA LUCIA CARUSO;G. D'ELIA;I GIORGIO;M. MATTEO","0.99;0.88;0.87;0.85;0.77;0.71;0.67;0.67;0.62;0.61;0.5;0.5;0.46;0.46;0.46;0.39;0.36;0.33;0.33;0.33","GIOACCHINO LEANDRO;GIUSEPPE D’AMATO;MARIA NOTARNICOLA;ETTORE CAROPPO;MARIA GABRIELLA CARUSO;DOMENICO CARONE;LUCA MARIA SCHONÄUER;G VIZZIELLO;MATTIA GENTILE;ALDO CAVALLINI;FRANCESCO RUSSO;PIERO PORCELLI;CATERINA MESSA;FILOMENA CARIOLA;MICHELE LINSALATA;C. TERRIBILE;ROMINA GIANNINI;PANTALEO GRECO;VITO GUERRA;CATERINA CLEMENTE","5;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","MARIA NOTARNICOLA;GIOACCHINO LEANDRO;GIUSEPPE D’AMATO;MARIA GABRIELLA CARUSO;ALDO CAVALLINI;ETTORE CAROPPO;C. TERRIBILE;P. MARIÑO;ROMINA GIANNINI;FRANCESCO RUSSO;PIERO PORCELLI;DOMENICO CARONE;LUCA MARIA SCHONÄUER;G VIZZIELLO;CATERINA CLEMENTE;MARIA LUCIA CARUSO;I GIORGIO;M. MATTEO;MATTIA GENTILE;PANTALEO GRECO","0.99;0.88;0.87;0.85;0.77;0.71;0.67;0.67;0.62;0.5;0.5;0.46;0.46;0.46;0.39;0.36;0.33;0.33;0.33;0.29","MARIA NOTARNICOLA;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;ALDO CAVALLINI;ANNA MARIA MALFITANO;ANTONIETTA SANTORO;CHIARA LAEZZA;CLAUDIA GRIMALDI;GIUSEPPE PORTELLA;IRMA IACUZZO;MARIO VITALE;MAURIZIO BIFULCO;SIMONA PISANTI;VINCENZO DI MARZO;ANDREA BONACCHI;ANTONIO MAZZOCCA;E. ZAMARA;ERICA NOVO;FABIO MARRA;ILARIA PETRAI","346;319;269;167;164;164;164;164;164;164;164;164;164;164;162;162;162;162;162;162","MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;GIOACCHINO LEANDRO;ALDO CAVALLINI;ANTONIO MAZZOCCA;ROMINA GIANNINI;CATERINA MESSA;VITO GUERRA;PIERO PORCELLI;FRANCESCO RUSSO;MICHELE LINSALATA;MATTIA GENTILE;FILOMENA CARIOLA;ANTONIA LUCIA BUONADONNA;ANNA MARIA VALENTINI;MARIA LUCIA CARUSO;CATERINA CLEMENTE;SILVANA LEO;G VIZZIELLO;ANGELA BUONADONNA","301;297;269;167;162;140;76;76;75;63;63;48;39;38;36;36;27;21;11;10","GIOACCHINO LEANDRO;GIUSEPPE D’AMATO;MARIA NOTARNICOLA;G VIZZIELLO;ALDO CAVALLINI;ETTORE CAROPPO;LUCA MARIA SCHONÄUER;MARIA GABRIELLA CARUSO;C. TERRIBILE;CATERINA MESSA;DOMENICO CARONE;FILOMENA CARIOLA;FRANCESCO RUSSO;M. MATTEO;MARIA LUCIA CARUSO;MATTIA GENTILE;MICHELE LINSALATA;P. MARIÑO;PIERO PORCELLI;ROMINA GIANNINI","5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;HISTORY;PHYSICS;PSYCHOLOGY;ART;ECONOMICS","21;16;3;3;2;2;2;1;1","INTERNAL MEDICINE;ENDOCRINOLOGY;GENETICS;BIOCHEMISTRY;CANCER RESEARCH;GASTROENTEROLOGY;IMMUNOLOGY;ANATOMY;ANDROLOGY;CELL BIOLOGY;PATHOLOGY;SURGERY;CLINICAL PSYCHOLOGY;DEVELOPMENTAL PSYCHOLOGY;FAMILY MEDICINE;GENERAL SURGERY;GYNECOLOGY;MOLECULAR BIOLOGY;NURSING;PROGRAMMING LANGUAGE","17;11;10;7;7;7;4;3;3;3;3;3;2;2;2;2;2;2;2;2","APOPTOSIS;CANCER;GENE;CELL GROWTH;DISEASE;ENZYME;RECEPTOR;HEPATOLOGY;ABDOMINAL SURGERY;ALEXITHYMIA;CIRRHOSIS;HORMONE;INSULIN;NAUSEA;POLYAMINE;PREGNANCY;SPERM;VIRUS;ABDOMINAL PAIN;ANALYSIS OF VARIANCE;ANTIBIOTICS;ANTIGEN;BACTERIA;BLOOD TRANSFUSION;BUBBLE;CELL;CELL CULTURE;CHEMOTHERAPY;COGNITION;COMPLICATION;CONSTRUCT (PYTHON LIBRARY);CRANIOFACIAL;DEPRESSION (ECONOMICS);DIARRHEA;DISTRESS;DISTRIBUTED DATABASE;EMBRYO;ENDOSCOPY;EPIDEMIOLOGY;FANTASY;FRAGMENTATION (COMPUTING);GENISTEIN;GUAR GUM;HEART FAILURE;HELICOBACTER PYLORI;HEPATIC STELLATE CELL;HEPATITIS;HEPATITIS C;HERNIA;HOMOGENEOUS;HUMAN FERTILIZATION;IMMUNOHISTOCHEMISTRY;INTESTINAL MUCOSA;IRRITABLE BOWEL SYNDROME;LIVER METABOLISM;MICROINJECTION;MULTIVARIATE ANALYSIS;NATURAL (ARCHAEOLOGY);NATURAL LANGUAGE;ODDS RATIO;OUTBREAK;PATIENT SATISFACTION;PHOSPHORYLATION;PRIMARY CARE;PSYCHOANALYTIC THEORY;PSYCHOMETRICS;PSYCHOPATHOLOGY;PSYCHOSIS;PSYCHOSOCIAL;QUALITY OF LIFE (HEALTHCARE);RANDOMIZED CONTROLLED TRIAL;RATING SCALE;RECTUM;REGIMEN;RISK FACTOR;RORSCHACH TEST;SALINE;SCALE (RATIO);SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);SCLEROTHERAPY;SECRETION;SEROTYPE;SIMVASTATIN;STIMULATION;STRAIN (INJURY);SUPERNUMERARY;THROMBOSIS;TUMOR NECROSIS FACTOR ALPHA;USER INTERFACE;VOMITING","5;5;5;4;4;4;4;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PROGRAMMED CELL DEATH;COLORECTAL CANCER;BREAST CANCER;CHROMOSOME;CONSTRUCT VALIDITY;IN VITRO FERTILISATION;INFERTILITY;LUTEINIZING HORMONE;ORNITHINE DECARBOXYLASE;REDUCTASE;TORONTO ALEXITHYMIA SCALE;AGONIST;ALLELE;ANHEDONIA;ANNEXIN;BASAL (MEDICINE);BLOATING;BRIEF PSYCHIATRIC RATING SCALE;CARCINOGENESIS;CARDIOMYOPATHY;CELL MIGRATION;DAPI;EMBRYO TRANSFER;EMBRYOGENESIS;ENDOCANNABINOID SYSTEM;EOSINOPHILIC ESOPHAGITIS;FACTOR V;GENE EXPRESSION;GENOTYPE;GONADOTROPIN;HEPATITIS C VIRUS;HISTONE;INFLAMMATORY BOWEL DISEASE;INGUINAL HERNIA;INSULIN RESISTANCE;INTERFACE DESCRIPTION LANGUAGE;LIVE BIRTH;LIVER CYTOLOGY;LOCUS (GENETICS);MAXIMUM BUBBLE PRESSURE METHOD;METASTASIS;METFORMIN;MISCARRIAGE;NATURAL LANGUAGE USER INTERFACE;PORTAL HYPERTENSION;PORTAL VEIN THROMBOSIS;POSITIVE AND NEGATIVE SYNDROME SCALE;POSTPRANDIAL;PREGNANCY RATE;PREIMPLANTATION GENETIC DIAGNOSIS;PRENYLATION;PROBIOTIC;PROLIFERATING CELL NUCLEAR ANTIGEN;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;REALITY TESTING;RECEPTOR TYROSINE KINASE;REFLUX;RIFAXIMIN;ROTAVIRUS;RYANODINE RECEPTOR;SIGMOID COLON;SURGICAL MESH;THROMBOPHILIA;TRANSCRIPTION FACTOR;TYROSINE PHOSPHORYLATION;UNIVARIATE ANALYSIS;UPPER GASTROINTESTINAL ENDOSCOPY;VARICES;VENOUS THROMBOSIS;VIABILITY ASSAY","4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DNA FRAGMENTATION;ESTROGEN RECEPTOR;GONADOTROPIN-RELEASING HORMONE;HMG-COA REDUCTASE;KARYOTYPE;ALPHA (FINANCE);BCL-XL;BLASTOMERE;BREAKPOINT;CANNABINOID RECEPTOR;CASPASE;CASPASE 3;COENZYME A;COMPARATIVE GENOMIC HYBRIDIZATION;ESOPHAGEAL VARICES;FACTOR V LEIDEN;FARNESYLTRANSFERASE;FLUORESCENCE IN SITU HYBRIDIZATION;FOLLICLE-STIMULATING HORMONE;HISTONE DEACETYLASE;INTERFACE (MATTER);INTRACYTOPLASMIC SPERM INJECTION;LEFT VENTRICULAR NONCOMPACTION;MALE INFERTILITY;MESALAZINE;MEVALONATE PATHWAY;MOLECULAR EPIDEMIOLOGY;NUCLEAR RECEPTOR;OESTROGEN RECEPTOR;PCAF;POLYCYSTIC OVARY;REOVIRIDAE;RIBAVIRIN;RYANODINE RECEPTOR 2;SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;COLORECTAL NEOPLASMS;APOPTOSIS;INTESTINAL MUCOSA;;AGED;PROTO-ONCOGENE PROTEINS C-BCL-2;ADULT;DYSPEPSIA;LIVER CIRRHOSIS;MIDDLE AGED;RNA, MESSENGER;CELL PROLIFERATION;COLONIC NEOPLASMS;RECEPTORS, CYTOPLASMIC AND NUCLEAR;ABNORMALITIES, MULTIPLE;POLYAMINES;TRANSCRIPTION FACTORS","19;14;13;12;10;10;9;8;8;7;7;7;7;7;6;6;6;5;5;5","DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;LIPID METABOLISM IN CANCER PATHOGENESIS;MECHANISMS OF ESTROGEN RECEPTOR SIGNALING;AMOEBIASIS: PATHOGENESIS AND CLINICAL MANAGEMENT;DATA STREAM MANAGEMENT SYSTEMS AND TECHNIQUES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;DIAGNOSIS AND TREATMENT OF DIVERTICULITIS;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;ESOPHAGEAL INTERVENTION TECHNIQUES;FERTILITY PRESERVATION IN CANCER PATIENTS;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HACKATHONS IN BIOMEDICAL ENGINEERING EDUCATION;HEALTH EFFECTS OF SOY ISOFLAVONES AND PHYTOESTROGENS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPATITIS C INFECTION AND TREATMENT;HERNIA REPAIR TECHNIQUES AND MATERIALS","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","POLYAMINE;TORONTO ALEXITHYMIA SCALE;TRIPTORELIN;ADAPTIVE EXPERTISE;ALEXITHYMIA;ALPHA (FINANCE);ANANDAMIDE;ANHEDONIA;ANTI-MULLERIAN HORMONE;APOPTOSIS;APOPTOTIC CELLS;APPROXIMATE QUERY PROCESSING;BASAL (MEDICINE);BCL-XL;BLASTOMERE;BLOATING;BREAKPOINT;CANCER;CANNABINOID RECEPTORS;CHEMOTHERAPY-INDUCED NAUSEA","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMAN COLORECTAL;CANCER CELLS;CAT EYE;COLON CANCER;EYE SYNDROME;HUMAN COLON;OVARIAN STIMULATION;ACCESSORY GLAND;ACQUIRED FACTORS;ACTIVATED HUMAN;ALEXITHYMIA RELATED;ALPHA ERRΑ;ANALOG COMPOUND;ANALOGUES PROTOCOL;ANANDAMIDE INHIBITS;APPROPRIATENESS CRITERIA;ART FAILURE;ASGE APPROPRIATENESS;ASSISTED INTRACYTOPLASMIC;BACTERIA VSL;BARKUNS LETTER;BOWEL SYNDROME;BREAST CANCER;CARCINOMA INDEPENDENT;CARE PHYSICIANS;CASPASE PATHWAY;CELL GROWTH;CELL PROLIFERATION;CELLS RESISTANCE;CHEMOTHERAPY-RELATED DYSPEPTIC","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","OVARIAN STIMULATION;SEMINAL PLASMA;SPERM PARAMETERS;DEPOT PREPARATION;FERTILIZATION RATES;IVF CYCLES;LH CONCENTRATION;LH LEVELS;PATIENTS UNDERGOING;PERIOVULATORY LH;RECOMBINANT FSH;RECOMBINANT LH;SINGLE DOSE;SUPPRESSION PROTOCOL;PREGNANCY RATE;HUMAN HSCMFS;METFORMIN TREATMENT;OOCYTE MATURATION;PLASMA LEVEL;STATISTICAL ANALYSIS;ADMINISTRATION LH;ADVERSELY AFFECTING;ANOVULATORY WOMEN;CHI SQUARE;CLINICAL IMPLANTATION;CONCENTRATION MIUML;CONSIDERED STATISTICALLY;CYCLES TRIPTORELIN;DATA AGREE;DEPOT PREPARATIONS","18;8;7;6;6;6;6;6;6;6;6;6;6;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3",4,0.13,7.81,4,7,0,1,1,1,0,1.75,6.25,0,0,1,0,0,0,0,1,0,0,0,55.5,55.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2006,30,9.36666666666667,2.56666666666667,0.38961038961039,0.3,0.233333333333333,0.3,0.333333333333333,1,14,8,3,0,0.47,0.27,0.1,0,39.83,0.779849872033071,0.333333333333333,0.933333333333333,NA,0.432033162807349,0.291666666666667,0.342857142857143,0.203703703703704,"GIOACCHINO LEANDRO;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;PIERO PORCELLI;VALÉRIE VILGRAIN;A. FRANCAVILLA;MAURIZIO BIFULCO;GIOVANNI A. FAVA;GIUSEPPE BRANCATELLI;S. MAZZUOLI;ALBERTO PILOTTO;LARA MANGELLI;MASSIMO RUGGE;GIOVANNI MISCIAGNA;ALFREDO DI LEO;FRANCESCO DI MARIO;C. LOGUERCIO;GIULIA MARTINA CAVESTRO;V. IORI;A PALMO","5;5;5;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","EMILIO JIRILLO;MARIA NOTARNICOLA;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;PIERO PORCELLI;ALBERTO PILOTTO;MAURIZIO BIFULCO;VALÉRIE VILGRAIN;GIUSEPPE BRANCATELLI;GIOVANNI A. FAVA;MARILISA FRANCESCHI;GIOVANNI MISCIAGNA;VITO GUERRA;A. FRANCAVILLA;S. MAZZUOLI;MICHELE LINSALATA;ROMINA GIANNINI;ALDO CAVALLINI;MICHAEL P. FEDERLE;FRANCESCO PERRI","1.17;0.75;0.64;0.58;0.51;0.38;0.38;0.35;0.35;0.31;0.29;0.29;0.29;0.26;0.26;0.25;0.25;0.25;0.25;0.25","GIOACCHINO LEANDRO;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;PIERO PORCELLI;A. FRANCAVILLA;GIOVANNI A. FAVA;GIUSEPPE BRANCATELLI;GIOVANNI MISCIAGNA;ALFREDO DI LEO;EMILIO JIRILLO;VITO GUERRA;FRANCESCO RUSSO;PALMA AURELIA IACOVAZZI;ENZO IERARDI;CATERINA MESSA;M. CORREALE;CESARE HASSAN;GIOVANNI FASSONE;FRANCESCA STELLA;ILARIA LEGA","5;5;5;4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1","EMILIO JIRILLO;MARIA NOTARNICOLA;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;PIERO PORCELLI;GIUSEPPE BRANCATELLI;GIOVANNI A. FAVA;GIOVANNI MISCIAGNA;VITO GUERRA;A. FRANCAVILLA;MICHELE LINSALATA;ROMINA GIANNINI;ALDO CAVALLINI;FRANCESCO RUSSO;PALMA AURELIA IACOVAZZI;M. CORREALE;M PIRRELLI;ANNA MARIA VALENTINI;MATTIA GENTILE;MARIA LUCIA CARUSO","1.17;0.75;0.64;0.58;0.51;0.35;0.31;0.29;0.29;0.26;0.25;0.25;0.25;0.23;0.2;0.2;0.2;0.2;0.2;0.2","GIUSEPPE BRANCATELLI;VALÉRIE VILGRAIN;GIOACCHINO LEANDRO;MARIA NOTARNICOLA;MARIA GABRIELLA CARUSO;MICHAEL P. FEDERLE;FRANCESCO PERRI;PIERO PORCELLI;A. IACOBELLIS;ANGELO ANDRIULLI;B.E. ANNICCHIARICO;G. BOMBARDIERI;L. ACCADIA;MASSIMO SICILIANO;N. CARUSO;ELLIOT K. FISHMAN;FRANCESCA PIACENTINI;LUIGI GRAZIOLI;LUIGI MARUZZELLI;OSAMU MATSUI","291;291;281;230;222;217;216;212;196;196;196;196;196;196;196;159;159;159;159;159","GIUSEPPE BRANCATELLI;GIOACCHINO LEANDRO;MARIA GABRIELLA CARUSO;PIERO PORCELLI;MARIA NOTARNICOLA;GIOVANNI MISCIAGNA;VITO GUERRA;A.‐S. RANGHEARD;CATERINA MESSA;S. ELBA;ALBERTINA TIAGO;ANGELO PICARDI;DAMIANO ABENI;EMANUELE SAGONI;EVA MAZZOTTI;GIOVANNI A. FAVA;GIOVANNI FASSONE;ILARIA LEGA;LUISA RAMIERI;PAOLO PASQUINI","291;281;222;212;203;100;100;74;56;51;47;47;47;47;47;47;47;47;47;47","GIOACCHINO LEANDRO;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;PIERO PORCELLI;GIUSEPPE BRANCATELLI;A. FRANCAVILLA;FRANCESCO RUSSO;GIOVANNI MISCIAGNA;VITO GUERRA;A.‐S. RANGHEARD;ALBERTINA TIAGO;ALDO CAVALLINI;ALFREDO DI LEO;ANGELO PICARDI;ANGELO ZULLO;ANNA MARIA CISTERNINO;ANNA MARIA VALENTINI;ANTONELLA ORLANDO;ANTONIO FRANAVILLA;BENEDETTA D’ATTOMA","5;5;4;4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;ECONOMICS;PHILOSOPHY;SOCIOLOGY","27;12;3;3;2;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;ENDOCRINOLOGY;GENETICS;IMMUNOLOGY;PATHOLOGY;CANCER RESEARCH;CLINICAL PSYCHOLOGY;PSYCHIATRY;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;MICROBIOLOGY;RADIOLOGY;SURGERY;MOLECULAR BIOLOGY;ANDROLOGY;BIOINFORMATICS;CARDIOLOGY;COMBINATORIAL CHEMISTRY;DEMOGRAPHY;DERMATOLOGY;ENVIRONMENTAL HEALTH;LINGUISTICS;MACROECONOMICS;NUCLEAR MEDICINE;OPTICS;PALEONTOLOGY;PHARMACOLOGY;QUANTUM MECHANICS;SOCIAL PSYCHOLOGY;VIROLOGY","20;8;6;5;5;5;4;4;4;3;3;3;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DISEASE;CANCER;GENE;HELICOBACTER PYLORI;VIRUS;ANTIBIOTICS;CHOLESTEROL;ENZYME;HEPATOCELLULAR CARCINOMA;ANXIETY;BIOPSY;HEPATITIS C;IMMUNE SYSTEM;INFLAMMATION;ODDS RATIO;RECEPTOR;ABDOMINAL SURGERY;ABLATION;ADENOMA;ADJUVANT;ALEXITHYMIA;ANTHROPOMETRY;APOPTOSIS;ASCITES;ASYMPTOMATIC;BODY MASS INDEX;BROAD SPECTRUM;CELL;CELL GROWTH;CIRRHOSIS;CONCORDANCE;CONFIDENCE INTERVAL;COPING (PSYCHOLOGY);CRITICALLY ILL;CYTOKINE;DEPRESSION (ECONOMICS);DERMATOLOGICAL DISEASES;DIABETES MELLITUS;DRUG;ESOMEPRAZOLE;FARNESOL;FEELING;FIBROSIS;GROUP A;GROUP B;IMMUNOHISTOCHEMISTRY;INCIDENCE (GEOMETRY);INTESTINAL PERMEABILITY;LACTOFERRIN;LIPID METABOLISM;LIVER DISEASE;LOGISTIC REGRESSION;MAGNETIC RESONANCE IMAGING;MALIGNANCY;MATRIX METALLOPROTEINASE;MEDICAL DIAGNOSIS;MONOCYTE;MOOD;MYOCARDIAL INFARCTION;NOSOLOGY;OBESITY;OMEPRAZOLE;PARENTERAL NUTRITION;PATHOGENESIS;PELIOSIS HEPATIS;PERCUTANEOUS;POLYAMINE;POPULATION;PREGNANCY;PRESENTATION (OBSTETRICS);PROPORTIONAL HAZARDS MODEL;PROSPECTIVE COHORT STUDY;PSYCHOPATHOLOGY;PSYCHOSOCIAL;PSYCHOSOMATIC MEDICINE;PSYCHOSOMATICS;REGIMEN;RETROSPECTIVE COHORT STUDY;RHEUMATOID ARTHRITIS;SPERM;STAGE (STRATIGRAPHY);SURVIVAL ANALYSIS;TERM (TIME);TERPENOID;TOLL;TRANSCRIPTION (LINGUISTICS);TRANSFORMING GROWTH FACTOR;TRANSPLANTATION;TUMOR NECROSIS FACTOR ALPHA","5;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CLARITHROMYCIN;AMOXICILLIN;COLORECTAL CANCER;GASTRITIS;HEPATITIS C VIRUS;LIPOPROTEIN;METRONIDAZOLE;ALLELE;APOLIPOPROTEIN B;ATP SYNTHASE;AUTOIMMUNE DISEASE;BIOSYNTHESIS;BREATH TEST;CANCER PAIN;CARCINOGENESIS;CELL CYCLE;CHRONIC HEPATITIS;CRITICAL ILLNESS;DOWNREGULATION AND UPREGULATION;FATTY ACID SYNTHASE;GENE EXPRESSION;GENOTYPE;GERANYLGERANIOL;HAZARD RATIO;HEPATIC ENCEPHALOPATHY;HEPATITIS B VIRUS;HEPATOCELLULAR ADENOMA;IMMUNITY;INFERTILITY;INNATE IMMUNE SYSTEM;INTERLEUKIN;IRRITABILITY;LEVOFLOXACIN;LIVER BIOPSY;LIVER CANCER;LIVER TRANSPLANTATION;MOOD DISORDERS;ORNITHINE DECARBOXYLASE;OVERWEIGHT;PANTOPRAZOLE;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;PHENOTYPE;PRENYLATION;PROINFLAMMATORY CYTOKINE;RABEPRAZOLE;RADIOFREQUENCY ABLATION;RARE DISEASE;REDUCTASE;REFLUX;SOMATIZATION;SPERMIDINE;SPERMINE;STEROL;TRANSCRIPTION FACTOR;TRANSGENE;VIRAL DISEASE;WHIPPLE'S DISEASE","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","RIBAVIRIN;TINIDAZOLE;CHRONIC GASTRITIS;COENZYME A;DNA MISMATCH REPAIR;ESOPHAGITIS;FARNESYL DIPHOSPHATE SYNTHASE;FARNESYL PYROPHOSPHATE;GENETICALLY MODIFIED MOUSE;HMG-COA REDUCTASE;LDL RECEPTOR;MALE INFERTILITY;MEVALONATE PATHWAY;MEVALONIC ACID;MICROARRAY ANALYSIS TECHNIQUES;MICROSATELLITE;MILAN CRITERIA;ONCOGENE;RAPID UREASE TEST;REFLUX ESOPHAGITIS;STEROL REGULATORY ELEMENT-BINDING PROTEIN;TOLL-LIKE RECEPTOR","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;AGED;MIDDLE AGED;ADULT;HEPATITIS C, CHRONIC;LIVER;COLORECTAL NEOPLASMS;CARCINOMA, HEPATOCELLULAR;PSYCHOPHYSIOLOGIC DISORDERS;ANTIVIRAL AGENTS;INTERFERON-ALPHA;RIBAVIRIN;AGED, 80 AND OVER;LIVER NEOPLASMS;TREATMENT OUTCOME;;ANTI-BACTERIAL AGENTS;ANTI-ULCER AGENTS","22;21;18;15;15;13;12;12;11;8;8;7;7;7;6;6;6;5;5;5","HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPATOCELLULAR CARCINOMA;HEPATITIS C INFECTION AND TREATMENT;BARTONELLA INFECTIONS AND ZOONOTIC POTENTIAL;BODY DYSMORPHIC DISORDER: PSYCHOSOCIAL, CLINICAL, AND TREATMENT ASPECTS;BORDERLINE PERSONALITY DISORDER: PSYCHOPATHOLOGY AND TREATMENT;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;GENITOURINARY SOFT TISSUE TUMORS AND ANOMALIES;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HEPATITIS B INFECTION AND TREATMENT;INNATE IMMUNE RECOGNITION AND SIGNALING PATHWAYS;INTEROCEPTION AND SOMATIC SYMPTOMS;LIPID METABOLISM IN CANCER PATHOGENESIS;METABOLIC SYNDROME AND CARDIOVASCULAR DISEASE;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;PATHOGENESIS AND TREATMENT OF WHIPPLE'S DISEASE","3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HEPATOCELLULAR CARCINOMA;HEPATIC ENCEPHALOPATHY;HEPATITIS C;LIVER CANCER;TINIDAZOLE;TREATMENT;ADAPTIVE IMMUNITY REGULATION;ALEXITHYMIA;ANTIMICROBIAL RESISTANCE;BIOMARKER ANALYSIS;BROAD SPECTRUM;CANNABINOID RECEPTORS;CANNABINOIDS;CARDIOVASCULAR EVALUATION;CB1 AND CB2 RECEPTORS;CELL REGULATION;CHOLESTEROL;CHOLESTEROL-LOWERING;CHRONIC GASTRITIS;COENZYME A","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLORECTAL CANCER;CHRONIC HEPATITIS;HEPATOCELLULAR CARCINOMA;HUMAN COLORECTAL;IHELICOBACTER PYLORII;RIBAVIRIN TREATMENT;TPN-RELATED DIGESTIVE;ABDOMINAL SURGERY;ACCESSORY GLAND;ACID SYNTHASE;ADJUSTMENT DISORDERS;AGERELATED HYPERCHOLESTEROLEMIA;ALEXITHYMIA COPING;ALTERATIONS ANIMAL;ANTINFLAMMATORY DRUGS;ARRESTS TUMOR;AUTOIMMUNE DISEASES;AUTOIMMUNE PATHOGENETIC;BEHAVIOR CORRELATES;BODY MASS;BOVINE LACTOFERRIN;CANCER PATIENTS;CANCER RELATIONSHIP;CANNABINOID TYPE-;CARCINOMA HCC;CELL DERIVED;CELL PROLIFERATION;CHRONIC GASTRITIS;CHRONIC THERAPY;CLARITHROMYCIN-RESISTANT GENOTYPES","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MG BD;ACCESSORY GLAND;GLAND INFECTION;MALE ACCESSORY;TRANSGENIC MOUSE;COMBINATION THERAPY;GENE EXPRESSION;K-RAS MUTATION;MG DAILY;POLYAMINE LEVELS;POLYAMINE METABOLISM;PPARΓ EXPRESSION;SPERM PARAMETERS;BD CLARITHROMYCIN;BODY MASS;BOVINE LACTOFERRIN;CELL GROWTH;CHRONIC HEPATITIS;CHRONIC THERAPY;CLARITHROMYCIN MG;COLORECTAL CANCER;COLORECTAL CARCINOMA;DCPR DIAGNOSES;ESOMEPRAZOLE MG;FOLD CHANGE;GASTRIC DAMAGE;GASTRIC PERMEABILITY;GROWTH FACTOR;INDUCED GASTRIC;LACTOFERRIN MG","8;5;5;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",1,0.03,4.2,8,0,0,0,0,0,0,0,8,0,0,8,0,0,1,1,2,4,0,0,90,90,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2007,36,8.38888888888889,1.25,0.8,0.194444444444444,0.25,0.0277777777777778,0.333333333333333,0,18,6,4,4,0.5,0.17,0.11,0.11,44.06,0.834765103807533,0.361111111111111,0.777777777777778,NA,0.487584748767792,0.355555555555556,0.532467532467532,0,"GIOACCHINO LEANDRO;FRANCESCO DI MARIO;ALBERTO PILOTTO;PIERO PORCELLI;ANGELO ANDRIULLI;STEFANO ZOCCOLELLA;ANGELA FRADDOSIO;VITO LEPORE;LUIGI SERLENGA;ISABELLA LAURA SIMONE;GIANCARLO LOGROSCINO;DAVIDE SERIPA;CARLO SCARCELLI;MARILISA FRANCESCHI;VALERIA NIRO;ETTORE BEGHI;VITO GUERRA;BRUNO DALLAPICCOLA;A. FRANCAVILLA;ELVIRA GRANDONE","13;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3","GIOACCHINO LEANDRO;PIERO PORCELLI;FRANCESCO DI MARIO;ALBERTO PILOTTO;NICOLETTA SONINO;CLAUDIO PAPI;LUCIO CAPURSO;ANGELO ANDRIULLI;EMILIO JIRILLO;DAVIDE SERIPA;CARLO SCARCELLI;MARILISA FRANCESCHI;VALERIA NIRO;A. FRANCAVILLA;BRIAN I. CARR;STEFANO ZOCCOLELLA;ANGELA FRADDOSIO;VITO LEPORE;LUIGI SERLENGA;ISABELLA LAURA SIMONE","1.83;1.62;0.53;0.53;0.5;0.48;0.48;0.46;0.45;0.38;0.38;0.38;0.38;0.38;0.38;0.37;0.37;0.37;0.37;0.37","GIOACCHINO LEANDRO;PIERO PORCELLI;VITO GUERRA;A. FRANCAVILLA;BRIAN I. CARR;L. AMATI;CATERINA MESSA;ANGELA TAFARO;ANNA MARIA VALENTINI;MICHELE LINSALATA;MATTIA GENTILE;GIUSEPPE BRANCATELLI;ANTONELLA ORLANDO;VITO GUERRA;ALDO CAVALLINI;FRANCESCO RUSSO;MARCELLO CHIEPPA;V. GUGLIELMI;RAFFAELE COZZOLONGO;MARIA LUCIA CARUSO","13;5;4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GIOACCHINO LEANDRO;PIERO PORCELLI;A. FRANCAVILLA;BRIAN I. CARR;VITO GUERRA;VITO GUERRA;V. GUGLIELMI;VITO COVELLI;DIONIGI LORUSSO;LUIGI AMATI;CATERINA MESSA;MICHELE LINSALATA;ANTONELLA ORLANDO;ALDO CAVALLINI;FRANCESCO RUSSO;L. AMATI;GIUSEPPE BRANCATELLI;MATTIA GENTILE;ANGELA TAFARO;ANNA MARIA VALENTINI","1.83;1.62;0.38;0.38;0.37;0.33;0.33;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.12;0.1;0.08","GIOACCHINO LEANDRO;ANGELO ANDRIULLI;ALBERTO PILOTTO;FRANCESCO DI MARIO;ANGELA FRADDOSIO;ETTORE BEGHI;GIANCARLO LOGROSCINO;ISABELLA LAURA SIMONE;LUIGI SERLENGA;STEFANO ZOCCOLELLA;VITO GUERRA;VITO LEPORE;VITO SAMARELLI;ALESSANDRA MANGIA;DONATO BACCA;F. VINELLI;FULVIO SPIRITO;G. PALAGANO;GAETANO SCOTTO;GIOVANNI RICCI","609;459;418;418;391;391;391;391;391;391;391;391;326;252;252;252;252;252;252;252","GIOACCHINO LEANDRO;VITO GUERRA;RAFFAELE COZZOLONGO;PIERO PORCELLI;BRIAN I. CARR;ALDO CAVALLINI;ANTONELLA ORLANDO;CATERINA MESSA;FRANCESCO RUSSO;MICHELE LINSALATA;MATTIA GENTILE;ANNA MARIA VALENTINI;MARIA LUCIA CARUSO;ANGELA TAFARO;DIONIGI LORUSSO;GIUSEPPE BRANCATELLI;MARCELLO CHIEPPA;LUIGI AMATI;VITO COVELLI;A. FRANCAVILLA","609;391;252;79;57;53;53;53;53;53;51;40;40;22;18;18;15;9;9;6","GIOACCHINO LEANDRO;PIERO PORCELLI;VITO GUERRA;A. FRANCAVILLA;BRIAN I. CARR;ALDO CAVALLINI;ANGELA TAFARO;ANNA MARIA VALENTINI;ANTONELLA ORLANDO;CATERINA MESSA;DIONIGI LORUSSO;FRANCESCO RUSSO;GIUSEPPE BRANCATELLI;LUIGI AMATI;MARCELLO CHIEPPA;MARIA LUCIA CARUSO;MATTIA GENTILE;MICHELE LINSALATA;RAFFAELE COZZOLONGO;VITO COVELLI","13;5;4;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;SOCIOLOGY;ECONOMICS;ENGINEERING;GEOLOGY;MATHEMATICS","32;9;5;5;3;2;1;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;SURGERY;IMMUNOLOGY;BIOCHEMISTRY;GENETICS;PATHOLOGY;PSYCHIATRY;CLINICAL PSYCHOLOGY;ENDOCRINOLOGY;GENERAL SURGERY;MICROBIOLOGY;PEDIATRICS;PHARMACOLOGY;QUANTUM MECHANICS;CELL BIOLOGY;DEVELOPMENTAL PSYCHOLOGY;INTENSIVE CARE MEDICINE;NURSING;PHYSICAL THERAPY;RADIOLOGY","28;9;7;7;6;5;5;5;5;4;3;3;3;3;3;3;2;2;2;2;2;2","DISEASE;POPULATION;RANDOMIZED CONTROLLED TRIAL;CONFIDENCE INTERVAL;GENE;PROPORTIONAL HAZARDS MODEL;CANCER;CIRRHOSIS;MULTIVARIATE ANALYSIS;TERM (TIME);ALEXITHYMIA;ANTIBIOTICS;COHORT;COHORT STUDY;HEPATITIS C;HEPATOCELLULAR CARCINOMA;IMMUNE SYSTEM;IN VITRO;METABOLISM;ODDS RATIO;PARENTERAL NUTRITION;PROSPECTIVE COHORT STUDY;PSYCHOSOCIAL;QUALITY OF LIFE (HEALTHCARE);RATING SCALE;TRANSPLANTATION;VIRUS","12;7;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","AMYOTROPHIC LATERAL SCLEROSIS;CROHN'S DISEASE;CYTOCHROME P450;GENOTYPE;HAZARD RATIO;HEPATITIS C VIRUS;INFLAMMATORY BOWEL DISEASE;LIVER TRANSPLANTATION;TORONTO ALEXITHYMIA SCALE;AGE OF ONSET;ARTIFICIAL NUTRITION;BREATH TEST;CANCER CELL;CD8;CHROMOSOMAL TRANSLOCATION;CLINICAL ENDPOINT;CYTOTOXIC T CELL;DEFENCE MECHANISMS;FATTY LIVER;FETUS;GLOBAL ASSESSMENT OF FUNCTIONING;GLUTATHIONE;GROWTH FACTOR;HELICOBACTER PYLORI INFECTION;HEPATITIS B VIRUS;HYPERINTENSITY;INNATE IMMUNE SYSTEM;INSULIN RESISTANCE;LACTOBACILLUS;LIVER ABSCESS;LIVER BIOPSY;LOG-RANK TEST;LOWER LIMBS VENOUS ULTRASONOGRAPHY;METRONIDAZOLE;OVERWEIGHT;PANTOPRAZOLE;PERIPHERAL BLOOD MONONUCLEAR CELL;POLYPHENOL;RADIOFREQUENCY ABLATION;RIFAXIMIN;SURVIVORSHIP CURVE;TLR4;TRANSPLANT SURGERY;TYPE 2 DIABETES MELLITUS;ULCERATIVE COLITIS;UPPER GASTROINTESTINAL BLEEDING;VARICES;VIREMIA","4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CYP2C9;GENOTYPING;CALPROTECTIN;CHILDHOOD OBESITY;CTGF;HBSAG;ILEITIS;LACTOBACILLUS RHAMNOSUS;MESALAZINE;PHARMACOGENETICS;PRENATAL DIAGNOSIS;RIBAVIRIN;RILUZOLE;UPPER MOTOR NEURON;UREA BREATH TEST","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;LIVER NEOPLASMS;AGED;AMYOTROPHIC LATERAL SCLEROSIS;;ATHEROSCLEROSIS;AFFECTIVE SYMPTOMS;TREATMENT OUTCOME;AGED, 80 AND OVER;CARCINOMA, HEPATOCELLULAR;ITALY;PEPTIC ULCER HEMORRHAGE;STRESS, PSYCHOLOGICAL;OBESITY;ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;CROHN DISEASE","26;22;19;17;16;13;12;11;9;9;8;8;7;7;7;7;7;6;5;5","AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;DRUG METABOLISM AND PHARMACOGENOMICS;INTEROCEPTION AND SOMATIC SYMPTOMS;AMOEBIASIS: PATHOGENESIS AND CLINICAL MANAGEMENT;CANCER SURVIVORSHIP AND QUALITY OF LIFE;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;DIAGNOSIS AND TREATMENT OF DIVERTICULITIS;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;ESOPHAGEAL INTERVENTION TECHNIQUES;EVOLUTION OF CHILD HEALTH SERVICES IN EUROPE;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;IMMUNOBIOLOGY OF DENDRITIC CELLS;INFLAMMATION AND OBESITY-RELATED METABOLIC DISORDERS","4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TREATMENT;SPINAL MUSCULAR ATROPHY;ALEXITHYMIA;CROHN'S DISEASE;CYTOCHROME P450;ENTERAL NUTRITION;HEPATITIS C;NSAIDS;PARENTERAL NUTRITION;PSYCHOSOCIAL OUTCOMES;TORONTO ALEXITHYMIA SCALE;ADIPOCYTOKINES;ADIPOKINES;ADIPOSE TISSUE;AMOEBIASIS;ARTIFICIAL NUTRITION;CANCER SURVIVORSHIP;CANCER THERAPY;CHILDHOOD CANCER SURVIVOR STUDY;CHILLS","4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","AMYOTROPHIC LATERAL;CROHNS DISEASE;LATERAL SCLEROSIS;FOLLOW-UP STUDY;POPULATION-BASED STUDY;ABLATION THERAPY;ABSCESS REPORT;ADOPTIVELY TRANSFERRED;ADVANCED HEPATOBILIARY;ALS MULTIDISCIPLINARY;AMEBIC LIVER;ANOMALOUS PULMONARY;ANTI-INFLAMMATORY DRUGRELATED;APPENDIX INTERVIEW;ARTERIALLY ENHANCING;ARTERY DISEASE;ARTIFICIAL NUTRITION;BASED STUDY;BFLOW IMAGING;BILE SALTS;BLEEDING ROLE;BLOOD MONONUCLEAR;BOWEL OBSESSION;CANCER CELLS;CANCER PATIENTS;CARCINOMA HCC;CELL GROWTH;CHILDHOOD OBESITY;CHRONIC HEPATITIS;COMMON INDICATIONS","3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;GASTRODUODENAL BLEEDING;PHARMACOL -CROSSREF;GASTROINTESTINAL BLEEDING;CYPC ALLELE;CLIN PHARMACOL;UPPER GASTROINTESTINAL;CYPC GENOTYPE;NONSTEROIDAL ANTI-INFLAMMATORY;NSAID USERS;CYPC POLYMORPHISMS;NSAID-RELATED GASTRODUODENAL;CYPC GENOTYPING;ANTI-INFLAMMATORY DRUGS;CLINICAL PRACTICE;ODDS RATIO;PYLORI INFECTION;ACUTE GASTROINTESTINAL;AD IMPACT;AFRICAN POPULATIONBR;BLACK AFRICAN;CONFIDENCE INTERVAL;CYCLOOXYGENASE INHIBITORS;CYPC GENE;CYPC GENOTYPES;DISP -CROSSREF;GASTROINTESTINAL ENDOSCOPY;HELICOBACTER PYLORI;METAB DISP","52;49;23;19;18;15;14;14;13;12;12;11;11;9;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6",8,0.22,3,1.25,0,1,0,0,2,0,1,2.25,0,1,1,1,0,0,0,1,0,0,0,100.25,100.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2008,26,7.65384615384615,1.80769230769231,0.553191489361702,0.346153846153846,0.384615384615385,0.0384615384615385,0.269230769230769,0,9,9,4,3,0.35,0.35,0.15,0.12,49.92,0.909811827028426,0.423076923076923,0.807692307692308,NA,0.385773144454325,0.25,0.209150326797386,0,"PIERO PORCELLI;M. CORREALE;A. FRANCAVILLA;VITO GUERRA;GIUSEPPE RIEZZO;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;VALERIA TUTINO;GIOVANNI MISCIAGNA;BRUNO DALLAPICCOLA;MATTIA GENTILE;EMILIO JIRILLO;MARISA CHILOIRO;RAFFAELE COZZOLONGO;MARIA NOTARNICOLA;L. AMATI;LORETO GESUALDO;ALAIN VERLOÈS;FERNANDO SOGARI;ROMINA GALLIZZI","3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1","PIERO PORCELLI;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;A. FRANCAVILLA;MASSIMO DE CARNE;GIOVANNI MISCIAGNA;ORLANDO TODARELLO;M. CORREALE;VITO GUERRA;GIUSEPPE RIEZZO;VALERIA TUTINO;T. CLARK GAMBLIN;M PIRRELLI;BRIAN I. CARR;ANNA MARIA VALENTINI;JENNIFER L. STEEL;MARIA LUCIA CARUSO;MAURIZIO TREVISAN;EMILIO JIRILLO;L. AMATI","1.11;1.03;0.7;0.58;0.5;0.5;0.5;0.46;0.46;0.43;0.34;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.29;0.29","PIERO PORCELLI;M. CORREALE;A. FRANCAVILLA;VITO GUERRA;GIUSEPPE RIEZZO;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;VALERIA TUTINO;GIOVANNI MISCIAGNA;MATTIA GENTILE;MARISA CHILOIRO;RAFFAELE COZZOLONGO;MARIA NOTARNICOLA;L. AMATI;PALMA AURELIA IACOVAZZI;MASSIMO DE CARNE;M PIRRELLI;FILOMENA CARIOLA;ELSA LANZILLOTTA;ANGELA TAFARO","3;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1","PIERO PORCELLI;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;A. FRANCAVILLA;MASSIMO DE CARNE;GIOVANNI MISCIAGNA;M. CORREALE;VITO GUERRA;GIUSEPPE RIEZZO;VALERIA TUTINO;M PIRRELLI;BRIAN I. CARR;ANNA MARIA VALENTINI;MARIA LUCIA CARUSO;L. AMATI;MARISA CHILOIRO;RAFFAELE COZZOLONGO;GIOACCHINO LEANDRO;PALMA AURELIA IACOVAZZI;ELSA LANZILLOTTA","1.11;1.03;0.7;0.58;0.5;0.5;0.46;0.46;0.43;0.34;0.33;0.33;0.33;0.33;0.29;0.27;0.24;0.22;0.17;0.17","BRUNO DALLAPICCOLA;GIOACCHINO LEANDRO;ALBERTO PILOTTO;CARLO SCARCELLI;DAVIDE SERIPA;FRANCESCO PARIS;GIULIANA PLACENTINO;LEANDRO CASCAVILLA;LUIGI D’AMBROSIO;LUIGI FERRUCCI;MARILISA FRANCESCHI;GIUSEPPE RIEZZO;FLAVIA INDRIO;FRANCESCO RAIMONDI;LUCIANO CAVALLO;MASSIMO BISCEGLIA;RUGGIERO FRANCAVILLA;MATTIA GENTILE;ALAIN VERLOÈS;ANNALISA MAZZOTTA","528;449;427;427;427;427;427;427;427;427;427;289;210;210;210;210;210;123;101;101","GIOACCHINO LEANDRO;GIUSEPPE RIEZZO;MATTIA GENTILE;RAFFAELE COZZOLONGO;MARISA CHILOIRO;FRANCESCO RUSSO;E. LÄWITZ;VITO GUERRA;ELISABETTA CAVALCANTI;PIERO PORCELLI;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;BRIAN I. CARR;M. CORREALE;ALDO CAVALLINI;VALERIA TUTINO;ANNA MARIA VALENTINI;M PIRRELLI;MARIA LUCIA CARUSO;A. FRANCAVILLA","449;289;123;82;79;57;48;46;45;45;43;42;35;35;31;31;30;30;30;23","A. FRANCAVILLA;MARIA GABRIELLA CARUSO;GIUSEPPE RIEZZO;PIERO PORCELLI;VITO GUERRA;GIOACCHINO LEANDRO;GIOVANNI MISCIAGNA;M. CORREALE;MARIA NOTARNICOLA;MARISA CHILOIRO;MATTIA GENTILE;RAFFAELE COZZOLONGO;ALDO CAVALLINI;ANGELA TAFARO;ANNA MARIA VALENTINI;BRIAN I. CARR;E. LÄWITZ;ELISABETTA CAVALCANTI;ELSA LANZILLOTTA;FILOMENA CARIOLA","3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ECONOMICS;PHILOSOPHY;COMPUTER SCIENCE;POLITICAL SCIENCE;PSYCHOLOGY","25;11;2;2;2;1;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;ENDOCRINOLOGY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;PATHOLOGY;PSYCHIATRY;VIROLOGY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;SURGERY;ANATOMY;CLINICAL PSYCHOLOGY;FOOD SCIENCE;INTENSIVE CARE MEDICINE;MACROECONOMICS;ONCOLOGY;PHYSIOLOGY;BIOTECHNOLOGY;COMMUNICATION;ENVIRONMENTAL ETHICS;EPISTEMOLOGY;FAMILY MEDICINE;GERONTOLOGY;KNOWLEDGE MANAGEMENT;LAW;NEUROSCIENCE;NURSING;ORGANIC CHEMISTRY;PEDIATRICS;PHARMACOLOGY;PSYCHOTHERAPIST","18;7;6;6;5;5;5;5;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;GENE;VIRUS;ALTERNATIVE MEDICINE;CHOLESTEROL;IMMUNE SYSTEM;POPULATION;ANTIBODY;CLINICAL NUTRITION;CYTOKINE;DEFECATION;DEPRESSION (ECONOMICS);DIABETES MELLITUS;DIARRHEA;DISEASE;INTERFERON;MENTAL HEALTH;TRANSPLANTATION;ABDOMINAL PAIN;ABO BLOOD GROUP SYSTEM;ADIPOSE TISSUE;ADVERSE EFFECT;AFFECT (LINGUISTICS);AGEING;ALEXITHYMIA;ANTIGEN;ANTIOXIDANT;ANXIETY;ATAXIA;ATRESIA;BACTERIA;BODY MASS INDEX;CLINICAL CHEMISTRY;CLINICAL PRACTICE;COHORT;COHORT STUDY;COLOBOMA;CONFIDENCE INTERVAL;CONSTIPATION;CRYING;DIALYSIS;DIFFERENTIAL DIAGNOSIS;DOMAIN KNOWLEDGE;DOSING;DYSGENESIS;EPIDEMIOLOGY;ESTROGEN;ETIOLOGY;GASTROINTESTINAL FUNCTION;HEALTH CARE;HELICOBACTER PYLORI;HEMOGLOBIN;HEPATITIS C;HIERARCHY;IDEAL (ETHICS);IMMUNOHISTOCHEMISTRY;IN VITRO;IN VIVO;INFLAMMATION;INSULIN;INULIN;IRRITABLE BOWEL SYNDROME;KNOWLEDGE ENGINEERING;LIVER DISEASE;MEDICAL DIAGNOSIS;MENOPAUSE;MYOCARDIAL INFARCTION;OBESITY;ORGANIZATIONAL LEARNING;OXIDATIVE PHOSPHORYLATION;OXIDATIVE STRESS;PATIENT SATISFACTION;PHASE (MATTER);POLITICS;POLYDACTYLY;POSTTRAUMATIC GROWTH;PREGNANCY;PSYCHOLOGICAL INTERVENTION;PSYCHOSOCIAL;PSYCHOSOMATICS;QUALITY OF LIFE (HEALTHCARE);RECEPTOR;SHORT COURSE;STEATOSIS;STOMACH;VAGINA;VOMITING;WINE","6;5;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLORECTAL CANCER;HEPATITIS C VIRUS;CHRONIC HEPATITIS;FRUCTOSAMINE;GENOTYPE;PHENOTYPE;ABO INCOMPATIBILITY;ALPHA INTERFERON;APOLIPOPROTEIN B;BLOATING;BREAST CANCER;CALCINEURIN;CD8;CHOANAL ATRESIA;CLINICAL DECISION SUPPORT SYSTEM;CONSTRUCT VALIDITY;CYTOTOXIC T CELL;DOWNREGULATION AND UPREGULATION;EPIDERMAL GROWTH FACTOR RECEPTOR;EVIDENCE-BASED MEDICINE;FATTY LIVER;FETUS;GASTRIC EMPTYING;GASTRITIS;GLYCATION;HAZARD RATIO;IMMUNOTHERAPY;INSULIN RESISTANCE;INTERLEUKIN;JOUBERT SYNDROME;KNOWLEDGE VALUE CHAIN;LIPID PROFILE;LIVER TRANSPLANTATION;METABOLIC SYNDROME;METASTASIS;MONOCLONAL ANTIBODY;MUTATION;ORGANIC DISEASE;PANIC;PANIC DISORDER;PERSONAL KNOWLEDGE MANAGEMENT;PLACEBO;POLYPHENOL;PROBIOTIC;PROINFLAMMATORY CYTOKINE;PROMOTION (CHESS);PSYCHOMOTOR RETARDATION;SOMATIZATION;T CELL;TARGETED THERAPY;TYPE 2 DIABETES;WAIST;WAITING LIST","4;4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","RIBAVIRIN;ALPHA (FINANCE);ANTIVIRAL THERAPY;ANTIVIRAL TREATMENT;CETUXIMAB;CILIOPATHIES;CILIOPATHY;COMPOUND HETEROZYGOSITY;EGFR INHIBITORS;ESTROGEN RECEPTOR;GLYCATED HEMOGLOBIN;HAEMOLYTIC DISEASE;HAPLOINSUFFICIENCY;LACTOBACILLUS REUTERI;UNITED NETWORK FOR ORGAN SHARING","4;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;INTERFERON-ALPHA;;ADULT;AGED;MIDDLE AGED;ABNORMALITIES, MULTIPLE;HEPACIVIRUS;HEPATITIS C, CHRONIC;PANIC DISORDER;POLYETHYLENE GLYCOLS;RIBAVIRIN;ABDOMINAL PAIN;BILIARY TRACT NEOPLASMS;BIOMARKERS;BLOOD GLUCOSE;CARCINOMA, RENAL CELL;CHOLESTEROL, HDL","19;12;11;9;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4","HEPATITIS C INFECTION AND TREATMENT;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;ANTIOXIDANTS AND FREE RADICALS IN HEALTH AND DISEASE;CANCER SURVIVORSHIP AND QUALITY OF LIFE;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;FRAILTY IN OLDER ADULTS AND GERIATRIC CARE;IMMUNOBIOLOGY OF DENDRITIC CELLS;IMPACT OF CHRONIC STRESS ON CANCER PROGRESSION;IMPACT OF FRUCTOSE ON METABOLIC HEALTH;IMPACT OF HEALTH INFORMATION TECHNOLOGY IN HEALTHCARE;INFANT CRYING AND COLIC STUDIES;INTEROCEPTION AND SOMATIC SYMPTOMS;LIPID METABOLISM IN CANCER PATHOGENESIS;LIVER TRANSPLANTATION AND GRAFT SURVIVAL ANALYSIS;MECHANISMS OF ESTROGEN RECEPTOR SIGNALING;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;ROLE OF FRUCTANS IN NUTRITION AND HEALTH;ROLE OF GALECTINS IN IMMUNITY AND DISEASE","4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TREATMENT;CLINICAL NUTRITION;DEPRESSION (ECONOMICS);FRUCTOSAMINE;ABO INCOMPATIBILITY;ADRENERGIC SIGNALING;AFFECT (LINGUISTICS);ALEXITHYMIA;ALPHA (FINANCE);ANTI-INFLAMMATORY;ANTIVIRAL THERAPY;ANTIVIRAL TREATMENT;BLOATING;CELL GROWTH;CEREBELLAR MALFORMATIONS;CETUXIMAB;CHOANAL ATRESIA;CHOLESTEROL;CILIOPATHIES;CILIOPATHY","4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLORECTAL CANCER;CHRONIC HEPATITIS;PEGINTERFERON ALPHA-A;ABO BLOOD;ACUTE REJECTION;ADIPOSE TISSUE;AFFECTS LIPID;AGE- RELATED;ALPHA-A REPLY;ANTIGENIC CHALLENGE;ANTIVIRAL THERAPY;ASSESS OPTIMAL;ATROPHIC HUMAN;BARI ITALY;BINDING PROTEIN;BIOCHEMISTRY MEETING;BLOOD GROUP-RELATED;BOWEL HABITS;BOWEL SYNDROME;CANCER DIRECTIONS;CANCER MODEL;CANDIDATES EFFECT;CASTELLANA GROTTE;CHRONIC PATIENTS;CLINICAL PRACTICE;COACH SYNDROME;COLON CANCER;COMBINED TREATMENT;COMPREHENSIVE GERIATRIC;DC PREFERENTIALLY","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLORECTAL CANCER;DR SPERL;GASTROINTESTINAL MUCOSA;MYOCARDIAL INFARCTION;ABO-COMPATIBLE ORGANS;ANTI-VIRAL TREATMENT;BLOOD VARIABLES;CANDIDATES RECEIVING;CELLULAR PROLIFERATION;CUMULATIVE PROBABILITY;ELDERLY PATIENTS;GRAFT FAILURE;GRAFT LOSS;GRAFT SURVIVAL;HEPATIC FIBROSIS;HOSPITALIZED PATIENTS;IMMUNOSUPPRESSIVE TREATMENT;LIVER TRANSPLANT;MELD ERA;PEGYLATED INTERFERON;RECEIVING INTERFERON;TRIPLE HELIX;WAITING LIST;ABO-COMPATIBLE TRANSPLANTS;ABO-IDENTICAL ORGANS;ACCUMULATED AMPLE;ACCURATE PSYCHOSOMATIC;ACCURATELY STRATIFIES;ACRONYM COACH;ACUTE GASTRIC","6;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1",2,0.08,18.52,13,0,0,0,1,7,0,2,13,0,0,6.5,0,0,0,0,5,2,0.75,0,171.5,171.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2009,32,9.15625,2.21875,0.450704225352113,0.28125,0.21875,0.0625,0.375,0,17,6,5,1,0.53,0.19,0.16,0.03,40.75,0.88094351632778,0.5,0.9375,NA,0.385268403419403,0.380952380952381,0.361111111111111,0.166666666666667,"EMILIO JIRILLO;GIUSEPPE RIEZZO;GIOACCHINO LEANDRO;FRANCESCO RAIMONDI;LUCIANO CAVALLO;RUGGIERO FRANCAVILLA;FELICITA JIRILLO;THEA MAGRONE;FLAVIA INDRIO;PIERO PORCELLI;BIAGIO SOLARINO;BRUNO DALLAPICCOLA;DOMENICO PISCITELLI;ANGELA TAFARO;GIANCARLO DI VELLA;LUIGI FERRUCCI;ALBERTO R. OSELLA;MATTIA GENTILE;MARILISA FRANCESCHI;ALDO CAVALLINI","6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","GIUSEPPE RIEZZO;FRANCESCO RAIMONDI;EMILIO JIRILLO;LUCIANO CAVALLO;RUGGIERO FRANCAVILLA;FLAVIA INDRIO;THEA MAGRONE;FELICITA JIRILLO;GIOACCHINO LEANDRO;ALDO CAVALLINI;ALBERTO R. OSELLA;PIERO PORCELLI;BIAGIO SOLARINO;DOMENICO PISCITELLI;GIANCARLO DI VELLA;LUCIA TATTOLI;ANGELA TAFARO;M. BISCEGLIA;VITO GUERRA;LUIGI AMATI","0.95;0.82;0.78;0.66;0.66;0.66;0.51;0.49;0.48;0.45;0.39;0.38;0.37;0.37;0.37;0.37;0.34;0.33;0.32;0.32","EMILIO JIRILLO;GIUSEPPE RIEZZO;GIOACCHINO LEANDRO;PIERO PORCELLI;BRUNO DALLAPICCOLA;LUIGI FERRUCCI;ALBERTO R. OSELLA;MATTIA GENTILE;MARILISA FRANCESCHI;ALDO CAVALLINI;FILOMENA ADDANTE;LUIGI AMATI;MARCO RIGATELLI;VITO GUERRA;RAFFAELE COZZOLONGO;LARA MANGELLI;F M DI MATTEO;F. RENGO;JOSÉ PETRUZZI;CATERINA MESSA","6;6;5;3;3;3;3;3;3;3;3;3;2;2;2;1;1;1;1;1","GIUSEPPE RIEZZO;EMILIO JIRILLO;GIOACCHINO LEANDRO;ALDO CAVALLINI;ALBERTO R. OSELLA;PIERO PORCELLI;VITO GUERRA;LUIGI AMATI;BRUNO DALLAPICCOLA;LUIGI FERRUCCI;MARILISA FRANCESCHI;FILOMENA ADDANTE;MATTIA GENTILE;MARCO RIGATELLI;CATERINA MESSA;MICHELE LINSALATA;ANTONELLA ORLANDO;FRANCESCO RUSSO;RAFFAELE COZZOLONGO;FILOMENA CARIOLA","0.95;0.78;0.48;0.45;0.39;0.38;0.32;0.32;0.29;0.29;0.29;0.29;0.28;0.25;0.2;0.2;0.2;0.2;0.16;0.14","GIOACCHINO LEANDRO;ALBERTO PILOTTO;BRUNO DALLAPICCOLA;FILOMENA ADDANTE;LUIGI FERRUCCI;MARILISA FRANCESCHI;ALFONSO GALEOTA LANZA;ANTONIO ASCIONE;F. LAMPASI;FRANCESCO PICCIOTTO;G. MARINO-MARSILIA;G.G. DI COSTANZO;LUCA FONTANELLA;M. DE LUCA;M.T. TARTAGLIONE;FLAVIA INDRIO;FRANCESCO RAIMONDI;GIUSEPPE RIEZZO;MATTIA GENTILE;ALBERTO R. OSELLA","542;245;245;245;245;245;200;200;200;200;200;200;200;200;200;196;196;196;191;167","GIOACCHINO LEANDRO;GIUSEPPE RIEZZO;MATTIA GENTILE;ALBERTO R. OSELLA;ALBERTO PILOTTO;BRUNO DALLAPICCOLA;F. RENGO;FABIO PELLEGRINI;FILOMENA ADDANTE;GIUSEPPE RENGO;LUIGI FERRUCCI;MARIA GRAZIA LONGO;MARILISA FRANCESCHI;P. D'AMBROSIO;PIERO PORCELLI;RAFFAELE COZZOLONGO;CATERINA BONFIGLIO;ELSA LANZILOTTA;G. BUONGIORNO;GIUSEPPE LEONE","542;196;191;167;148;148;148;148;148;148;148;148;148;148;118;99;97;97;97;97","GIUSEPPE RIEZZO;GIOACCHINO LEANDRO;ALBERTO R. OSELLA;ALDO CAVALLINI;MATTIA GENTILE;PIERO PORCELLI;LUIGI AMATI;RAFFAELE COZZOLONGO;A. FRANCAVILLA;ALBERTO PILOTTO;ALESSANDRA BRAVI;ANNA MARIA VALENTINI;ANTONELLA ORLANDO;BRUNO DALLAPICCOLA;CATERINA BONFIGLIO;CATERINA MESSA;CATIA LIPPOLIS;CHIARA RAFANELLI;ELSA LANZILOTTA;F M DI MATTEO","6;5;3;3;3;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;SOCIOLOGY;BUSINESS;ECONOMICS;POLITICAL SCIENCE","26;17;5;4;3;3;2;2;1;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;GENETICS;GASTROENTEROLOGY;IMMUNOLOGY;PATHOLOGY;ENDOCRINOLOGY;FAMILY MEDICINE;FOOD SCIENCE;PEDIATRICS;PSYCHIATRY;QUANTUM MECHANICS;SURGERY;VIROLOGY;ANDROLOGY;CANCER RESEARCH;CELL BIOLOGY;CLINICAL PSYCHOLOGY;DEMOGRAPHY;ENVIRONMENTAL HEALTH;GERONTOLOGY;INTENSIVE CARE MEDICINE;WORLD WIDE WEB","18;9;9;7;7;7;6;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","GENE;CANCER;DISEASE;IMMUNE SYSTEM;VIRUS;ALTERNATIVE MEDICINE;APOPTOSIS;CYTOKINE;IN VITRO;PREBIOTIC;ANXIETY;AUTOPSY;BREAST MILK;CELL;CELL GROWTH;CIRRHOSIS;CONFIDENCE INTERVAL;ENDOSCOPY;EPIDEMIOLOGY;FOLLICULAR PHASE;IMMUNOHISTOCHEMISTRY;INDEX (TYPOGRAPHY);INFANT FORMULA;LOGISTIC REGRESSION;LYMPHATIC SYSTEM;MOTILITY;ODDS RATIO;PATIENT SATISFACTION;POPULATION;PSYCHOPATHOLOGY;STOMACH;TERM (TIME);TUMOR NECROSIS FACTOR ALPHA","6;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GENOTYPE;HEPATITIS C VIRUS;PLACEBO;ALLELE;BREAST CANCER;CHRONIC HEPATITIS;COLORECTAL CANCER;GASTRIC EMPTYING;PERIPHERAL BLOOD MONONUCLEAR CELL;SOMATIZATION;ADENOCARCINOMA;ALPHA INTERFERON;ANGIOTENSIN-CONVERTING ENZYME;APOLIPOPROTEIN E;CANCER CELL;CANCER INCIDENCE;CARCINOGENESIS;CD14;CEREBELLAR HYPOPLASIA (NON-HUMAN);CEREBELLAR VERMIS;COHORT EFFECT;COMMUNITY-ACQUIRED PNEUMONIA;CONSTRUCT VALIDITY;CRYOPRESERVATION;DOWNREGULATION AND UPREGULATION;ELASTOGRAPHY;ENTERAL ADMINISTRATION;FATTY LIVER;FORENSIC PATHOLOGY;GASTRIC DISTENSION;GENE DUPLICATION;GENE EXPRESSION;GENOME;HEPATITIS B VIRUS;INSULIN RESISTANCE;INTERLEUKIN;INTERLEUKIN 10;INTERNAL CONSISTENCY;INTESTINAL MOTILITY;JOUBERT SYNDROME;LACTOBACILLUS;LIVER FIBROSIS;LOCUS (GENETICS);METABOLIC SYNDROME;OVARIAN FOLLICLE;OVARIAN TISSUE;PEYER'S PATCH;POISSON REGRESSION;PORTAL HYPERTENSION;PROBIOTIC;REFLUX;SEROLOGY;SURVIVIN;TRYPAN BLUE;TUNEL ASSAY","3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ESTROGEN RECEPTOR;OVARIAN CORTEX;RIBAVIRIN;ADENOMATOUS POLYPOSIS COLI;ALPHA (FINANCE);CONGENITAL HEPATIC FIBROSIS;CONVERGENT VALIDITY;DOUBLE BLIND;ESOPHAGITIS;FAMILIAL ADENOMATOUS POLYPOSIS;HBSAG;HOX GENE;LACTOBACILLUS REUTERI;LACTOBACILLUS RHAMNOSUS;MITOTIC CROSSOVER;PNEUMONIA SEVERITY INDEX;PSEUDOGENE;SEROPREVALENCE;SOMATIZATION DISORDER;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE;TRANSIENT ELASTOGRAPHY","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;AGED;;MIDDLE AGED;ADOLESCENT;AGED, 80 AND OVER;PEYER'S PATCHES;SOMATOFORM DISORDERS;OVARY;APOPTOSIS;ESTROGEN RECEPTOR BETA;HEPACIVIRUS;INFANT FORMULA;ITALY;OLIGOSACCHARIDES;OVARIAN FOLLICLE;RNA, MESSENGER","22;20;18;10;10;9;9;7;7;7;7;6;5;5;5;5;5;5;5;5","GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HEPATITIS C INFECTION AND TREATMENT;INTEROCEPTION AND SOMATIC SYMPTOMS;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;CHARGE SYNDROME AND RELATED GENETIC DISORDERS;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;COUNTER-CURRENT CHROMATOGRAPHY TECHNIQUES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;DIAGNOSIS AND TREATMENT OF HEART FAILURE;FACTORS INFLUENCING PATIENT SATISFACTION WITH HEALTHCARE;FERTILITY PRESERVATION IN CANCER PATIENTS;GENOMIC REARRANGEMENT DISORDERS IN SKIN DISEASES;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;INFANT CRYING AND COLIC STUDIES;INNATE IMMUNE RECOGNITION AND SIGNALING PATHWAYS;INNATE LYMPHOID CELLS IN IMMUNITY;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;MANAGEMENT OF HYPERBILIRUBINEMIA IN NEWBORN INFANTS","3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PREBIOTIC;PROBIOTICS;CANCER INCIDENCE;OVARIAN CORTEX;PEGYLATED INTERFERON;TREATMENT;ADAPTIVE IMMUNITY REGULATION;ADENOMATOUS POLYPOSIS COLI;AGING;ALPHA (FINANCE);APOLIPOPROTEIN E;BILIRUBIN MEASUREMENT;BILIRUBIN METABOLISM;CENTRAL SENSITIZATION;CEREBELLAR HYPOPLASIA (NON-HUMAN);CEREBELLAR VERMIS;CLINICAL LONGITUDINAL DATA;CLINICAL PRACTICE;CLINICAL PRACTICE GUIDELINES;CLINICAL PREDICTION RULE","3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PEYERS PATCHES;CHRONIC HEPATITIS;HUMAN PEYERS;MULTIDIMENSIONAL PROGNOSTIC;PROGNOSTIC INDEX;ADIPOSE TISSUE;ANGIOTENSIN CONVERTING;APC MIN;APOPTOTIC FACTORS;APPROPRIATENESS GUIDELINES;ASSESSING SOMATIZATION;ASSESSMENT PREDICTS;BLOOD CELLS;CANCER CELL;CANCER INCIDENCE;CANCER MORTALITY;CELL LINES;CLINICAL OUTCOMES;COACH SYNDROME;COLONIC CANCER;COLORECTAL CANCER;COMBINED TREATMENT;COMPREHENSIVE GERIATRIC;CONGENITAL HEPATIC;CONSULTATION-LIAISON PSYCHIATRY;CONVERTING ENZYME;CORDOBA ARGENTINA;COUNTERACTS INTESTINAL;CRYOPRESERVED HUMAN;CYTOKINE RELEASE","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICAL DEPARTMENT;GRADE GRADE;COACH SYNDROME;COMPREHENSIVE GERIATRIC;GERIATRIC ASSESSMENT;ACE DD;HEART FAILURE;LIVER DISEASE;MPI- MPI-;WOMEN CI;APOE Ε;BODY WEIGHT;CELL PROLIFERATION;DCPR SOMATIZATION;DEPARTMENT HOSPITAL;ESOPHAGEAL SPHINCTER;GASTROESOPHAGEAL REFLUX;IMKSI MUTATIONS;INDEX MPI;LIPID INCREASED;LOWER ESOPHAGEAL;MPI GRADE;MPI VALUES;MULTIDIMENSIONAL IMPAIRMENT;MULTIDIMENSIONAL PROGNOSTIC;OPERATING CHARACTERISTIC;PEGINTERFERON ALFA-A;PEGINTERFERON ALFA-B;PROGNOSTIC INDEX;RECEIVER OPERATING","7;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",6,0.19,5.25,2,0,1,0,0,1,0,1.75,2,0,0,1,0,4,0,0,1,0,0,0,72.5,72.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2010,33,7.24242424242424,1.81818181818182,0.55,0.303030303030303,0.272727272727273,0.0909090909090909,0.181818181818182,1,8,13,5,5,0.24,0.39,0.15,0.15,50.03,1.10709550414945,0.303030303030303,0.818181818181818,NA,0.435322370323993,0.300925925925926,0.309523809523809,0.333333333333333,"PIERO PORCELLI;MICHELE LINSALATA;ANTONELLA ORLANDO;FRANCESCO RUSSO;MARIA GABRIELLA CARUSO;VITO GUERRA;GIUSEPPE RIEZZO;MARIA NOTARNICOLA;VALERIA TUTINO;CATERINA MESSA;MAURIZIO BIFULCO;EMILIO JIRILLO;MARISA CHILOIRO;L. AMATI;ANTONIETTA SANTORO;DONATO F. ALTOMARE;ORLANDO TODARELLO;SIMONA PISANTI;SILVIA FRISULLO;MARIA GRAZIA REFOLO","6;5;5;5;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2","PIERO PORCELLI;ANTONELLA ORLANDO;FRANCESCO RUSSO;MICHELE LINSALATA;GIUSEPPE RIEZZO;VITO GUERRA;MARIA GABRIELLA CARUSO;JONI L. MIHURA;MARIA NOTARNICOLA;CATERINA MESSA;MARISA CHILOIRO;EMILIO JIRILLO;L. AMATI;MARIA GRAZIA REFOLO;VALERIA TUTINO;ROBERTO MIRIZZI;ALDO CAVALLINI;N. MIRIZZI;MAURIZIO BIFULCO;M. MARTULLI","2.21;0.75;0.75;0.71;0.71;0.62;0.6;0.5;0.5;0.48;0.44;0.42;0.42;0.37;0.35;0.33;0.33;0.33;0.31;0.31","PIERO PORCELLI;MICHELE LINSALATA;ANTONELLA ORLANDO;FRANCESCO RUSSO;MARIA GABRIELLA CARUSO;VITO GUERRA;GIUSEPPE RIEZZO;MARIA NOTARNICOLA;VALERIA TUTINO;CATERINA MESSA;EMILIO JIRILLO;MARISA CHILOIRO;L. AMATI;SILVIA FRISULLO;MARIA GRAZIA REFOLO;ALDO CAVALLINI;MARCELLO CHIEPPA;CATERINA CLEMENTE;GIOACCHINO LEANDRO;F M DI MATTEO","6;5;5;5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;1;1","PIERO PORCELLI;ANTONELLA ORLANDO;FRANCESCO RUSSO;MICHELE LINSALATA;GIUSEPPE RIEZZO;VITO GUERRA;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;CATERINA MESSA;MARISA CHILOIRO;EMILIO JIRILLO;L. AMATI;MARIA GRAZIA REFOLO;VALERIA TUTINO;ALDO CAVALLINI;SILVIA FRISULLO;MARCELLO CHIEPPA;BRIAN I. CARR;ALBERTO R. OSELLA;CATERINA CLEMENTE","2.21;0.75;0.75;0.71;0.71;0.62;0.6;0.5;0.48;0.44;0.42;0.42;0.37;0.35;0.33;0.29;0.27;0.25;0.25;0.24","MARCELLO CHIEPPA;ELISA MAZZINI;ERIKA MILETI;FRANCESCA FALLARINO;GIANLUCA MATTEOLI;ILIYAN D. ILIEV;MARÍA RESCIGNO;PAOLO PUCCETTI;PIERO PORCELLI;FRANCESCO RUSSO;MICHELE LINSALATA;MARIA GABRIELLA CARUSO;EMILIO JIRILLO;ANTONELLA ORLANDO;MARIA NOTARNICOLA;MAURIZIO BIFULCO;GIUSEPPE RIEZZO;ALBERTO MANTOVANI;GIUSEPPE BIANCHI;GORDANA LAŠKARIN","508;349;349;349;349;349;349;349;319;225;214;210;184;180;174;162;160;159;159;159","MARCELLO CHIEPPA;PIERO PORCELLI;MICHELE LINSALATA;MARIA GABRIELLA CARUSO;GIUSEPPE RIEZZO;MARIA NOTARNICOLA;CATERINA CLEMENTE;EMILIO JIRILLO;MARISA CHILOIRO;ANTONELLA ORLANDO;ANTONIO GENTILE;VALERIA TUTINO;FRANCESCO RUSSO;BENEDETTA D’ATTOMA;CATERINA MESSA;ANTONIO MAZZOCCA;ANGELA TAFARO;ALDO CAVALLINI;SILVIA FRISULLO;VITO GUERRA","508;319;185;162;160;126;116;116;116;105;97;97;76;74;63;62;55;48;48;48","PIERO PORCELLI;GIUSEPPE RIEZZO;MICHELE LINSALATA;ANTONELLA ORLANDO;MARIA GABRIELLA CARUSO;VITO GUERRA;ALDO CAVALLINI;CATERINA CLEMENTE;CATERINA MESSA;FRANCESCO RUSSO;L. AMATI;MARCELLO CHIEPPA;MARIA NOTARNICOLA;MARISA CHILOIRO;SILVIA FRISULLO;ALBERTO R. OSELLA;ANGELA TAFARO;ANTONIO GENTILE;ANTONIO MAZZOCCA;BENEDETTA D’ATTOMA","6;4;4;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;ECONOMICS;PHYSICS;ENGINEERING;GEOGRAPHY;MATERIALS SCIENCE;PHILOSOPHY;SOCIOLOGY","25;19;5;5;2;2;1;1;1;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;GENETICS;ENDOCRINOLOGY;CANCER RESEARCH;IMMUNOLOGY;GASTROENTEROLOGY;CLINICAL PSYCHOLOGY;PHARMACOLOGY;PSYCHIATRY;FOOD SCIENCE;MOLECULAR BIOLOGY;ONCOLOGY;PATHOLOGY;CELL BIOLOGY;ECOLOGY;MACROECONOMICS;MICROBIOLOGY;SOCIAL PSYCHOLOGY;SURGERY","21;12;9;8;7;7;6;4;4;4;3;3;3;3;2;2;2;2;2;2","CANCER;CELL GROWTH;ENZYME;DISEASE;IMMUNE SYSTEM;RECEPTOR;ANTIGEN;ANXIETY;APOPTOSIS;CELL CULTURE;POLYAMINE;RORSCHACH TEST;ALEXITHYMIA;ANTIOXIDANT;BACTERIA;BIOMARKER;CHOLESTEROL;COHORT;CYTOKINE;DEPRESSION (ECONOMICS);DIABETES MELLITUS;FECES;FEELING;GENE;HEPATOLOGY;INULIN;KIDNEY DISEASE;PREBIOTIC;STOMACH;TUMOR NECROSIS FACTOR ALPHA","9;5;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CANCER CELL;COLORECTAL CANCER;SPERMIDINE;SPERMINE;AGONIST;ENDOCANNABINOID SYSTEM;FRUCTOSAMINE;GASTRIC EMPTYING;HOSPITAL ANXIETY AND DEPRESSION SCALE;INTERLEUKIN 6;METASTASIS;ORNITHINE DECARBOXYLASE;POLYPHENOL;PROBIOTIC;PUTRESCINE;ANXIETY DISORDER;BREAST CANCER;CANNABINOID;CAUSE OF DEATH;CELL CYCLE;CHEMOKINE;CHROMOSOMAL TRANSLOCATION;CHROMOSOME;COHORT EFFECT;CONSTRUCT VALIDITY;DEFENSIN;ENZYME ASSAY;EPIDERMAL GROWTH FACTOR RECEPTOR;EPITOPE;FATTY ACID SYNTHASE;FLAVONOID;FOXP3;GELATINASE;GENERALIZED ANXIETY DISORDER;GENOTYPE;HEPATITIS C VIRUS;HEPATORENAL SYNDROME;IMMUNE TOLERANCE;IMMUNOSENESCENCE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLAMMATORY BOWEL DISEASE;INSULIN RESISTANCE;INTEGRIN;INTERLEUKIN;INTERLEUKIN 10;INTERNAL CONSISTENCY;INTESTINAL EPITHELIUM;LACTOBACILLUS;LACTOBACILLUS CASEI;LEPTIN;MACROPHAGE;METABOLIC SYNDROME;MICROFOLD CELL;OLEUROPEIN;OLIGURIA;OVERWEIGHT;PANIC;PANIC DISORDER;PHENOTYPE;PLACEBO;POISSON REGRESSION;PRENYLATION;PRIMARY SCLEROSING CHOLANGITIS;PROGRAMMED CELL DEATH;PSYCHOLOGICAL DISTRESS;QUERCETIN;REDUCTASE;SOMATIZATION;T CELL;TORONTO ALEXITHYMIA SCALE;TRANSPLANT SURGERY;TRIGLYCERIDE;TRYPTOPHAN;ULCERATIVE COLITIS;WAVEFORM;X CHROMOSOME","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANNABINOID RECEPTOR;ADIPOKINE;AGORAPHOBIA;APIGENIN;BREAKPOINT;CETUXIMAB;CHILDHOOD OBESITY;CONVERGENT VALIDITY;CORONAVIRUS DISEASE 2019 (COVID-19);CROSSOVER STUDY;DISCRIMINANT VALIDITY;DNA FRAGMENTATION;GELATINASES;GENOTYPING;HYDROXYTYROSOL;IL-2 RECEPTOR;INDOLEAMINE 2,3-DIOXYGENASE;INFLAMMATORY BOWEL DISEASES;KARYOTYPE;KRAS;LACTOBACILLUS PARACASEI;LACTOBACILLUS RHAMNOSUS;MAMMARY GLAND;MANNOSE RECEPTOR;METASTATIC BREAST CANCER;RIBAVIRIN;SENTINEL LYMPH NODE;SOMATIZATION DISORDER;TERLIPRESSIN","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;AFFECTIVE SYMPTOMS;MIDDLE AGED;BREAST NEOPLASMS;INFLAMMATION;;AGED;BIOMARKERS, TUMOR;COLONIC NEOPLASMS;CYTOKINES;INTERLEUKIN-10;INTESTINAL MUCOSA;ITALY;ORNITHINE DECARBOXYLASE;RNA, MESSENGER;ADAPTIVE IMMUNITY;INTERLEUKIN-12","26;16;15;11;10;10;8;7;6;6;6;6;6;6;6;6;6;6;5;5","POLYAMINES AND BIOGENIC AMINES IN BIOLOGY AND HEALTH;ROLE OF FRUCTANS IN NUTRITION AND HEALTH;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;INTEROCEPTION AND SOMATIC SYMPTOMS;PSYCHOLOGICAL ASSESSMENT AND MOTIVATION RESEARCH;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;BIOCHEMISTRY OF DIABETIC COMPLICATIONS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF LIVER DISEASES;EMBODIED COGNITION AND SOCIAL INTERACTION;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;GLOBAL CANCER INCIDENCE AND MORTALITY PATTERNS;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HEPATITIS C INFECTION AND TREATMENT;IMMUNOBIOLOGY OF DENDRITIC CELLS;IMMUNOLOGICAL RESPONSES IN AQUATIC ORGANISMS;INFLAMMATION AND OBESITY-RELATED METABOLIC DISORDERS;LIPID METABOLISM IN CANCER PATHOGENESIS;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS","3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","POLYAMINE;RORSCHACH TEST;ANANDAMIDE;DEPRESSION (ECONOMICS);FRUCTOSAMINE;INULIN;PREBIOTIC;RORSCHACH COMPREHENSIVE SYSTEM;THERAPEUTIC ASSESSMENT;AGORAPHOBIA;ALEXITHYMIA;AM251;ANOSMIA;ANURIA;ANXIETY;BREAKPOINT;CANCER BIOMARKERS;CANCER INCIDENCE;CANCER PATIENTS;CANNABINOID RECEPTORS","3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER CELLS;COLORECTAL CANCER;BREAST CANCER;CANCER CELL;CELL GROWTH;COLON CANCER;COMPREHENSIVE SYSTEM;GASTRIC CANCER;HUMAN COLON;INULIN-ENRICHED PASTA;RORSCHACH COMPREHENSIVE;ACID SYNTHASE;AGE-PERIOD-COHORT ANALYSIS;AGE-RELATED DIFFERENCES;AGED IMMUNE;ALEXITHYMIA SCALE;AMBIGUOUS STIMULI;ANTIGEN-SAMPLING CELLS;ANTITUMOR EFFECTS;ANXIETY DISORDERS;ARRAY CGH;BIOMARKERS PREVENTION;BIOPSYCHOLOGICAL DISTRESS;BOWEL DISEASE;CANCER MORTALITY;CANCER PAIN;CANCER PATIENTS;CAT COLON;CD DENDRITIC;CELL BALANCE","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CELL LINES;CELL PROLIFERATION;ENZYMATIC ACTIVITY;MORTALITY RATES;CANCER CELL;SW CELLS;AGE-STANDARDIZED MORTALITY;CANCER MORTALITY;GENE EXPRESSION;HMG-COA REDUCTASE;RIBAVIRIN DOSE;ANANDAMIDE ANALOG;ANTI-PROLIFERATIVE EFFECT;BIRTH COHORT;BREAST CANCER;COHORT EFFECT;COLORECTAL CANCER;ENZYME ACTIVITY;FNK ENZYME;HCV GENOTYPES;HUMAN BREAST;HUMAN COLON;HUMAN COLORECTAL;IMMUNE SUPPRESSIVE;JOINPOINT REGRESSION;MORTALITY TRENDS;OIL POLYPHENOLS;OLIVE OIL;REDUCTASE ACTIVITY;RIBAVIRIN DOSES","5;5;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",5,0.15,6,2,0,1,0,0,1.5,0,0,2,0,0,1,0,1,0,0,0,1,0,0,75,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2011,28,8.53571428571429,2.07142857142857,0.482758620689655,0.25,0.285714285714286,0,0.428571428571429,0,18,5,1,3,0.64,0.18,0.04,0.11,30.32,0.712870268329225,0.464285714285714,0.785714285714286,NA,0.388695272481015,0.257142857142857,0.285714285714286,0,"PIERO PORCELLI;ALESSANDRO ZAMBELLI;MARIA ANTONIA BIANCO;LIVIO CIPOLLETTA;GIOVANNI DI MATTEO;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;GIOACCHINO LEANDRO;VALERIA TUTINO;GIOVANNI MISCIAGNA;M. DEL PIANO;RICCARDO MARMO;G. ROTONDANO;M. KOCH;ROSALBA D’ALESSANDRO;BRIAN I. CARR;ALBERTO R. OSELLA;VITO GUERRA;MARÍA DEL PILAR DÍAZ;RAFFAELE COZZOLONGO","5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","BRIAN I. CARR;PIERO PORCELLI;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;ROSALBA D’ALESSANDRO;VALERIA TUTINO;PETR PANČOŠKA;ALBERTO R. OSELLA;MARÍA DEL PILAR DÍAZ;VITO GUERRA;JACOPO MELDOLESI;ALESSANDRO ZAMBELLI;GIOVANNI MISCIAGNA;MARIA ANTONIA BIANCO;LIVIO CIPOLLETTA;GIOVANNI DI MATTEO;DIONIGI LORUSSO;M. DEL PIANO;RICCARDO MARMO;G. ROTONDANO","0.75;0.73;0.73;0.73;0.67;0.6;0.58;0.58;0.58;0.51;0.5;0.46;0.44;0.41;0.41;0.41;0.4;0.36;0.36;0.36","PIERO PORCELLI;GIOVANNI DI MATTEO;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;GIOACCHINO LEANDRO;GIOVANNI MISCIAGNA;ROSALBA D’ALESSANDRO;BRIAN I. CARR;ALBERTO R. OSELLA;VITO GUERRA;RAFFAELE COZZOLONGO;JOSÉ PETRUZZI;ALDO CAVALLINI;G. BUONGIORNO;DIONIGI LORUSSO;V. GIANUZZI;S. ELBA;MARIA GRATZIA REFOLO;M PIRRELLI;A. FRANCAVILLA","5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;1;1;1","BRIAN I. CARR;PIERO PORCELLI;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;ROSALBA D’ALESSANDRO;ALBERTO R. OSELLA;VITO GUERRA;GIOVANNI MISCIAGNA;GIOVANNI DI MATTEO;DIONIGI LORUSSO;ALDO CAVALLINI;RAFFAELE COZZOLONGO;GIOACCHINO LEANDRO;JOSÉ PETRUZZI;G. BUONGIORNO;V. GIANUZZI;S. ELBA;MARIA GRATZIA REFOLO;CATIA LIPPOLIS;M PIRRELLI","0.75;0.73;0.73;0.73;0.67;0.58;0.51;0.44;0.41;0.4;0.33;0.32;0.29;0.25;0.25;0.25;0.25;0.17;0.17;0.12","PIERO PORCELLI;ALESSANDRO ZAMBELLI;ANNALISA PERNA;CARLA OLIVIERI;CESARE DANESINO;DARIO CONTE;EDOARDO BOCCARDI;ELISABETTA BUSCARINI;ERICA DAINA;F. DE GRAZIA;FABIO PAGELLA;FERNANDA MENOZZI;G. LUPINACCI;G. ROSSI;GIACOMO PONGIGLIONE;GIANFRANCO BRAMBILLA;GIOACCHINO LEANDRO;GIUSEPPE INAMA;GUIDO MANFREDI;MAURIZIO GROSSO","227;180;115;115;115;115;115;115;115;115;115;115;115;115;115;115;115;115;115;115","PIERO PORCELLI;GIOACCHINO LEANDRO;ROSALBA D’ALESSANDRO;MATTIA GENTILE;GIOVANNI DI MATTEO;ALDO CAVALLINI;BRIAN I. CARR;MARIA GABRIELLA CARUSO;VITO GUERRA;DIONIGI LORUSSO;MARIA NOTARNICOLA;ALBERTO R. OSELLA;CATIA LIPPOLIS;A. FRANCAVILLA;ANTONELLA ORLANDO;FRANCESCO RUSSO;GIUSEPPE RIEZZO;MARIA GRATZIA REFOLO;RAFFAELE COZZOLONGO;ANNA MARIA VALENTINI","227;115;112;76;65;61;45;45;42;37;37;36;36;28;28;28;28;25;15;12","PIERO PORCELLI;GIOVANNI DI MATTEO;GIOACCHINO LEANDRO;ALBERTO R. OSELLA;BRIAN I. CARR;MARIA GABRIELLA CARUSO;RAFFAELE COZZOLONGO;ROSALBA D’ALESSANDRO;VITO GUERRA;ALDO CAVALLINI;MARIA NOTARNICOLA;A. FRANCAVILLA;ANNA MARIA CISTERNINO;ANNA MARIA VALENTINI;ANTONELLA ORLANDO;CATIA LIPPOLIS;DIONIGI LORUSSO;FRANCESCO RUSSO;GIOVANNI MISCIAGNA;GIUSEPPE RIEZZO","5;4;3;3;3;3;3;3;3;2;2;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;SOCIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;MATHEMATICS;PHYSICS","24;7;5;4;3;3;2;2;2","INTERNAL MEDICINE;GASTROENTEROLOGY;BIOCHEMISTRY;SURGERY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;CLINICAL PSYCHOLOGY;DEMOGRAPHY;PATHOLOGY;PSYCHIATRY;CELL BIOLOGY;GENETICS;NEUROSCIENCE;PROGRAMMING LANGUAGE;CANCER RESEARCH;DEVELOPMENTAL PSYCHOLOGY;MACROECONOMICS;SOCIAL PSYCHOLOGY;STATISTICS;COGNITIVE PSYCHOLOGY;FOOD SCIENCE;GERONTOLOGY;IMMUNOLOGY;MICROBIOLOGY;NURSING;ONCOLOGY;OPTICS;PEDIATRICS;PHARMACOLOGY;QUANTUM MECHANICS;VIROLOGY","20;8;6;6;5;5;4;4;4;4;3;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;COHORT;ENDOSCOPY;POPULATION;PROSPECTIVE COHORT STUDY;ALBUMIN;ALEXITHYMIA;ANXIETY;CHOLESTEROL;GENE;HEPATOCELLULAR CARCINOMA;LOGISTIC REGRESSION;OBESITY;ODDS RATIO;RECEPTOR;ADENOMA;ANTHROPOMETRY;BILIRUBIN;CELL;CELL GROWTH;CENTRAL NERVOUS SYSTEM;COMORBIDITY;DEPRESSION (ECONOMICS);ENZYME;HEPATOLOGY;LIVER DISEASE;MORTALITY RATE;MYOCARDIAL INFARCTION;SIGNAL TRANSDUCTION","8;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;UPPER GASTROINTESTINAL BLEEDING;HCCS;PHENOTYPE;ADDED SUGAR;APOLIPOPROTEIN B;ASTROCYTE;BREAST CANCER;CATABOLISM;CELL ADHESION;CHRONIC HEPATITIS;CHRONIC LIVER DISEASE;CONFIRMATORY FACTOR ANALYSIS;CYTOSKELETON;EXON;FATTY ACID SYNTHASE;FATTY LIVER;FOREBRAIN;FRUCTOSAMINE;GENE DUPLICATION;GENE ISOFORM;GENOME;HEPATECTOMY;HEPATOCYTE;HEPATOCYTE GROWTH FACTOR;IMMUNOGENICITY;INTER-RATER RELIABILITY;L1;LACTOBACILLUS;LEPTIN;LIPIDOLOGY;LIPOLYSIS;LIPOPROTEIN LIPASE;LIVER REGENERATION;MAJOR DEPRESSIVE DISORDER;METHYLGLYOXAL;NESTED CASE-CONTROL STUDY;ODDS;OVERWEIGHT;PANIC DISORDER;PEPTIC;PI3K/AKT/MTOR PATHWAY;PROBIOTIC;PROTEIN KINASE B;PSYCHOLOGICAL DISTRESS;RAC1;RELIABILITY (SEMICONDUCTOR);RNA;SATURATED FAT;SEROCONVERSION;SOMATIZATION;SORAFENIB;TORONTO ALEXITHYMIA SCALE;TRANSCRIPTION FACTOR;TRIGLYCERIDE;TUMOR PROGRESSION;TYPE 2 DIABETES;UNIVARIATE ANALYSIS","5;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADIPOSE TRIGLYCERIDE LIPASE;ALTERNATIVE SPLICING;COLONOSCOPY;COPY-NUMBER VARIATION;ESTROGEN RECEPTOR;LACTOBACILLUS PARACASEI;LACTOYLGLUTATHIONE LYASE;LEPTIN RECEPTOR;LY294002;NEURAL CELL ADHESION MOLECULE;POLYUNSATURATED FAT;RAC GTP-BINDING PROTEINS;REPRESSOR;RIBAVIRIN;RNA SPLICING;SOMATIZATION DISORDER","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;COLORECTAL NEOPLASMS;FEMALE;MIDDLE AGED;AGED;ADENOCARCINOMA;ADULT;ITALY;AFFECTIVE SYMPTOMS;CARCINOMA, HEPATOCELLULAR;GASTROINTESTINAL NEOPLASMS;LIVER;LIVER NEOPLASMS;RECOMBINANT PROTEINS;CEREBRAL CORTEX;AGED, 80 AND OVER;ARTERIOVENOUS MALFORMATIONS;DIET;RNA, SMALL INTERFERING","21;19;18;18;14;13;11;11;9;8;8;7;7;7;7;6;5;5;5;5","INTEROCEPTION AND SOMATIC SYMPTOMS;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;BIOCHEMISTRY OF DIABETIC COMPLICATIONS;HEPATOCELLULAR CARCINOMA;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPATITIS C INFECTION AND TREATMENT;LIPID METABOLISM IN CANCER PATHOGENESIS;MECHANISMS AND TREATMENT OF LIVER FIBROSIS;MECHANISMS OF INTRACELLULAR MEMBRANE TRAFFICKING;MTOR SIGNALING IN GROWTH AND DISEASE;NEUROENDOCRINE REGULATION OF APPETITE AND BODY WEIGHT;PSYCHOLOGICAL ASSESSMENT AND MOTIVATION RESEARCH;REGULATION OF RNA PROCESSING AND FUNCTION;ROLE OF FRUCTANS IN NUTRITION AND HEALTH","4;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","UPPER GASTROINTESTINAL BLEEDING;CANCER RISK;DEPRESSION (ECONOMICS);HCCS;LIVER BIOPSY;LIVER DISEASE;MORTALITY PREDICTION;NUTRITIONAL EPIDEMIOLOGY;OBSCURE GASTROINTESTINAL BLEEDING;ADDED SUGAR;ADIPOSE TRIGLYCERIDE LIPASE;ALEXITHYMIA;ALTERNATIVE SPLICING;ASTROCYTE FUNCTION;CATABOLISM;CHRONIC LIVER DISEASE;COPY NUMBER VARIATION;DEPRESSION SYMPTOMS;DEPRESSIVE SYMPTOMS;DIAGNOSTIC CRITERIA","4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER PATIENTS;COLORECTAL CANCER;SOUTHERN ITALY;DATABASE STUDY;HIGH-RISK PATIENTS;MEDICALLY ILL;NONVARICEAL HEMORRHAGE;POPULATION-BASED STUDY;PROSPECTIVE DATABASE;RANDOM SAMPLE;SAMPLE POPULATION-BASED;ULCER BLEEDING;ADIPOSE TISSUE;ADVANCED TUMOR;ALTERNATIVE SPLICING;ANALYSIS-DERIVED CLASSIFICATION;ANTI-INTERFERON NEUTRALIZING;APOPTOTIC PROCESS;APPLYING MULTILEVEL;ASTROCYTE STELLATION;BIOCHEMICAL PARAMETERS;BLOOD CELL;C-MET-AKT PATHWAY-MEDIATED;C-RAF PHOSPHORYLATION;CASE-CONTROL STUDY;CASECONTROL STUDY;CELL LEVELS;CHINESE PATIENTS;CHRONIC HEPATITIS;CLUSTER ANALYSIS","4;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HEMORRHAGIC TELANGIECTASIA;HEREDITARY HEMORRHAGIC;BLOOD CELLS;C-RAF PHOSPHORYLATION;RED BLOOD;VASCULAR MALFORMATIONS;ASA SCORE;CELL GROWTH;VARICEAL UGIH;DUODENAL ULCER;FNK ACTIVITY;GENE CONTENT;HEALTH STATUS;HEPATIC VASCULAR;LIVER DISEASE;NEURAL CELLS;SURFACE EXPANSION;AGE HMETHODSH;ALCOHOL INTAKE;ALTERNATIVE SPLICING;ANTHROPOMETRIC MEASURES;APPROXIMATELY TIMES;CHC PATIENTS;COLORECTAL CANCER;COMBINATION VITAMIN;CULTURED ASTROCYTES;DAILY ALCOHOL;DEATH NA;DRAWN SUBJECTS;ENHANCED SORAFENIB-INDUCED","9;8;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2",7,0.25,6.39,2,1,1,0,0,0,0,1,2,0,0,1.5,1,1,0,1,1,1,0,0,55,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2012,31,8.74193548387097,2.41935483870968,0.413333333333333,0.419354838709677,0.354838709677419,0.193548387096774,0.451612903225806,1,10,12,4,2,0.32,0.39,0.13,0.06,35.65,0.853401540624662,0.32258064516129,0.806451612903226,4.44351464435146,0.419263196957195,0.410714285714286,0.224489795918367,0.346666666666667,"BRIAN I. CARR;CATERINA MESSA;A. FRANCAVILLA;VITO GUERRA;PIERO PORCELLI;MARIA GRAZIA REFOLO;ALDO CAVALLINI;CATIA LIPPOLIS;VERONICA BERNABUCCI;PETR PANČOŠKA;GIOVANNI MISCIAGNA;ALFREDO DI LEO;ANTONELLO BELLOMO;CALOGERO CAMMÀ;SILVANA GRANDI;NICOLA DE MARIA;MARIA RENDINA;ROSALBA D’ALESSANDRO;ANGELA TAFARO;CHIARA RAFANELLI","7;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","BRIAN I. CARR;VITO GUERRA;CATERINA MESSA;PETR PANČOŠKA;MARIA GABRIELLA CARUSO;MARIA NOTARNICOLA;MARIA GRAZIA REFOLO;ALDO CAVALLINI;CATIA LIPPOLIS;PIERO PORCELLI;A. FRANCAVILLA;ANGELA TAFARO;ANTONELLA ORLANDO;GIUSEPPE RIEZZO;EMILIO JIRILLO;ROSALBA D’ALESSANDRO;GIOVANNI MISCIAGNA;SHIRA TIBON;M PIRRELLI;MARIANNA DI MAGGIO","2;0.8;0.73;0.53;0.46;0.46;0.4;0.4;0.4;0.37;0.33;0.29;0.27;0.27;0.27;0.25;0.25;0.2;0.2;0.2","BRIAN I. CARR;CATERINA MESSA;A. FRANCAVILLA;VITO GUERRA;PIERO PORCELLI;MARIA GRAZIA REFOLO;ALDO CAVALLINI;CATIA LIPPOLIS;GIOVANNI MISCIAGNA;ROSALBA D’ALESSANDRO;ANGELA TAFARO;MATTIA GENTILE;EMILIO JIRILLO;ANTONELLA ORLANDO;GIUSEPPE RIEZZO;MARIA GABRIELLA CARUSO;ROBERTO QUARTESAN;GIOACCHINO LEANDRO;PALMA AURELIA IACOVAZZI;M. CORREALE","7;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1","BRIAN I. CARR;VITO GUERRA;CATERINA MESSA;MARIA GABRIELLA CARUSO;MARIA GRAZIA REFOLO;ALDO CAVALLINI;CATIA LIPPOLIS;PIERO PORCELLI;A. FRANCAVILLA;ANGELA TAFARO;ANTONELLA ORLANDO;GIUSEPPE RIEZZO;EMILIO JIRILLO;ROSALBA D’ALESSANDRO;GIOVANNI MISCIAGNA;M PIRRELLI;MARIANNA DI MAGGIO;ANNA MARIA VALENTINI;MARIA LUCIA CARUSO;RAFFAELE ARMENTANO","2;0.8;0.73;0.46;0.4;0.4;0.4;0.37;0.33;0.29;0.27;0.27;0.27;0.25;0.25;0.2;0.2;0.2;0.2;0.2","BRIAN I. CARR;A. FRANCAVILLA;ANTONELLA ORLANDO;GIUSEPPE RIEZZO;VITO GUERRA;CATERINA MESSA;ALDO CAVALLINI;CATIA LIPPOLIS;MARIA GRAZIA REFOLO;ROSALBA D’ALESSANDRO;A MASCIALE;BARRY L. DOWELL;C. FONTANA;DAWN M. CARLSON;ELENA LIONETTI;EVELYN MCKEEGAN;F. CIRUZZI;FLAVIA INDRIO;FRANK A. SCAPPATICCI;HAN CHONG TOH","287;235;179;179;151;142;121;121;121;121;102;102;102;102;102;102;102;102;102;102","BRIAN I. CARR;A. FRANCAVILLA;ANTONELLA ORLANDO;GIUSEPPE RIEZZO;VITO GUERRA;CATERINA MESSA;ALDO CAVALLINI;CATIA LIPPOLIS;MARIA GRAZIA REFOLO;ROSALBA D’ALESSANDRO;CATERINA CLEMENTE;FRANCESCO RUSSO;MARISA CHILOIRO;MICHELE LINSALATA;BENEDETTA D’ATTOMA;ANGELA TAFARO;PIERO PORCELLI;GIOACCHINO LEANDRO;ANTONIO DI CARLO;M. CORREALE","287;235;179;179;151;142;121;121;121;121;98;98;98;98;81;68;65;57;53;53","BRIAN I. CARR;A. FRANCAVILLA;CATERINA MESSA;VITO GUERRA;ALDO CAVALLINI;CATIA LIPPOLIS;MARIA GRAZIA REFOLO;PIERO PORCELLI;ANGELA TAFARO;ANTONELLA ORLANDO;EMILIO JIRILLO;GIOVANNI MISCIAGNA;GIUSEPPE RIEZZO;MATTIA GENTILE;ROSALBA D’ALESSANDRO;ANNA MARIA CISTERNINO;ANNA MARIA VALENTINI;ANTONIO DI CARLO;ANTONIO MAZZOCCA;B. PESETTI","7;4;4;4;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ECONOMICS;PSYCHOLOGY;POLITICAL SCIENCE","25;14;6;2;2;1","INTERNAL MEDICINE;GASTROENTEROLOGY;BIOCHEMISTRY;PATHOLOGY;GENETICS;CANCER RESEARCH;CELL BIOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PHARMACOLOGY;CLINICAL PSYCHOLOGY;ONCOLOGY;PEDIATRICS;PSYCHIATRY;MOLECULAR BIOLOGY;SURGERY;ANATOMY;ANIMAL SCIENCE;BIOINFORMATICS;DEVELOPMENTAL PSYCHOLOGY;ECOLOGY;ENDOCRINOLOGY;FINANCE;GENERAL SURGERY;GERONTOLOGY;GYNECOLOGY;LAW;MACROECONOMICS;NEUROSCIENCE;NURSING;PALEONTOLOGY;PHYSIOLOGY;PSYCHOTHERAPIST;RADIOLOGY;VIROLOGY","23;11;9;8;7;6;4;4;4;4;3;3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HEPATOCELLULAR CARCINOMA;CANCER;GENE;CELL GROWTH;POPULATION;APOPTOSIS;BIOPSY;CIRRHOSIS;TRANSPLANTATION;ALTERNATIVE MEDICINE;BILIRUBIN;CHEMOTHERAPY;CLINICAL TRIAL;ENZYME;FIBROSIS;HEPATITIS C;IMMUNOHISTOCHEMISTRY;IN VITRO;KINASE;MOOD;RETROSPECTIVE COHORT STUDY;THROMBOSIS;VIRUS","9;7;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;SORAFENIB;GROWTH INHIBITION;CANCER CELL;GENOTYPE;LIVER BIOPSY;LIVER TRANSPLANTATION;PHENOTYPE;PLACEBO;PORTAL VEIN THROMBOSIS;ACUTE DIARRHEA;ALKALINE PHOSPHATASE;ALLELE;ATOPY;BREAST CANCER;CANNABINOID;CARCINOGENESIS;CARDIOMYOPATHY;CELL CYCLE;CHROMOSOME;CHRONIC HEPATITIS;CLINICAL ENDPOINT;CLUSTERIN;COLORECTAL SURGERY;FATTY ACID SYNTHASE;FUNCTIONAL CONSTIPATION;GENE DUPLICATION;GENE EXPRESSION;GLUCAGON-LIKE PEPTIDE-2;HCCS;HEPATITIS B VIRUS;HEPATITIS C VIRUS;IC50;IMMUNOGLOBULIN E;LIVER CANCER;MAPK/ERK PATHWAY;MICRODISSECTION;NITROSOUREA;PHASES OF CLINICAL RESEARCH;PLASMINOGEN ACTIVATOR INHIBITOR-1;PORTAL HYPERTENSION;PRENYLATION;PROBIOTIC;PROGRAMMED CELL DEATH;PROGRESSION-FREE SURVIVAL;PROGRESSIVE DISEASE;PROTEIN KINASE A;SOMATIZATION;THERAPEUTIC ENDOSCOPY;TYPE 2 DIABETES;TYPE A AND TYPE B PERSONALITY THEORY;UPPER GASTROINTESTINAL BLEEDING","6;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REGORAFENIB;ABDOMINOPERINEAL RESECTION;ALLELE FREQUENCY;COLOANAL ANASTOMOSIS;COLONIC DISEASE;COMPARATIVE GENOMIC HYBRIDIZATION;CROSSOVER STUDY;DOUBLE BLIND;FARNESYLTRANSFERASE;GENE POLYMORPHISM;GENOTYPE-PHENOTYPE DISTINCTION;GLUCAGON-LIKE PEPTIDE-1;KARYOTYPE;LACTOBACILLUS PARACASEI;LASER CAPTURE MICRODISSECTION;MICRODELETION SYNDROME;P38 MITOGEN-ACTIVATED PROTEIN KINASES;POLYMORPHISM (COMPUTER SCIENCE);RIBAVIRIN;SINGLE-NUCLEOTIDE POLYMORPHISM;SOMATIZATION DISORDER;TRASTUZUMAB","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARCINOMA, HEPATOCELLULAR;HUMANS;LIVER NEOPLASMS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ANTINEOPLASTIC AGENTS;PHENYLUREA COMPOUNDS;THROMBOCYTOPENIA;AGED, 80 AND OVER;ALPHA-FETOPROTEINS;ABNORMALITIES, MULTIPLE;APOPTOSIS;HEPATITIS C;HEPATITIS C, CHRONIC;INTELLECTUAL DISABILITY;LIVER CIRRHOSIS;NIACINAMIDE","26;26;26;21;18;14;12;10;10;10;8;7;7;6;6;6;6;6;6;6","HEPATOCELLULAR CARCINOMA;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;ARTICHOKE NUTRACEUTICAL AND FUNCTIONAL FOOD RESEARCH;CARDIAC REHABILITATION AND CARDIOVASCULAR HEALTH INTERVENTIONS;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;EQUINE HEALTH AND WELFARE;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GLIOMAS;HEPATITIS C INFECTION AND TREATMENT;HER2 SIGNALING IN BREAST CANCER TREATMENT;IMMUNOLOGICAL RESPONSES IN AQUATIC ORGANISMS;INFANT CRYING AND COLIC STUDIES;INTEROCEPTION AND SOMATIC SYMPTOMS;LIPID METABOLISM IN CANCER PATHOGENESIS;MAMMALIAN MAP KINASE SIGNALING PATHWAYS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION","6;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GROWTH INHIBITION;HEPATOCELLULAR CARCINOMA;REGORAFENIB;HEPATITIS C;HEPATOCYTE GROWTH FACTOR;INTESTINAL PERMEABILITY;LIVER BIOPSY;LIVER CANCER;PORTAL VEIN THROMBOSIS;PROBIOTICS;TREATMENT;ABDOMINOPERINEAL RESECTION;ABERRANT CRYPT FOCI;ACUTE DIARRHEA;ANASTOMOTIC LEAKAGE;APOPTOSIS;ATOPY;CANCER CELL METABOLISM;CANCER THERAPY;CANNABINOID RECEPTORS","3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","HEPATOCELLULAR CARCINOMA;CLINICAL TRIAL;COLORECTAL CANCER;HEPATOMA CELLS;RANDOMISED CLINICAL;ABDOMINOPERINEAL RESECTION;ABSTRACT REGORAFENIB;ACTIVATOR INHIBITOR-;ACUTE DIARRHOEA;AFP MIGRATION;ALLERGIC RHINITIS;ANNIVERSARY REACTIONS;ANTIGEN EXPRESSION;APOPTOTIC RESPONSE;ARTERY CHEMOEMBOLIZATION;ASSESSMENT PROCEDURE;BIOPSY SPECIMENS;CANCER CELLS;CANCER PATIENTS;CANNABINOID TYPE;CAPTURE MICRODISSECTION;CARCINOMA RECURRENCE;CARDIOMYOPATHY SYNDROME;CARDIOVASCULAR DISEASE;CELL AFP;CELLS GROWTH;CENTRAL NERVOUS;CHRONIC HEPATITIS;CIRCULATING LEVELS;CIRCULATING SERPINE-","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FIBROSIS PROGRESSION;CHILD-PUGH CLASS;DRUG CONCENTRATIONS;HEPATIC FUNCTION;HEPATOCELLULAR CARCINOMA;ISHAK STAGE;ACUTE DIARRHOEA;CELL GROWTH;ESTRADIOLTESTOSTERONE RATIO;ADVERSE EVENTS;CARCINOMA HCC;CELL LINES;CHRONIC HEPATITIS;COLORECTAL CANCER;DE NOVO;DRUG REMOVAL;FAST FIBROSERS;GBM PATIENTS;GROWTH FACTOR;HISTOLOGICAL DE;LIVER TRANSPLANTATION;MACRONUTRIENT INTAKE;PROBIOTIC-ENRICHED ARTICHOKES;PROGRESSION RATE;PV THROMBOSIS;RECURRENT GBM;REPRODUCTIVE AGE;SCFA PRODUCTION;SIGNALING PATHWAYS;ACTOBACILLUS REUTERI","6;5;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2",12,0.39,3,5.25,1.5,0,0,0,0,0,1,5.25,0,0,3,1,4,0,0,2.75,1.25,0,0,93,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2013,36,9.13888888888889,2.63888888888889,0.378947368421053,0.5,0.333333333333333,0.222222222222222,0.416666666666667,1,17,10,3,2,0.47,0.28,0.08,0.06,19.94,0.57159582912209,0.222222222222222,0.833333333333333,4.65925925925926,0.547255633146169,0.367117117117117,0.35016835016835,0.371428571428571,"BRIAN I. CARR;VITO GUERRA;GIUSEPPE RIEZZO;IVAN LOLLI;GIOACCHINO LEANDRO;ALFREDO DI LEO;FRANCESCO RUSSO;PIERO PORCELLI;GIOVANNI MISCIAGNA;ROSALBA D’ALESSANDRO;GIULIA MARTINA CAVESTRO;RAFFAELLA ALESSIA ZUPPARDO;MICHELE LINSALATA;LEONARDO RESTA;BENEDETTA D’ATTOMA;ANTONELLA ORLANDO;SILVIA CARRARA;ELISABETTA GONI;G CAMPANELLA;ROBERTA ROSSI","7;7;6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","BRIAN I. CARR;VITO GUERRA;GIOACCHINO LEANDRO;GIUSEPPE RIEZZO;ROSALBA D’ALESSANDRO;ALFREDO DI LEO;PIERO PORCELLI;FRANCESCO RUSSO;IVAN LOLLI;GIOVANNI MISCIAGNA;MICHELE LINSALATA;BENEDETTA D’ATTOMA;ANTONELLA ORLANDO;CATERINA CLEMENTE;SHENG‐NAN LU;CHIH‐YUN LIN;JACOPO MELDOLESI;GIULIA MARTINA CAVESTRO;RAFFAELLA ALESSIA ZUPPARDO;SARA NEGRINI","2.25;2.03;1.33;0.59;0.59;0.46;0.45;0.42;0.38;0.37;0.34;0.34;0.34;0.34;0.33;0.33;0.33;0.33;0.33;0.33","BRIAN I. CARR;VITO GUERRA;GIUSEPPE RIEZZO;IVAN LOLLI;GIOACCHINO LEANDRO;FRANCESCO RUSSO;PIERO PORCELLI;GIOVANNI MISCIAGNA;ROSALBA D’ALESSANDRO;MICHELE LINSALATA;BENEDETTA D’ATTOMA;ANTONELLA ORLANDO;G CAMPANELLA;CATERINA CLEMENTE;CATERINA MESSA;A. FRANCAVILLA;ALDO CAVALLINI;MARIA NOTARNICOLA;CATIA LIPPOLIS;MASSIMO DE CARNE","7;7;6;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;1","BRIAN I. CARR;VITO GUERRA;GIOACCHINO LEANDRO;GIUSEPPE RIEZZO;ROSALBA D’ALESSANDRO;PIERO PORCELLI;FRANCESCO RUSSO;IVAN LOLLI;GIOVANNI MISCIAGNA;MICHELE LINSALATA;BENEDETTA D’ATTOMA;ANTONELLA ORLANDO;CATERINA CLEMENTE;G CAMPANELLA;CATERINA MESSA;ALDO CAVALLINI;CATIA LIPPOLIS;LUCIA MONTENEGRO;ALBERTO R. OSELLA;MARIA NOTARNICOLA","2.25;2.03;1.33;0.59;0.59;0.45;0.42;0.38;0.37;0.34;0.34;0.34;0.34;0.33;0.25;0.25;0.25;0.2;0.2;0.19","GIUSEPPE RIEZZO;FRANCESCO RUSSO;ALFREDO DI LEO;VITO GUERRA;A. FRANCAVILLA;LORENZO POLIMENO;RUGGIERO FRANCAVILLA;ANTONELLA DEMICHINA;ENZO IERARDI;GIOVANNI MAUROGIOVANNI;GIUSEPPE SCACCIANOCE;JAMES VERSALOVIC;LUCIANO CAVALLO;MARIABEATRICE PRINCIPI;PIERO PORCELLI;IVAN LOLLI;BRIAN I. CARR;MARIA GRAZIA FABRINI;GIOVANNI MISCIAGNA;ANTONELLA ORLANDO","192;191;166;159;131;131;109;108;108;108;108;108;108;108;103;89;87;87;86;83","GIUSEPPE RIEZZO;FRANCESCO RUSSO;VITO GUERRA;A. FRANCAVILLA;PIERO PORCELLI;IVAN LOLLI;BRIAN I. CARR;GIOVANNI MISCIAGNA;ANTONELLA ORLANDO;BENEDETTA D’ATTOMA;CATERINA CLEMENTE;MICHELE LINSALATA;LUCIA MONTENEGRO;G CAMPANELLA;ROSALBA D’ALESSANDRO;ALBERTO R. OSELLA;FILOMENA CARIOLA;MASSIMO DE CARNE;ANNA MARIA CISTERNINO;CATERINA BONFIGLIO","192;191;145;131;103;89;87;86;83;83;83;83;58;54;34;31;30;30;28;28","BRIAN I. CARR;VITO GUERRA;GIUSEPPE RIEZZO;IVAN LOLLI;FRANCESCO RUSSO;GIOACCHINO LEANDRO;ANTONELLA ORLANDO;BENEDETTA D’ATTOMA;CATERINA CLEMENTE;G CAMPANELLA;GIOVANNI MISCIAGNA;MICHELE LINSALATA;ROSALBA D’ALESSANDRO;PIERO PORCELLI;A. FRANCAVILLA;ALDO CAVALLINI;CATERINA MESSA;CATIA LIPPOLIS;MARIA NOTARNICOLA;ALBERTO R. OSELLA","7;6;6;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;ENGINEERING;POLITICAL SCIENCE;COMPUTER SCIENCE;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;SOCIOLOGY","32;11;7;3;3;2;2;1;1;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;BIOCHEMISTRY;ONCOLOGY;GENETICS;SURGERY;PATHOLOGY;CANCER RESEARCH;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;CELL BIOLOGY;IMMUNOLOGY;PHARMACOLOGY;PSYCHIATRY;INTENSIVE CARE MEDICINE;LAW;NEUROSCIENCE;OPTICS;ANESTHESIA;CIVIL ENGINEERING;COGNITIVE PSYCHOLOGY;COMPOSITE MATERIAL;DEMOGRAPHY;DERMATOLOGY;DEVELOPMENTAL PSYCHOLOGY;EMERGENCY MEDICINE;FAMILY MEDICINE;FOOD SCIENCE;GENERAL SURGERY;GERONTOLOGY;LINGUISTICS;MATHEMATICAL ANALYSIS;MICROBIOLOGY;MOLECULAR BIOLOGY;PEDIATRICS;PHYSIOLOGY;PROGRAMMING LANGUAGE;PSYCHOTHERAPIST;QUANTUM MECHANICS;SOCIAL PSYCHOLOGY;STRUCTURAL ENGINEERING","29;15;10;8;7;7;6;5;5;5;4;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;HEPATOCELLULAR CARCINOMA;CHEMOTHERAPY;CIRRHOSIS;PLATELET;POPULATION;CELL GROWTH;COHORT;DISEASE;IN VITRO;LOGISTIC REGRESSION;TOXICITY;ACUTE PANCREATITIS;ALTERNATIVE MEDICINE;BACTERIA;BILIRUBIN;BODY MASS INDEX;CARCINOMA;CELL;CLINICAL TRIAL;COGNITION;DIARRHEA;ENZYME;GENE;GLIOBLASTOMA;HEPATITIS C;HORMONE;INCIDENCE (GEOMETRY);KINASE;LIVER FUNCTION;MEDLINE;MULTIVARIATE ANALYSIS;OBESITY;PANCREATITIS;PROTHROMBIN TIME;RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;VIRUS","10;7;6;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;BREAST CANCER;TEMOZOLOMIDE;ALKALINE PHOSPHATASE;CLINICAL ENDPOINT;CYCLOPHOSPHAMIDE;GHRELIN;GROWTH INHIBITION;HEPATITIS C VIRUS;MAPK/ERK PATHWAY;PLACEBO;PROBIOTIC;TRANSCRIPTION FACTOR;UNIVARIATE ANALYSIS;ALCOHOL CONSUMPTION;BEVACIZUMAB;CARCINOGENESIS;CELL CYCLE;CHEMOTHERAPY REGIMEN;CHRONIC DIARRHEA;CLINICAL ONCOLOGY;CLUSTERIN;COGNITIVE IMPAIRMENT;DEMENTIA;EC50;FATTY LIVER;GASTRIC EMPTYING;GENE EXPRESSION;GLUCAGON-LIKE PEPTIDE-2;GLUTAMINE;HELICOBACTER PYLORI INFECTION;HEPATECTOMY;HEPATOCYTE;INFANTILE COLIC;ISOPRENALINE;LEPTIN;LIVER BIOPSY;LIVER REGENERATION;METABOLIC SYNDROME;METASTASIS;METHYLATION;MTT ASSAY;NEONATOLOGY;NERVE GROWTH FACTOR;NEURITE;NEUROTROPHIN;NEUTROPENIA;OVERWEIGHT;PAIN MEDICINE;PANCREATIC DUCT;PI3K/AKT/MTOR PATHWAY;PROGRESSION-FREE SURVIVAL;REFINED GRAINS;RNA;SORAFENIB;STRESS–STRAIN CURVE;SUPEROXIDE DISMUTASE;THROMBOCYTOSIS;TIMOLOL;TYPE 2 DIABETES;VIREMIA","5;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CETUXIMAB;EPIRUBICIN;IRINOTECAN;LACTOBACILLUS REUTERI;OXALIPLATIN;REGORAFENIB;ADIPOKINE;BETAXOLOL;CA15-3;COGNITIVE DECLINE;CYCLIN D1;ELEVATED ALKALINE PHOSPHATASE;ESTROGEN RECEPTOR;FEBRILE NEUTROPENIA;GASTROINTESTINAL CANCER;GASTROPARESIS;KEAP1;LOW-AFFINITY NERVE GROWTH FACTOR RECEPTOR;METHYLTRANSFERASE;MTORC1;NUCLEAR RECEPTOR;PANCREAS DIVISUM;RIBAVIRIN;SMALL HAIRPIN RNA;SOD1;TROPOMYOSIN RECEPTOR KINASE A;UREA BREATH TEST;VASCULAR DEMENTIA","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARCINOMA, HEPATOCELLULAR;HUMANS;LIVER NEOPLASMS;FEMALE;MALE;MIDDLE AGED;;AGED;BREAST NEOPLASMS;BRAIN NEOPLASMS;CARCINOMA, DUCTAL, BREAST;ITALY;ADULT;ANTINEOPLASTIC AGENTS;DIARRHEA;INTESTINAL MUCOSA;NEOPLASM RECURRENCE, LOCAL;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CARCINOMA, SMALL CELL;CYCLOPHOSPHAMIDE","23;23;23;17;14;14;12;10;10;9;8;8;6;6;6;6;6;5;5;5","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;GLIOMAS;HEPATOCELLULAR CARCINOMA;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;HEPATITIS C INFECTION AND TREATMENT;INTEROCEPTION AND SOMATIC SYMPTOMS;PATHOBIOLOGY AND MANAGEMENT OF MUCOSITIS IN CANCER THERAPY;CANCER STEM CELLS AND TUMOR METASTASIS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CUTANEOUS MANIFESTATIONS OF COVID-19: A COMPREHENSIVE REVIEW;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EMBODIED COGNITION AND SOCIAL INTERACTION;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;IMPACT OF CHRONIC STRESS ON CANCER PROGRESSION;INFLAMMATION'S ROLE IN CANCER DEVELOPMENT AND PROGRESSION;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;NURR1/COREST PATHWAY IN NEUROPROTECTION AND INFLAMMATION;ROLE OF CLUSTERIN IN CANCER AND DISEASE","4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","HEPATOCELLULAR CARCINOMA;TEMOZOLOMIDE;CHEMOTHERAPY;CLINICAL ENDPOINT;EPIRUBICIN;GLIOBLASTOMA;GROWTH INHIBITION;HEPATITIS C;INTESTINAL PERMEABILITY;LACTOBACILLUS REUTERI;LIVER FUNCTION;METASTATIC COLORECTAL CANCER;REGORAFENIB;TREATMENT;UNIVARIATE ANALYSIS;ALEXITHYMIA;ASSOCIATION (PSYCHOLOGY);BETAXOLOL;BRAIN METASTASES;CA 15-3","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","BREAST CANCER;HEPATOCELLULAR CARCINOMA;ALCOHOL CONSUMPTION;CANCER MCRC;CANCER PATIENTS;CHRONIC PANCREATITIS;CIGARETTE SMOKING;COLORECTAL CANCER;CONSUMPTION CIGARETTE;HEPATOCELLULAR CARCINOMAS;LOGISTIC REGRESSION;MEDICALLY ILL;METABOLIC PROFILE;METASTATIC COLORECTAL;MULTIVARIABLE LOGISTIC;OBSERVER STUDY;PANCREAS DIVISUM;RECURRENT ACUTE;RECURRENT GLIOBLASTOMA;SKIN TOXICITY;ABSTRACT REGORAFENIB-MEDIATED;ACUTE PANCREATITIS;ADIPOKINE PROFILE;AFFECTED PATIENTS;AINO ITALIAN;ALKALINE PHOSPHATASE;ALLEVIATES VASCULOPATHY;AMP-GLUTAMYL TRANSPEPTIDASE;BARRIER FUNCTION;BLOOD PLATELET","4;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","TUMOR SIZE;CTD PATIENTS;INTESTINAL PERMEABILITY;BREAST CANCER;GLIOBLASTOMA PATIENTS;HCC PATIENTS;LARGER TUMORS;MU SUPPRESSION;BILIRUBIN LEVELS;CELL GROWTH;GROWTH MIGRATION;HCC SAMPLES;HEPATOCELLULAR CARCINOMA;HEPATOCYTE PROLIFERATION;HIPPURIC ACID;PC- CELLS;PLATELET COUNTS;QUIESCENT HEPATOCYTES;SERUM LEVELS;SIGNIFICANTLY LOWER;SIZE TERCILE;ADVANCED DISEASE;ALCOHOL INTAKE;ALKALINE PHOSPHATASE;ALKP LEVELS;AP ETIOLOGY;ATTAINED SVR;BASELINE CHARACTERISTICS;BASELINE VARIABLES;BILIARY ETIOLOGY","8;7;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2",13,0.36,3.5,3,7.5,0,0,1,0,0,0,4,0,0,2,0,1,0,1,2.25,0,0,0,76,76,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2014,37,11.2162162162162,2.51351351351351,0.397849462365591,0.45945945945946,0.351351351351351,0.216216216216216,0.486486486486487,0,13,15,4,1,0.35,0.41,0.11,0.03,28.41,0.751630770738945,0.216216216216216,0.837837837837838,4.36785714285714,0.472521569521229,0.448387096774194,0.366666666666667,0.532467532467532,"BRIAN I. CARR;M. BARONE;FABIO FARINATI;GIOACCHINO LEANDRO;FRANCO BORZIO;CATERINA MESSA;MARCO ZOLI;EDOARDO G. GIANNINI;ANGELO ANDRIULLI;IVAN LOLLI;ROSALBA D’ALESSANDRO;FRANCO TREVISANI;GIAN LUDOVICO RAPACCINI;FRANCESCA CICCARESE;LUISA BENVEGNÙ;VITO GUERRA;ALDO CAVALLINI;RAFFAELE COZZOLONGO;EUGENIO CATURELLI;MARIA CHIARAMONTE","13;6;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4","BRIAN I. CARR;VITO GUERRA;CATERINA MESSA;ROSALBA D’ALESSANDRO;ALDO CAVALLINI;CATIA LIPPOLIS;PETR PANČOŠKA;GIOACCHINO LEANDRO;M. BARONE;FRANCESCO RUSSO;MARIA GRAZIA REFOLO;ANTONELLA ORLANDO;ALFREDO DI LEO;PIERO PORCELLI;MASSIMO DE CARNE;SHENG‐NAN LU;CHIH-YUN LIN;FABIO FARINATI;FRANCO BORZIO;MARCO ZOLI","2.47;0.73;0.58;0.58;0.58;0.58;0.58;0.53;0.5;0.44;0.41;0.37;0.35;0.33;0.33;0.33;0.33;0.31;0.31;0.31","BRIAN I. CARR;GIOACCHINO LEANDRO;CATERINA MESSA;IVAN LOLLI;ROSALBA D’ALESSANDRO;VITO GUERRA;ALDO CAVALLINI;RAFFAELE COZZOLONGO;CATIA LIPPOLIS;ANTONIO MAZZOCCA;MARIA GRAZIA REFOLO;FRANCESCO RUSSO;VALERIA TUTINO;AURORE GILIBERTI;A. FRANCAVILLA;MARGHERITA BIANCO;B. PESETTI;MICHELE LINSALATA;ALBERTO R. OSELLA;ANTONELLA ORLANDO","13;4;4;4;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2","BRIAN I. CARR;VITO GUERRA;CATERINA MESSA;ROSALBA D’ALESSANDRO;ALDO CAVALLINI;CATIA LIPPOLIS;GIOACCHINO LEANDRO;FRANCESCO RUSSO;MARIA GRAZIA REFOLO;ANTONELLA ORLANDO;PIERO PORCELLI;MASSIMO DE CARNE;IVAN LOLLI;VALERIA TUTINO;MARIA NOTARNICOLA;ANTONIO MAZZOCCA;MICHELE LINSALATA;NICOLA CARELLA;RAFFAELE COZZOLONGO;GIUSEPPE RIEZZO","2.47;0.73;0.58;0.58;0.58;0.58;0.53;0.44;0.41;0.37;0.33;0.33;0.3;0.3;0.3;0.3;0.28;0.27;0.26;0.24","BRIAN I. CARR;GIUSEPPE RIEZZO;ANTONIO DEL VECCHIO;ANTONIO DI MAURO;CRISTINA INTINI;ELISA BALLARDINI;ELISA CIVARDI;EMANUELA BRAZZODURO;FLAVIA INDRIO;LUIGI CORVAGLIA;MASSIMO BISCEGLIA;MAURO CINQUETTI;RUGGIERO FRANCAVILLA;SILVIO TAFURI;M. BARONE;ALFREDO DI LEO;ALDO CAVALLINI;CATERINA MESSA;CATIA LIPPOLIS;MARIA GRAZIA REFOLO","457;220;200;200;200;200;200;200;200;200;200;200;200;200;177;161;151;151;151;151","BRIAN I. CARR;GIUSEPPE RIEZZO;ALDO CAVALLINI;CATERINA MESSA;CATIA LIPPOLIS;MARIA GRAZIA REFOLO;ROSALBA D’ALESSANDRO;MARIA NOTARNICOLA;VALERIA TUTINO;FRANCESCO RUSSO;ANTONELLA ORLANDO;VITO GUERRA;GIOACCHINO LEANDRO;MICHELE LINSALATA;NICOLA CARELLA;AURORE GILIBERTI;MARGHERITA BIANCO;ELISA VADRUCCI;ELISABETTA CAVALCANTI;FRANCESCO ADDABBO","457;220;151;151;151;151;151;123;123;122;114;113;102;102;47;45;45;41;41;41","BRIAN I. CARR;ALDO CAVALLINI;CATERINA MESSA;CATIA LIPPOLIS;RAFFAELE COZZOLONGO;ROSALBA D’ALESSANDRO;VITO GUERRA;FRANCESCO RUSSO;GIOACCHINO LEANDRO;IVAN LOLLI;MARIA GRAZIA REFOLO;A. FRANCAVILLA;ALBERTO R. OSELLA;ANTONELLA ORLANDO;AURORE GILIBERTI;B. PESETTI;GIUSEPPE RIEZZO;MARGHERITA BIANCO;MARIA NOTARNICOLA;MAURO MASTRONARDI","13;4;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;ECONOMICS;PHYSICS;PSYCHOLOGY;SOCIOLOGY;GEOGRAPHY;HISTORY","35;18;8;3;3;2;2;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;BIOCHEMISTRY;ONCOLOGY;PATHOLOGY;CANCER RESEARCH;CELL BIOLOGY;GENETICS;IMMUNOLOGY;PALEONTOLOGY;PHARMACOLOGY;SURGERY;ENDOCRINOLOGY;PSYCHIATRY;ARCHAEOLOGY;DEMOGRAPHY;MICROBIOLOGY;NURSING;OPTICS;PEDIATRICS","33;16;13;11;10;8;5;4;4;4;4;4;3;3;2;2;2;2;2;2","HEPATOCELLULAR CARCINOMA;CANCER;GENE;COHORT;PLATELET;APOPTOSIS;BILIRUBIN;CARCINOMA;CELL GROWTH;RECEPTOR;CHEMOTHERAPY;CIRRHOSIS;CONFIDENCE INTERVAL;DISEASE;HEPATITIS C;ODDS RATIO;PROPORTIONAL HAZARDS MODEL;REGIMEN;VIRUS;ABLATION;ACUTE PANCREATITIS;ANXIETY;CONTEXT (ARCHAEOLOGY);ENZYME;GLUTEN;IN VITRO;INCIDENCE (GEOMETRY);INFLAMMATION;NATURAL HISTORY;PANCREATITIS;PROSPECTIVE COHORT STUDY;QUALITY OF LIFE (HEALTHCARE);SIGNAL TRANSDUCTION;STAGE (STRATIGRAPHY);SURVIVAL ANALYSIS;TOXICITY","12;9;7;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;PHENOTYPE;ALPHA-FETOPROTEIN;CHEMOKINE;CHRONIC HEPATITIS;CROHN'S DISEASE;GENOTYPE;GROWTH FACTOR;GROWTH INHIBITION;LIVER CANCER;METASTASIS;RADIOFREQUENCY ABLATION;SORAFENIB;ALCOHOLIC LIVER DISEASE;ALKALINE PHOSPHATASE;ALLELE;ANNEXIN;BEVACIZUMAB;BREAST CANCER;CARCINOGENESIS;CIPROFLOXACIN;COELIAC DISEASE;CONSTRUCT VALIDITY;DOXORUBICIN;EPIDERMAL GROWTH FACTOR;FATTY ACID SYNTHASE;FINANCIAL CAPITAL;GENE EXPRESSION;GENE KNOCKDOWN;GENE SILENCING;GLIADIN;GLUTEN FREE;HAZARD RATIO;HEALTH RELATED QUALITY OF LIFE;HEALTH TECHNOLOGY;HEPATIC CARCINOMA;HEPATIC ENCEPHALOPATHY;HEPATITIS C VIRUS;HEPATOCYTE;HEPATOCYTE GROWTH FACTOR;INFANTILE COLIC;INFLAMMATORY BOWEL DISEASE;LIVER REGENERATION;LOCUS (GENETICS);LOG-RANK TEST;LUTEAL PHASE;MAPK/ERK PATHWAY;MYOMETRIUM;NEUTROPENIA;OVERWEIGHT;PHASES OF CLINICAL RESEARCH;PI3K/AKT/MTOR PATHWAY;PLACEBO;POLYPHENOL;POLYUNSATURATED FATTY ACID;PORTAL VEIN THROMBOSIS;PROBIOTIC;PROGRAMMED CELL DEATH;PROINFLAMMATORY CYTOKINE;PROSTATE CANCER;QUERCETIN;REDUCTASE;TEMOZOLOMIDE;THROMBOCYTOSIS;UNIVARIATE ANALYSIS;VIRAL LOAD","6;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","RIBAVIRIN;CIRCULATING TUMOR CELL;CXCL1;REGORAFENIB;ALCOHOLIC HEPATITIS;ALPHA (FINANCE);CAPECITABINE;CAPITAL FORMATION;CETUXIMAB;COLONOSCOPY;DOCOSAHEXAENOIC ACID;ELEVATED ALKALINE PHOSPHATASE;ENROFLOXACIN;EQ-5D;LACTOBACILLUS REUTERI;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;PTEN;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL HAIRPIN RNA;TUMOR PROMOTION","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;HUMANS;FEMALE;MALE;MIDDLE AGED;BLOOD PLATELETS;BIOMARKERS, TUMOR;ALPHA-FETOPROTEINS;AGED;ADULT;;COLORECTAL NEOPLASMS;ITALY;HEPATITIS C, CHRONIC;APOPTOSIS;PROGNOSIS;LIVER CIRRHOSIS;PROSPECTIVE STUDIES;AGED, 80 AND OVER","40;39;25;19;19;15;14;13;12;11;10;9;9;9;8;7;7;6;6;5","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;CANCER STEM CELLS AND TUMOR METASTASIS;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;LIPID METABOLISM IN CANCER PATHOGENESIS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;GLIOMAS;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;IMPACT OF OBESITY ON CANCER RISK AND PROGNOSIS;INFANT CRYING AND COLIC STUDIES;INFLAMMATION'S ROLE IN CANCER DEVELOPMENT AND PROGRESSION;INTEROCEPTION AND SOMATIC SYMPTOMS;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;MECHANISMS AND TREATMENT OF LIVER FIBROSIS;MOLECULAR MECHANISMS OF ANGIOGENESIS AND VASCULAR FUNCTION","4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","HEPATOCELLULAR CARCINOMA;HEPATITIS C;REGIMEN;TREATMENT;ACUTE PANCREATITIS;ALPHA-FETOPROTEIN;CHRONIC PANCREATITIS;CIRCULATING TUMOR CELL;CXCL1;DIETARY PATTERNS;GROWTH INHIBITION;LIVER CANCER;PANCREATIC DISEASE;PEGYLATED INTERFERON;RADIOFREQUENCY ABLATION;REGORAFENIB;TUMOR MICROENVIRONMENT;ALCOHOLIC HEPATITIS;ALCOHOLIC NEUROPATHY;ALEXITHYMIA","6;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","HEPATOCELLULAR CARCINOMA;COLORECTAL CANCER;METASTATIC COLORECTAL;ACUTE PANCREATITIS;AFP LEVELS;AGGRESSIVE PHENOTYPE;CARCINOMA PATIENTS;CELLS CTCS;CIRCULATING CYTOKINES;CLINICAL HEPATOCELLULAR;CLUSTERED CIRCULATING;COHORT STUDY;CROHNS DISEASE;CYTOKINES DEFINE;FATTY ACIDS;GROWTH INHIBITION;NATURAL HISTORY;PLATELET FACTORS;PROSPECTIVE COHORT;RADIOFREQUENCY ABLATION;SOLE STUDY;ABNORMAL PLASMA;ABSTRACT ANTAGONISM;ACIDS SUPPRESS;ACUTE INTESTINAL;AGGRESSIVE HEPATOCELLULAR;AINO ITALIAN;ALPHA-FETOPROTEIN HCC;APCMIN MICE;APOPTOTIC PROCESS","8;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CD PATIENTS;VIROLOGICAL RESPONSE;EQ-D-L QUESTIONNAIRE;HCC PATIENTS;SUSTAINED VIROLOGICAL;AFP LEVELS;HCC CELL;HEALTHY SUBJECTS;CELL LINES;PARACELLULAR PERMEABILITY;PORTAL VEIN;TUMOR SIZE;VIABLE LGG;YEARLY COST;BC RISKS;BILIRUBIN LEVELS;CACO- CELLS;CANCER RISK;GFD INTERVENTION;SD MEDIAN;VAS SCORES;VEIN THROMBOSIS;ALPHA-FETOPROTEIN AFP;BLOOD ALPHA-FETOPROTEIN;CARCINOMA HCC;CELL GROWTH;DISEASE CD;GENE EXPRESSION;HEALTH TECHNOLOGIES;HEPATOCELLULAR CARCINOMA","12;9;8;8;8;7;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3",14,0.38,2.69,3,4.5,1.75,2,12.25,2,0,1,3,0,1,3.25,1,0,1,1.25,2,2,0,0,42.5,42.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2015,35,10.1428571428571,2.62857142857143,0.380434782608696,0.4,0.371428571428571,0.171428571428571,0.371428571428571,0,16,12,0,4,0.46,0.34,0,0.11,78.2,2.09830320421819,0.457142857142857,0.771428571428571,4.34713375796178,0.481573188936528,0.191452991452991,0.31404958677686,0.3,"BRIAN I. CARR;ALBERTO R. OSELLA;VALERIA TUTINO;PIERO PORCELLI;CATERINA MESSA;IVAN LOLLI;ROSALBA D’ALESSANDRO;MARIA GRAZIA REFOLO;ANTONELLA ORLANDO;ALDO CAVALLINI;FRANCESCO RUSSO;MARÍA DEL PILAR DÍAZ;RAFFAELE COZZOLONGO;MARIA NOTARNICOLA;SILVIA SCOCCIANTI;GIOACCHINO LEANDRO;MAURO ARCICASA;ANTONIO SILVANI;ANDREA P. SPONGHINI;MARINA FAEDI","6;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3","BRIAN I. CARR;ALBERTO R. OSELLA;PIERO PORCELLI;MARÍA DEL PILAR DÍAZ;VITO GUERRA;ANTONELLA ORLANDO;FRANCESCO RUSSO;VALERIA TUTINO;MARIA NOTARNICOLA;ALDO CAVALLINI;CATERINA MESSA;ROSALBA D’ALESSANDRO;MARIA GRAZIA REFOLO;JAMES H. KLEIGER;GIOACCHINO LEANDRO;CATIA LIPPOLIS;RAFFAELE COZZOLONGO;CAMILA NICLIS;MICHELE LINSALATA;BENEDETTA D’ATTOMA","1.35;0.96;0.92;0.9;0.81;0.75;0.75;0.69;0.69;0.58;0.56;0.56;0.56;0.5;0.47;0.45;0.44;0.4;0.33;0.33","BRIAN I. CARR;ALBERTO R. OSELLA;VALERIA TUTINO;PIERO PORCELLI;CATERINA MESSA;IVAN LOLLI;ROSALBA D’ALESSANDRO;MARIA GRAZIA REFOLO;ANTONELLA ORLANDO;ALDO CAVALLINI;FRANCESCO RUSSO;RAFFAELE COZZOLONGO;MARIA NOTARNICOLA;GIOACCHINO LEANDRO;VITO GUERRA;CATIA LIPPOLIS;VITO GIANNUZZI;MICHELE LINSALATA;BENEDETTA D’ATTOMA;ELSA LANZILOTTA","6;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;2;2;2;2","BRIAN I. CARR;ALBERTO R. OSELLA;PIERO PORCELLI;VITO GUERRA;ANTONELLA ORLANDO;FRANCESCO RUSSO;VALERIA TUTINO;MARIA NOTARNICOLA;ALDO CAVALLINI;CATERINA MESSA;ROSALBA D’ALESSANDRO;MARIA GRAZIA REFOLO;GIOACCHINO LEANDRO;CATIA LIPPOLIS;RAFFAELE COZZOLONGO;MICHELE LINSALATA;BENEDETTA D’ATTOMA;VITO GIANNUZZI;ELSA LANZILOTTA;IVAN LOLLI","1.35;0.96;0.92;0.81;0.75;0.75;0.69;0.69;0.58;0.56;0.56;0.56;0.47;0.45;0.44;0.33;0.33;0.32;0.32;0.3","ANNUNZIATA SCIROCCO;CAROLA SEVERI;M.A. MASELLI;MARILIA CARABOTTI;MARIA NOTARNICOLA;VALERIA TUTINO;CATERINA MESSA;MARIA GRAZIA REFOLO;ROSALBA D’ALESSANDRO;BRIAN I. CARR;ALBERTO R. OSELLA;CHIARA LAEZZA;MARIA GABRIELLA CARUSO;MAURIZIO BIFULCO;NATASCIA MALERBA;ALDO CAVALLINI;VITO GUERRA;CLAUDIA CURCI;DIMITRIOS GOUMENOS;ENYU IMAI","2061;2061;2061;2061;150;150;135;135;135;130;123;95;95;95;95;90;87;72;72;72","M.A. MASELLI;CATERINA MESSA;MARIA GRAZIA REFOLO;ROSALBA D’ALESSANDRO;ALBERTO R. OSELLA;VITO GUERRA;BRIAN I. CARR;ALDO CAVALLINI;GRAZIA SERINO;ANTONELLA ORLANDO;FRANCESCO RUSSO;GIOVANNI MISCIAGNA;PIERO PORCELLI;MARIA NOTARNICOLA;VALERIA TUTINO;C. LIPPOLIS;CATIA LIPPOLIS;NICOLA CARELLA;CRISTIANO SIMONE;GIOVANNA FORTE","2061;135;135;135;123;87;81;72;72;70;70;60;56;55;55;50;40;40;37;37","ALBERTO R. OSELLA;ANTONELLA ORLANDO;CATERINA MESSA;FRANCESCO RUSSO;MARIA GRAZIA REFOLO;PIERO PORCELLI;RAFFAELE COZZOLONGO;ROSALBA D’ALESSANDRO;MARIA NOTARNICOLA;VALERIA TUTINO;VITO GUERRA;ALDO CAVALLINI;BRIAN I. CARR;CATIA LIPPOLIS;GIOACCHINO LEANDRO;BENEDETTA D’ATTOMA;ELSA LANZILOTTA;MICHELE LINSALATA;NICOLA CARELLA;VITO GIANNUZZI","5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;SOCIOLOGY;ECONOMICS;PHYSICS;GEOGRAPHY;HISTORY;MATERIALS SCIENCE;MATHEMATICS","30;15;6;5;4;2;2;1;1;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;CANCER RESEARCH;GASTROENTEROLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;CELL BIOLOGY;ENDOCRINOLOGY;ONCOLOGY;PSYCHIATRY;GENETICS;PHARMACOLOGY;DEMOGRAPHY;FOOD SCIENCE;CLINICAL PSYCHOLOGY;PATHOLOGY;ARCHAEOLOGY;GERONTOLOGY;NEUROSCIENCE;SURGERY","27;11;10;9;8;7;6;6;6;6;5;5;4;4;3;3;2;2;2;2","CANCER;POPULATION;RECEPTOR;APOPTOSIS;CELL GROWTH;HEPATOCELLULAR CARCINOMA;CHEMOTHERAPY;DISEASE;VIRUS;ANXIETY;CELL CULTURE;COHORT;CONFIDENCE INTERVAL;GLIOBLASTOMA;IMMUNE SYSTEM;KINASE;OBESITY;REGIMEN;ABDOMINAL SURGERY;ANTIOXIDANT;CELL;CIRRHOSIS;COGNITION;DIABETES MELLITUS;HEPATITIS B;HEPATITIS C;HEPATOLOGY;IRRITABLE BOWEL SYNDROME;LOGISTIC REGRESSION;MULTIVARIATE ANALYSIS;PROPORTIONAL HAZARDS MODEL;PROSPECTIVE COHORT STUDY;RADIATION THERAPY","11;8;7;6;6;5;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;MAPK/ERK PATHWAY;GROWTH FACTOR;AGONIST;BEVACIZUMAB;BREAST CANCER;CANCER CELL;CELL CYCLE;CHRONIC HEPATITIS;ENDOCANNABINOID SYSTEM;EPIDERMAL GROWTH FACTOR;EPIDERMAL GROWTH FACTOR RECEPTOR;HAZARD RATIO;HEPATITIS B VIRUS;HEPATITIS C VIRUS;LIVER CANCER;PROSTATE CANCER;SORAFENIB;TEMOZOLOMIDE;UNIVARIATE ANALYSIS","6;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","REGORAFENIB;CANNABINOID RECEPTOR;ERLOTINIB;3T3-L1;ANTIGEN PRESENTATION;BRAIN-DERIVED NEUROTROPHIC FACTOR;CHEMOKINE RECEPTOR;COLONOSCOPY;DOCOSAHEXAENOIC ACID;EGFR INHIBITORS;HBSAG;HYDROXYTYROSOL;INSULIN-LIKE GROWTH FACTOR;NUTRITION TRANSITION;ONCOGENE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;RECEPTOR ANTAGONIST","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;CELL PROLIFERATION;COLONIC NEOPLASMS;FEMALE;MALE;MIDDLE AGED;ADULT;APOPTOSIS;HEPATITIS C, CHRONIC;AGED;ANTINEOPLASTIC AGENTS;ANTIVIRAL AGENTS;DEPRESSION;INTERFERON-ALPHA;MAP KINASE SIGNALING SYSTEM;MICRORNAS;RECEPTOR, CANNABINOID, CB1","19;14;13;13;12;12;12;12;11;9;8;7;6;6;6;6;6;6;6;6","GLIOMAS;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;HEPATOCELLULAR CARCINOMA;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;POLYAMINES AND BIOGENIC AMINES IN BIOLOGY AND HEALTH;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ANORECTAL SURGICAL PROCEDURES;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;EMBODIED COGNITION AND SOCIAL INTERACTION;GLOBAL CANCER INCIDENCE AND MORTALITY PATTERNS;HEPATITIS B INFECTION AND TREATMENT;IMMUNOBIOLOGY OF DENDRITIC CELLS;IMMUNOTOXIN THERAPY FOR CANCER TREATMENT;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;INTEROCEPTION AND SOMATIC SYMPTOMS;MENTAL HEALTH AND QUALITY OF LIFE","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","TREATMENT;GLIOBLASTOMA;REGIMEN;REGORAFENIB;CANCER;CANNABINOID RECEPTORS;CB1 AND CB2 RECEPTORS;DIETARY PATTERNS;HEPATITIS B;HEPATITIS C;HEPATOCELLULAR CARCINOMA;LIVER CANCER;TEMOZOLOMIDE;UNIVARIATE ANALYSIS;3T3-L1;ABDOMINAL CAVITY;ACUTE PANCREATITIS;ADDED SUGAR;ADJUVANT THERAPY;AGING","4;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","CELL LINES;AINO ITALIAN;CHRONIC HEPATITIS;GLIOBLASTOMA PATIENTS;GLIOBLASTOMA REGISTRY;ITALIAN ASSOCIATION;NITROSOUREA FOTEMUSTINE;STUPP REGIMEN;CANCER CELL;CB RECEPTOR;COLON CANCER;CÓRDOBA ARGENTINA;EPIDERMAL GROWTH;GLIOSTRY GLIOBLASTOMA;GROWTH FACTOR;HEPATOCELLULAR CARCINOMA;HUMAN COLON;INFLUENCING SURVIVAL;NEURO-ONCOLOGY ANALYSIS;PATIENTS RECEIVING;ABSTRACT ANTAGONISM;ACTIONS MEDIATED;ADMINISTRATION IMPAIRS;ADVANCED-STAGE HEPATOCELLULAR;AFFECTIVE DISORDERS;ALPHA-FETOPROTEIN LEVELS;ANAL FISSURE;ANALOGUE THERAPY;ANGIOTENSIN RECEPTOR;ANSWER STUDY","4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CELL LINES;GROWTH INHIBITION;REGORAFENIB-MEDIATED GROWTH;DIETARY PATTERNS;HCC CELL;CANCER CELLS;CELL PROLIFERATION;COLON CANCER;HR CI;POLYAMINE BIOSYNTHESIS;CANCER CELL;CELL CYCLE;CELL GROWTH;CELL MIGRATION;COMPLETE HEALING;DC MATURATION;LEVORAG EMULGEL;MAPK PATHWAY;MGMT STATUS;PC OCCURRENCE;PCA CELLS;STARCHY VEGETABLES;AFFECTING CELL;ANDOR ANALOGUES;ANTAGONIZED REGORAFENIB-MEDIATED;ANTAGONIZING REGORAFENIB-MEDIATED;APOPTOTIC EFFECTS;BEV HR;BLOCKED REGORAFENIB-INDUCED;BLOOD PLATELET","10;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2",18,0.51,4.5,4,1.5,1,2,5.25,1,0,1,4,0,0,2.75,0,0,2,1,2.25,1,0,0,65.25,65.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2016,39,11.1538461538462,2.05128205128205,0.4875,0.205128205128205,0.384615384615385,0.17948717948718,0.564102564102564,0,20,10,2,1,0.51,0.26,0.05,0.03,34.92,1.07511824761272,0.487179487179487,0.897435897435897,4,0.493368276096272,0.144230769230769,0.350649350649351,0.303571428571429,"GRAZIA SERINO;FABIO SALLUSTIO;GIOACCHINO LEANDRO;BRIAN I. CARR;FRANCESCO PAOLO SCHENA;CLAUDIA CURCI;SHARON NATASHA COX;VITO GUERRA;GIUSEPPE DE PALMA;IVAN LOLLI;ALBERTO R. OSELLA;MARÍA DEL PILAR DÍAZ;CAROLINA TOMBA;PIERO PORCELLI;MARIO FALCHI;ISABELLA FRANCO;M. CORREALE;ANNALISA GIAMPETRUZZI;LUCA ELLI;ROSALBA D’ALESSANDRO","8;7;6;6;6;5;5;5;5;4;3;3;2;2;2;2;2;2;2;2","BRIAN I. CARR;VITO GUERRA;GRAZIA SERINO;FABIO SALLUSTIO;MARIA GRAZIA REFOLO;GIOACCHINO LEANDRO;FRANCESCO PAOLO SCHENA;ALBERTO R. OSELLA;MARÍA DEL PILAR DÍAZ;SHARON NATASHA COX;PIERO PORCELLI;ROSALBA D ALESSANDRO;MICHELE LINSALATA;ANTONELLA ORLANDO;FRANCESCO RUSSO;CLAUDIA CURCI;GIUSEPPE DE PALMA;MASSIMO DE CARNE;ROSALBA D’ALESSANDRO;LICIANA VAZ DE ARRUDA SILVEIRA","1.84;1.68;0.75;0.67;0.67;0.67;0.57;0.56;0.56;0.51;0.5;0.5;0.5;0.5;0.5;0.46;0.46;0.33;0.33;0.33","GRAZIA SERINO;GIOACCHINO LEANDRO;VITO GUERRA;IVAN LOLLI;ALBERTO R. OSELLA;PIERO PORCELLI;ISABELLA FRANCO;M. CORREALE;ROSALBA D’ALESSANDRO;CATERINA BONFIGLIO;MARIA GRAZIA REFOLO;VANESSA GALLEGGIANTE;MICHELE LINSALATA;GIANLUIGI ZAZA;ANTONELLA ORLANDO;ALDO CAVALLINI;G CAMPANELLA;FRANCESCO RUSSO;NICOLA CARELLA;SERENA MANCARELLA","8;6;5;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","VITO GUERRA;GRAZIA SERINO;MARIA GRAZIA REFOLO;GIOACCHINO LEANDRO;ALBERTO R. OSELLA;PIERO PORCELLI;ROSALBA D ALESSANDRO;MICHELE LINSALATA;ANTONELLA ORLANDO;FRANCESCO RUSSO;MASSIMO DE CARNE;ROSALBA D’ALESSANDRO;ALDO CAVALLINI;NICOLA CARELLA;IVAN LOLLI;ISABELLA FRANCO;GIANLUIGI ZAZA;VANESSA GALLEGGIANTE;CATERINA MESSA;ELISA STASI","1.68;0.75;0.67;0.67;0.56;0.5;0.5;0.5;0.5;0.5;0.33;0.33;0.29;0.29;0.25;0.23;0.2;0.19;0.17;0.17","BRIAN I. CARR;VITO GUERRA;CARLO SMIRNE;CLARENCE YEN;DAVID J. PINATO;DOMINIK BETTINGER;ELIAS ALLARA;JEONG WON JANG;JESSICA HOWELL;JUSTIN STEBBING;KEIICHI KUBOTA;MARIO PIRISI;MASATOSHI KUDO;MICHELA EMMA BURLONE;MITSURU ISHIZUKA;RAMYA RAMASWAMI;ROBERT THIMME;ROHINI SHARMA;TADAAKI ARIZUMI;YOUNG WOON KIM","468;468;322;322;322;322;322;322;322;322;322;322;322;322;322;322;322;322;322;322","VITO GUERRA;GIOACCHINO LEANDRO;GRAZIA SERINO;ALBERTO R. OSELLA;ISABELLA FRANCO;ANTONELLA MIRIZZI;CATERINA BONFIGLIO;D.V. CARAMIA;DANIELA ISABEL ABBRESCIA;GIOVANNI MISCIAGNA;MATTHEW V TANZI;FRANCESCO DITURI;GIANLUIGI GIANNELLI;SERENA MANCARELLA;ELISA STASI;GIANLUIGI ZAZA;ANTONELLA ORLANDO;FRANCESCO RUSSO;MICHELE LINSALATA;PIERO PORCELLI","468;317;165;122;122;118;118;118;118;118;118;85;85;85;62;47;45;45;45;42","GRAZIA SERINO;VITO GUERRA;GIOACCHINO LEANDRO;IVAN LOLLI;ALBERTO R. OSELLA;ALDO CAVALLINI;ANTONELLA ORLANDO;CATERINA BONFIGLIO;FRANCESCO RUSSO;G CAMPANELLA;ISABELLA FRANCO;MARIA GRAZIA REFOLO;MICHELE LINSALATA;NICOLA CARELLA;PIERO PORCELLI;ROSALBA D’ALESSANDRO;ANGELA TAFARO;ANNAMARIA SONNANTE;ANTONELLA MIRIZZI;CATERINA CLEMENTE","8;5;5;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATHEMATICS;PSYCHOLOGY;SOCIOLOGY;COMPUTER SCIENCE;ECONOMICS;HISTORY","37;22;5;5;4;3;2;1;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;ENDOCRINOLOGY;CANCER RESEARCH;GASTROENTEROLOGY;IMMUNOLOGY;GENETICS;PATHOLOGY;ONCOLOGY;CELL BIOLOGY;ENVIRONMENTAL HEALTH;STATISTICS;SURGERY;OPTICS;PHARMACOLOGY;DEMOGRAPHY;ECOLOGY;NEUROSCIENCE;PALEONTOLOGY;PEDIATRICS;PSYCHIATRY;RADIOLOGY","31;13;12;10;9;9;8;6;5;4;4;4;4;3;3;2;2;2;2;2;2;2","CANCER;GENE;HEPATOCELLULAR CARCINOMA;CHEMOTHERAPY;CIRRHOSIS;CONFIDENCE INTERVAL;IMMUNE SYSTEM;KIDNEY;POPULATION;RECEPTOR;APOPTOSIS;BILIRUBIN;CARCINOMA;CELL;CELL GROWTH;COHORT;DIABETES MELLITUS;DISEASE;ENZYME;INCIDENCE (GEOMETRY);RANDOMIZED CONTROLLED TRIAL","9;7;6;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","COLORECTAL CANCER;CLINICAL ENDPOINT;HAZARD RATIO;NEPHROPATHY;BREAST CANCER;DOXORUBICIN;GENOTYPE;GROWTH FACTOR;LIVER CANCER;MAPK/ERK PATHWAY;SORAFENIB;T CELL;TRANSCRIPTION FACTOR;ACQUIRED IMMUNE SYSTEM;ADENOCARCINOMA;ALLELE;ALLERGEN;ALLERGIC INFLAMMATION;CANCER CELL;CD8;CELL CYCLE;CHEMOTHERAPY REGIMEN;CLEAR CELL RENAL CELL CARCINOMA;CYTOTOXIC T CELL;DEPRESSIVE SYMPTOMS;DNA SEQUENCING;DOWNREGULATION AND UPREGULATION;ENTEROPATHY;FATTY ACID SYNTHASE;FATTY LIVER;FINE-NEEDLE ASPIRATION;FOCAL ADHESION;FOOD ALLERGY;GAMMA-GLUTAMYLTRANSFERASE;GENE EXPRESSION;GENE SILENCING;GENETIC LINKAGE;GHRELIN;GLOMERULONEPHRITIS;GLUTEN FREE;GROWTH INHIBITION;GTP';HEPATIC CARCINOMA;IMMORTALISED CELL LINE;IMMUNITY;IMMUNOGLOBULIN E;IMMUNOTHERAPY;IMPUTATION (STATISTICS);INNATE IMMUNE SYSTEM;INSULIN RESISTANCE;INTEGRIN;INTENTION-TO-TREAT ANALYSIS;KIDNEY CANCER;LACTOBACILLUS;LAMININ;LOVASTATIN;METABOLIC SYNDROME;METASTASIS;METHYLATION;MTT ASSAY;MULTICENTER STUDY;MUTATION;NEPHRECTOMY;NEUROPSYCHOLOGY;NONALLERGIC RHINITIS;NUTRITIONAL EPIDEMIOLOGY;PHENOTYPE;PLACEBO;PLATELET AGGREGATION;PORTAL VEIN THROMBOSIS;PRIMING (AGRICULTURE);PROGENITOR CELL;PROSTATE;PROSTATE CANCER;PROTEIN KINASE A;PROTEOGLYCAN;QUERCETIN;RANDOM EFFECTS MODEL;RANDOMIZATION;REDUCTASE;RELATIVE RISK;SLPI;SOCIOECONOMIC STATUS;SURVIVIN;TEMOZOLOMIDE;TLR4;TORONTO ALEXITHYMIA SCALE;WEIGHT LOSS","4;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INSULIN-LIKE GROWTH FACTOR;KRAS;ADIPONECTIN;ARYL HYDROCARBON RECEPTOR;CETUXIMAB;CROSSOVER STUDY;DECORIN;DNA METHYLATION;ESTROGEN RECEPTOR;EXOME SEQUENCING;GERIATRIC DEPRESSION SCALE;IL-2 RECEPTOR;IRINOTECAN;LACTOBACILLUS RHAMNOSUS;MITOGEN-ACTIVATED PROTEIN KINASE KINASE;MULTICENTER TRIAL;NASAL PROVOCATION TEST;OBESTATIN;ONCOGENE;ORLISTAT;OXALIPLATIN;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;PROGENITOR;PROSTATE ADENOCARCINOMA;RENAL STEM CELL;REPRESSOR;SANGER SEQUENCING;T-CELL RECEPTOR;TLR2;WHEAT ALLERGY","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;MALE;ADULT;FEMALE;CELIAC DISEASE;MIDDLE AGED;IRRITABLE BOWEL SYNDROME;AGED;BILIRUBIN;CELL PROLIFERATION;GLOMERULONEPHRITIS, IGA;LIVER;LIVER CIRRHOSIS;ALKALINE PHOSPHATASE;ALPHA-FETOPROTEINS;BIOMARKERS, TUMOR;CHEMOEMBOLIZATION, THERAPEUTIC","19;18;15;15;12;11;11;9;9;8;7;6;6;6;5;5;4;4;4;4","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATOCELLULAR CARCINOMA;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;LIPID METABOLISM IN CANCER PATHOGENESIS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;BIOLOGICAL ACTIVITIES OF TRITERPENOIDS AND SAPONINS;EMBODIED COGNITION AND SOCIAL INTERACTION;ENGINEERING BACTERIA FOR CANCER TREATMENT;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GLIOMAS;HEPATITIS C INFECTION AND TREATMENT;IMPACT OF OBESITY ON CANCER RISK AND PROGNOSIS;IMPACT OF PERSISTENT ORGANIC POLLUTANTS ON ENVIRONMENT AND HEALTH;INFLUENCE OF AGING ON EMOTIONAL EXPERIENCE AND WELL-BEING;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;KIDNEY TRANSPLANTATION","3;3;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CLINICAL ENDPOINT;GLUTEN SENSITIVITY;HEPATOCELLULAR CARCINOMA;IGA NEPHROPATHY;CANCER CELL METABOLISM;INSULIN-LIKE GROWTH FACTORS;LIVER CANCER;LIVER DISEASE;LIVER FUNCTION;REGIMEN;TUMOR MICROENVIRONMENT;ALLERGEN IMMUNOTHERAPY;ALLERGIC INFLAMMATION;BIOMARKERS;BRAF GENE;CELIAC DISEASE;CELL ADHESION;CETUXIMAB;CHEMOTHERAPY REGIMEN;CLINICAL SIGNIFICANCE","3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","HEPATOCELLULAR CARCINOMA;IGA NEPHROPATHY;AGGRESSIVENESS INDEX;BOWEL SYNDROME;CANCER PATIENTS;DNA REGIONS;DOXORUBICIN ACTIONS;FAMILIAL IGA;FILTRATION RATE;GENETIC VARIANTS;GLOMERULAR FILTRATION;GROWTH FACTOR-I;HCC AGGRESSIVENESS;INSULIN-LIKE GROWTH;IRRITABLE BOWEL;LOW ACTIVATION;METHYLATED DNA;REGIONS LEAD;ABERRANTLY METHYLATED;ABSTRACT ANTI-TUMOR;ABSTRACT MODULATION;ADAPTIVE IMMUNITY;ADDRESSING MISSING;ADENOCARCINOMA CELLS;ADHESION KINASE;ADIPOQ RS;ADJUVANT TEMOZOLOMIDE;ADULT CELIAC;ADULT RENAL;AHR PATHWAY","5;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","ALBI GRADE;ALLERGIC RHINITIS;NASAL IGE;SKIN REACTIONS;AGGRESSIVENESS INDEX;CANCER CELLS;CELL PROLIFERATION;CHRONIC TCMR;HCC AGGRESSIVENESS;HEAVY METALS;HEPATOCELLULAR CARCINOMA;LIVER FUNCTION;CARCINOMA HCC;SIGNIFICANT INCREASE;CD EFFECTOR;CELIAC DISEASE;COLON CANCER;EFFECTOR MEMORY;FATTY ACID;GAUGE NEEDLE;GENE EXPRESSION;GLUTEN SENSITIVITY;GLUTEN-RELATED DISORDERS;HCC CELLS;HCC PATIENTS;LIVER INDEX;NON-CELIAC GLUTEN;NONALLERGIC RHINITIS;RISK RATIO;TNFΑ SECRETION","6;6;6;6;5;5;5;5;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",14,0.36,8.82,11.5,8,1.75,0,3.5,1,0,2,12.75,0,1,7,3,4,2.25,3,6,5.5,0,0,86.25,86.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2017,64,14.28125,2.46875,0.40506329113924,0.296875,0.296875,0.265625,0.609375,0,31,19,7,1,0.48,0.3,0.11,0.02,35.08,1.19009644612074,0.375,0.890625,4.29565217391305,0.444947944956386,0.263848396501458,0.229845626072041,0.185975609756098,"MARCELLO CHIEPPA;GIANLUIGI GIANNELLI;VITO GUERRA;PIETRO CAMPIGLIA;GIUSEPPE RIEZZO;MARIA NOTARNICOLA;STEFANIA MAGGI;BRENDON STUBBS;BRIAN I. CARR;NICOLA VERONESE;FRANCESCO PANZA;GRAZIA SERINO;RAFFAELE COZZOLONGO;FILOMENA MORISCO;CATERINA BONFIGLIO;VANESSA GALLEGGIANTE;GIANCARLO LOGROSCINO;MADIA LOZUPONE;RODOLFO SARDONE;CHIARA MASETTI","8;7;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4","VITO GUERRA;BRIAN I. CARR;GIUSEPPE RIEZZO;MARCELLO CHIEPPA;MARIA NOTARNICOLA;ANTONELLA ORLANDO;FRANCESCO RUSSO;GIANLUIGI GIANNELLI;STEFANIA MAGGI;BENEDETTA D’ATTOMA;BRENDON STUBBS;NICOLA VERONESE;PIETRO CAMPIGLIA;MARIA LUCIA CARUSO;N. MIRIZZI;MARIA GABRIELLA CARUSO;VALERIA TUTINO;VALENTINA DE NUNZIO;MICHELE LINSALATA;GRAZIA SERINO","1.52;1.35;1.18;0.93;0.73;0.68;0.68;0.63;0.56;0.56;0.54;0.54;0.53;0.52;0.5;0.49;0.44;0.44;0.42;0.41","MARCELLO CHIEPPA;GIANLUIGI GIANNELLI;VITO GUERRA;GIUSEPPE RIEZZO;MARIA NOTARNICOLA;BRIAN I. CARR;NICOLA VERONESE;FRANCESCO PANZA;GRAZIA SERINO;RAFFAELE COZZOLONGO;CATERINA BONFIGLIO;VANESSA GALLEGGIANTE;MADIA LOZUPONE;RODOLFO SARDONE;ANTONELLA ORLANDO;FRANCESCO RUSSO;MARIA GABRIELLA CARUSO;MARIA LUCIA CARUSO;GIOACCHINO LEANDRO;ANNA GRAZIA MONTEDURO","8;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3","VITO GUERRA;BRIAN I. CARR;GIUSEPPE RIEZZO;MARCELLO CHIEPPA;MARIA NOTARNICOLA;ANTONELLA ORLANDO;FRANCESCO RUSSO;GIANLUIGI GIANNELLI;BENEDETTA D’ATTOMA;NICOLA VERONESE;MARIA LUCIA CARUSO;MARIA GABRIELLA CARUSO;VALERIA TUTINO;VALENTINA DE NUNZIO;MICHELE LINSALATA;GRAZIA SERINO;FRANCESCO DITURI;ELISABETTA CAVALCANTI;VANESSA GALLEGGIANTE;RAFFAELE ARMENTANO","1.52;1.35;1.18;0.93;0.73;0.68;0.68;0.63;0.56;0.54;0.52;0.49;0.44;0.44;0.42;0.41;0.37;0.35;0.33;0.32","MARCELLO CHIEPPA;PIETRO CAMPIGLIA;MARIA NOTARNICOLA;GRAZIA SERINO;EDUARDO SOMMELLA;GIANLUIGI GIANNELLI;ANASTASIA SOBOLEWSKI;ALDO PINTO;ANGELO SANTINO;STEFANIA DE SANTIS;VANESSA GALLEGGIANTE;STEFANIA MAGGI;LETIZIA SCANDIFFIO;MARINA LISO;VITO SPILOTRO;VITO GUERRA;FRANCESCO PANZA;BRENDON STUBBS;NICOLA VERONESE;BRIAN I. CARR","601;424;380;365;345;345;337;331;331;331;331;330;291;291;252;248;243;231;231;223","MARCELLO CHIEPPA;MARIA NOTARNICOLA;GRAZIA SERINO;GIANLUIGI GIANNELLI;LETIZIA SCANDIFFIO;MARINA LISO;STEFANIA DE SANTIS;VANESSA GALLEGGIANTE;VITO SPILOTRO;VITO GUERRA;NICOLA VERONESE;MARIA LUCIA CARUSO;ELISABETTA CAVALCANTI;GIOACCHINO LEANDRO;RODOLFO SARDONE;RAFFAELE COZZOLONGO;GIUSEPPE RIEZZO;CATERINA BONFIGLIO;DANIELA ISABEL ABBRESCIA;MARIA GABRIELLA CARUSO","562;380;365;345;291;291;291;291;252;248;231;194;171;156;143;136;134;128;127;95","GIANLUIGI GIANNELLI;MARCELLO CHIEPPA;GIUSEPPE RIEZZO;MARIA NOTARNICOLA;VITO GUERRA;RAFFAELE COZZOLONGO;GRAZIA SERINO;NICOLA VERONESE;ANTONELLA ORLANDO;CATERINA BONFIGLIO;FRANCESCO RUSSO;MARIA GABRIELLA CARUSO;MARIA LUCIA CARUSO;IVAN LOLLI;ANNA GRAZIA MONTEDURO;ELISABETTA CAVALCANTI;FRANCESCO DITURI;GIOACCHINO LEANDRO;M. CORREALE;RODOLFO SARDONE","7;7;6;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;SOCIOLOGY;ECONOMICS;POLITICAL SCIENCE","51;26;18;10;6;5;3;3;2;2;2;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;GASTROENTEROLOGY;PATHOLOGY;IMMUNOLOGY;CANCER RESEARCH;ENDOCRINOLOGY;GENETICS;CELL BIOLOGY;GERONTOLOGY;OPTICS;FOOD SCIENCE;ONCOLOGY;ORGANIC CHEMISTRY;ENVIRONMENTAL HEALTH;METALLURGY;NANOTECHNOLOGY;NEUROSCIENCE;PALEONTOLOGY;PHARMACOLOGY;PHYSICAL THERAPY;PSYCHIATRY;SURGERY","44;18;16;15;13;11;9;9;8;8;6;5;5;5;4;3;3;3;3;3;3;3;3","CANCER;HEPATOCELLULAR CARCINOMA;COHORT;DISEASE;ANTIOXIDANT;CIRRHOSIS;PROPORTIONAL HAZARDS MODEL;ALTERNATIVE MEDICINE;COHORT STUDY;GENE;CONFIDENCE INTERVAL;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);POPULATION;STEM CELL;ANTIBODY;APOPTOSIS;BACTERIA;CARCINOMA;CELL;COGNITION;CONFOUNDING;CYTOKINE;FATTY ACID;INFLAMMATION;LOGISTIC REGRESSION;NANOPARTICLE;RECEPTOR;REGIMEN;SIGNAL TRANSDUCTION;STAGE (STRATIGRAPHY);TRANSFORMING GROWTH FACTOR;VIRUS","9;9;8;7;6;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","COLORECTAL CANCER;HAZARD RATIO;DEMENTIA;IMMUNOASSAY;PROBIOTIC;PROTEIN KINASE B;QUERCETIN;ALCOHOLIC LIVER DISEASE;CITRUS × SINENSIS;HEPATITIS C VIRUS;INFLAMMATORY BOWEL DISEASE;LACTOBACILLUS;LIVER CANCER;LOWER RISK;OSTEOARTHRITIS;PHASES OF CLINICAL RESEARCH;PHENOTYPE;PI3K/AKT/MTOR PATHWAY;PLACEBO;POLYUNSATURATED FATTY ACID;PROINFLAMMATORY CYTOKINE;SORAFENIB;TRANSFORMING GROWTH FACTOR BETA","5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","LACTOBACILLUS REUTERI;REGORAFENIB;COGNITIVE DECLINE;ADENOMATOUS POLYPOSIS COLI;ADHERENS JUNCTION;ANTIVIRAL THERAPY;CETUXIMAB;DOCOSAHEXAENOIC ACID;EPITHELIAL–MESENCHYMAL TRANSITION;ESOPHAGITIS;FAMILIAL ADENOMATOUS POLYPOSIS;FARNESYL DIPHOSPHATE SYNTHASE;FERROPORTIN;FREE THYROXINE;GENE EXPRESSION PROFILING;GENETICALLY MODIFIED MOUSE;GERD;GERIATRIC DEPRESSION SCALE;GLUTAMINASE;HEARTBURN;HEPACIVIRUS;IN UTERO;LACTOBACILLUS RHAMNOSUS;MAGNETIC HYPERTHERMIA;MEVALONATE PATHWAY;MTORC1;NEUROTENSIN;NS3;ONCOGENE;OXALIPLATIN;PALMITOLEIC ACID;PANCREATIC TUMOR;PARACELLULAR TRANSPORT;RENAL STEM CELL;RIBAVIRIN;SELECTED REACTION MONITORING;SUPERPARAMAGNETISM;TBARS;TIME-OF-FLIGHT MASS SPECTROMETRY;TLR2;TRANSCRIPTOME;VINCRISTINE","3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;MIDDLE AGED;AGED;;ADULT;LIVER CIRRHOSIS;FRAILTY;INFLAMMATION;INTESTINAL MUCOSA;ITALY;BIOMARKERS, TUMOR;DENDRITIC CELLS;EPITHELIAL CELLS;PROBIOTICS;ANIMALS;ANTIOXIDANTS","40;30;30;26;26;20;17;16;15;14;13;11;11;9;8;8;8;8;7;7","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATITIS C INFECTION AND TREATMENT;ANTIOXIDANTS AND FREE RADICALS IN HEALTH AND DISEASE;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS;CANCER STEM CELLS AND TUMOR METASTASIS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GENOMIC LANDSCAPE OF CANCER AND MUTATIONAL SIGNATURES;GLIOMAS;HEPATOCELLULAR CARCINOMA;LIPID METABOLISM IN CANCER PATHOGENESIS;METABOLIC REPROGRAMMING IN CANCER BIOLOGY;THYROID DISEASE AND HORMONE REGULATION;ADVANCES IN METABOLOMICS RESEARCH;BONE TISSUE ENGINEERING AND BIOMATERIALS;CHOLANGIOCARCINOMA;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK","4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","FRAILTY;HEPATOCELLULAR CARCINOMA;TREATMENT;TUMOR MICROENVIRONMENT;COGNITIVE DECLINE;LACTOBACILLUS REUTERI;REGIMEN;REGORAFENIB;ANTIOXIDANT ACTIVITY;ANTIVIRAL THERAPY;CANCER GENOMICS;CITRUS × SINENSIS;CONSTIPATION;DENDRITIC CELLS;DIET QUALITY;DIETARY PATTERNS;GASTROENTEROPANCREATIC NEOPLASMS;GLIOBLASTOMA;GOLD STANDARD (TEST);HEALTHY EATING INDEX","5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","HEPATOCELLULAR CARCINOMA;COHORT STUDY;INCIDENT FRAILTY;LONGITUDINAL COHORT;LONGITUDINAL STUDY;APCMIN MICE;CLINICAL TRIAL;COLONIC TRANSIT;CONTROLLED OPEN-LABEL;DENDRITIC CELLS;EIGHT-YEAR LONGITUDINAL;EVALUATING REGORAFENIB;FATTY ACIDS;II CLINICAL;LACTOBACILLUS REUTERI;LIVER DISEASE;MASS SPECTROMETRY;MULTICENTER CONTROLLED;OPEN-LABEL PHASE;PHASE II;POLYUNSATURATED FATTY;QUERCETIN EXPOSURE;RANDOMIZED MULTICENTER;RELAPSED GLIOBLASTOMA;REUTERI DSM;TRANSFORMING GROWTH;TRIAL EVALUATING;ACID DECORATED;ACID PROFILE;ACIDS INHIBIT","6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","HR CI;CB RECEPTOR;TNF Α;MEDITERRANEAN DIET;TGF- Β;ALBUMIN LEVELS;CITRUS SINENSIS;HCC PATIENTS;REUTERI DSM;SERUM ALBUMIN;SEVERE INFECTIONS;CARCINOMA HCC;FUNCTIONAL HEARTBURN;HEPATOCELLULAR CARCINOMA;MG INTAKE;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;MOUSE MODEL;QUERCETIN EXPOSURE;RECEPTOR GENE;SPORADIC DTS;ACID REFLUX;AKTYAPSA ICC;CELL LINES;CHOLANGIOCARCINOMA ICC;COMPETING RISK;COXS REGRESSION;CRYPT ORGANOID;DII SCORE;HCC CELL;ICC CELL","11;9;9;8;8;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4",33,0.52,7,6,1,0,0,2.5,1.25,0,0,6,0,0,4,0,1,1,1.75,3,2,0,0,88,88,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2018,99,15.3333333333333,3.36363636363636,0.297297297297297,0.313131313131313,0.292929292929293,0.222222222222222,0.686868686868687,0,46,21,8,2,0.46,0.21,0.08,0.02,34.75,1.13895322991976,0.363636363636364,0.868686868686869,4.50124069478908,0.461410985527669,0.319855358316897,0.349624060150376,0.334346504559271,"GIANLUIGI GIANNELLI;NICOLA VERONESE;MARIA NOTARNICOLA;VITO GUERRA;CRISTIANO SIMONE;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;IVAN LOLLI;VALENTINA GROSSI;PAOLA SANESE;MARTINA LEPORE SIGNORILE;CANDIDA FASANO;ANNA GRAZIA MONTEDURO;GIANCARLO LOGROSCINO;FRANCESCO PANZA;MARCELLO CHIEPPA;VALERIA TUTINO;ALESSIA PESERICO;BRIAN I. CARR;MADIA LOZUPONE","17;12;12;11;10;10;9;9;9;9;8;8;7;7;7;7;6;6;6;6","GIANLUIGI GIANNELLI;MARIA NOTARNICOLA;MARCELLO CHIEPPA;NICOLA VERONESE;VITO GUERRA;ANTONIA IGNAZZI;ANNA GRAZIA MONTEDURO;CRISTIANO SIMONE;MARIA GABRIELLA CARUSO;VALENTINA GROSSI;PAOLA SANESE;GIUSEPPE MARUCCIO;MARIA LUCIA CARUSO;ELISABETTA CAVALCANTI;FRANCESCO RUSSO;CANDIDA FASANO;MARTINA LEPORE SIGNORILE;GIOACCHINO LEANDRO;BENEDETTA D’ATTOMA;ANTONELLA ORLANDO","1.99;1.03;0.98;0.94;0.92;0.88;0.87;0.87;0.84;0.79;0.79;0.79;0.78;0.77;0.77;0.76;0.74;0.65;0.6;0.6","GIANLUIGI GIANNELLI;NICOLA VERONESE;MARIA NOTARNICOLA;VITO GUERRA;CRISTIANO SIMONE;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;IVAN LOLLI;PAOLA SANESE;MARTINA LEPORE SIGNORILE;CANDIDA FASANO;ANNA GRAZIA MONTEDURO;FRANCESCO PANZA;MARCELLO CHIEPPA;VALERIA TUTINO;BRIAN I. CARR;MADIA LOZUPONE;ALBERTO R. OSELLA;RODOLFO SARDONE;FRANCESCO RUSSO","17;12;12;11;10;10;9;9;9;8;8;7;7;7;6;6;6;6;6;6","GIANLUIGI GIANNELLI;MARIA NOTARNICOLA;MARCELLO CHIEPPA;NICOLA VERONESE;VITO GUERRA;ANTONIA IGNAZZI;ANNA GRAZIA MONTEDURO;CRISTIANO SIMONE;MARIA GABRIELLA CARUSO;PAOLA SANESE;MARIA LUCIA CARUSO;ELISABETTA CAVALCANTI;FRANCESCO RUSSO;CANDIDA FASANO;MARTINA LEPORE SIGNORILE;GIOACCHINO LEANDRO;BENEDETTA D’ATTOMA;ANTONELLA ORLANDO;FRANCESCO DE MICHELE;GIUSEPPE RIEZZO","1.99;1.03;0.98;0.94;0.92;0.88;0.87;0.87;0.84;0.79;0.78;0.77;0.77;0.76;0.74;0.65;0.6;0.6;0.56;0.56","GIANLUIGI GIANNELLI;MARIA DE MARSICO;RAFFAELE COZZOLONGO;ANTONIO GASBARRINI;FILOMENA MORISCO;FRANCESCO DE LEONARDIS;M. ANGÉLICO;MARIA RENDINA;NICOLA CAPORASO;PIERLUIGI TONIUTTO;V. CALVARUSO;VINCENZO SANGIOVANNI;FRANCESCO GIUSEPPE FOSCHI;GIANLUCA SVEGLIATI‐BARONI;MAURO BERNARDI;A. PECCHIOLI;A. STICCA;A. TORTORA;AGOSTINO RIZZOTTO;ALBA KOSTANDINI","673;518;499;468;468;437;437;437;437;437;437;437;428;428;428;397;397;397;397;397","GIANLUIGI GIANNELLI;RAFFAELE COZZOLONGO;CRISTIANO SIMONE;MARIA NOTARNICOLA;IVAN LOLLI;VITO GUERRA;NICOLA VERONESE;MARCELLO CHIEPPA;MARIA GABRIELLA CARUSO;FRANCESCO RUSSO;GRAZIA SERINO;STEFANIA DE SANTIS;ANTONELLA ORLANDO;BENEDETTA D’ATTOMA;GIOVANNA FORTE;GIUSEPPE RIEZZO;GIOACCHINO LEANDRO;ELISABETTA CAVALCANTI;EVANGELIA STASI;CATERINA CLEMENTE","673;499;338;334;313;306;288;270;270;266;223;200;194;194;182;180;171;149;146;144","GIANLUIGI GIANNELLI;VITO GUERRA;MARIA NOTARNICOLA;MARIA GABRIELLA CARUSO;NICOLA VERONESE;IVAN LOLLI;CANDIDA FASANO;GIOACCHINO LEANDRO;MARCELLO CHIEPPA;ANNA GRAZIA MONTEDURO;CRISTIANO SIMONE;VALERIA TUTINO;ALBERTO R. OSELLA;RODOLFO SARDONE;FRANCESCO RUSSO;MARIA LUCIA CARUSO;ANTONIA IGNAZZI;GIOVANNA FORTE;ANNA MARIA CISTERNINO;ANTONELLA ORLANDO","17;12;12;10;9;9;8;8;7;7;6;6;6;6;6;5;5;5;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATERIALS SCIENCE;ENGINEERING;PSYCHOLOGY;ECONOMICS;SOCIOLOGY;COMPUTER SCIENCE;ENVIRONMENTAL SCIENCE;GEOLOGY;HISTORY;MATHEMATICS;PHILOSOPHY","74;53;28;10;7;6;5;4;4;3;2;1;1;1;1","INTERNAL MEDICINE;BIOCHEMISTRY;CANCER RESEARCH;GENETICS;GASTROENTEROLOGY;CELL BIOLOGY;ONCOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;ENDOCRINOLOGY;ORGANIC CHEMISTRY;PHARMACOLOGY;PSYCHIATRY;SURGERY;BIOINFORMATICS;CHROMATOGRAPHY;ECOLOGY;NANOTECHNOLOGY;PALEONTOLOGY","64;29;24;21;19;18;15;14;13;10;9;8;8;7;7;5;5;5;5;5","CANCER;GENE;DISEASE;POPULATION;HEPATOCELLULAR CARCINOMA;CHEMOTHERAPY;CONFIDENCE INTERVAL;CLINICAL TRIAL;COHORT;RANDOMIZED CONTROLLED TRIAL;CELL;COHORT STUDY;COGNITION;IMMUNE SYSTEM;MITOCHONDRION;RECEPTOR;STEATOSIS;APOPTOSIS;CIRRHOSIS;ENZYME;IMMUNOHISTOCHEMISTRY;INFLAMMATION;KINASE;PROPORTIONAL HAZARDS MODEL;SIGNAL TRANSDUCTION","28;20;15;11;10;9;9;7;7;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4","COLORECTAL CANCER;CLINICAL ENDPOINT;FATTY LIVER;HAZARD RATIO;INFLAMMATORY BOWEL DISEASE;BEVACIZUMAB;CARCINOGENESIS;GENE EXPRESSION;LIVER CANCER;PHASES OF CLINICAL RESEARCH;TEMOZOLOMIDE;ADENOCARCINOMA;CYCLOPHOSPHAMIDE;DOWNREGULATION AND UPREGULATION;HELICOBACTER PYLORI INFECTION;HEPATITIS C VIRUS;IMMUNOTHERAPY;MAPK/ERK PATHWAY;METABOLIC SYNDROME;MUTATION;PHENOTYPE;PROTEIN KINASE A;PROTEIN KINASE B;ULCERATIVE COLITIS","16;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","REGORAFENIB;PD-L1;VINCRISTINE;AMPK;CAPECITABINE;CATENIN;CD163;CETUXIMAB;EICOSAPENTAENOIC ACID;IRINOTECAN;NONALCOHOLIC FATTY LIVER DISEASE;UREA BREATH TEST;ADHERENS JUNCTION;AKT1;AZOXYMETHANE;BETA-CATENIN;BRAIN-DERIVED NEUROTROPHIC FACTOR;CANNABINOID RECEPTOR;CARBOPLATIN;CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE;CERAMIC CAPACITOR;COLONIC DISEASE;COLONOSCOPY;DNA MISMATCH REPAIR;ENHANCER;EPITHELIAL–MESENCHYMAL TRANSITION;FERROELECTRIC CERAMICS;FLAVONOLS;FOXO3;GERIATRIC DEPRESSION SCALE;GERMLINE MUTATION;GLUCOSE HOMEOSTASIS;GLYCEMIC INDEX;HEPACIVIRUS;HIATAL HERNIA;HSP70;KNEE PAIN;KRAS;LACTOBACILLUS REUTERI;LACTOBACILLUS RHAMNOSUS;LIVER STEATOSIS;METASTATIC BREAST CANCER;MICROSATELLITE;MISSENSE MUTATION;MOUSE MODEL OF COLORECTAL AND INTESTINAL CANCER;NANOLITHOGRAPHY;NS3;ONCOGENE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PDGFRA;PEMETREXED;PENTOSE PHOSPHATE PATHWAY;PLACENTAL GROWTH FACTOR;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POINT MUTATION;POLYPYRROLE;PORTAL VENOUS PRESSURE;PROANTHOCYANIDIN;RAPID UREASE TEST;RELATIVE PERMITTIVITY;RNA SPLICING;STEAROYL-COA DESATURASE;TFAM;TIMP1;TRANSCRIPTOME;TRANSIENT ELASTOGRAPHY;TUMOR-INFILTRATING LYMPHOCYTES;VASCULAR DEMENTIA","5;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CARCINOMA, HEPATOCELLULAR;;MIDDLE AGED;LIVER NEOPLASMS;AGED;ADULT;ITALY;NON-ALCOHOLIC FATTY LIVER DISEASE;ANTINEOPLASTIC AGENTS;INTESTINAL MUCOSA;IRRITABLE BOWEL SYNDROME;COLORECTAL NEOPLASMS;DIARRHEA;ANIMALS;BIOMARKERS;HELICOBACTER INFECTIONS;LIVER CIRRHOSIS","58;42;40;37;35;34;32;27;24;20;17;16;15;15;12;12;11;11;11;11","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GLIOMAS;LIPID METABOLISM IN CANCER PATHOGENESIS;METABOLIC REPROGRAMMING IN CANCER BIOLOGY;REGULATION AND FUNCTIONS OF FOXO TRANSCRIPTION FACTORS;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPATOCELLULAR CARCINOMA;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;MECHANISMS AND TREATMENT OF LIVER FIBROSIS;MECHANISMS OF ALZHEIMER'S DISEASE;PANCREATIC CANCER RESEARCH AND TREATMENT;ROLE OF NRF2 SIGNALING IN OXIDATIVE STRESS RESPONSE;WNT SIGNALING IN DEVELOPMENT AND DISEASE;ADSORPTION OF WATER CONTAMINANTS;ADVANCES IN CHEMICAL SENSOR TECHNOLOGIES","7;6;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;1;1","CLINICAL ENDPOINT;STEATOSIS;INTESTINAL PERMEABILITY;REGORAFENIB;GLIOBLASTOMA;HEPATOCELLULAR CARCINOMA;LIVER CANCER;NAFLD;TEMOZOLOMIDE;CANCER;CANCER CELL METABOLISM;FATTY ACID METABOLISM;FOXO TRANSCRIPTION FACTORS;HELICOBACTER PYLORI;INFLAMMATORY BOWEL DISEASE;LOMUSTINE;LONGITUDINAL STUDY;MEDITERRANEAN DIET;PD-1 AND PD-L1;REGIMEN","6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","HEPATOCELLULAR CARCINOMA;COLORECTAL CANCER;BOWEL DISEASE;INFLAMMATORY BOWEL;RELAPSED GLIOBLASTOMA;CANCER CELLS;CLINICAL TRIAL;COHORT STUDY;FATTY LIVER;PHASE II;CELLS UNDERGOING;CLINICAL IMPLICATIONS;CLINICAL PRACTICE;CONTROLLED OPEN-LABEL;DIETARY INFLAMMATORY;DISEASE PREVALENCE;EVALUATING REGORAFENIB;EXPRESSION PATTERNS;FOXOA MITOCHONDRIAL;GIANT CELLS;HCC PATIENTS;IHELICOBACTER PYLORII;II CLINICAL;INFLAMMATORY INDEX;LIVER DISEASE;LONGITUDINAL COHORT;LONGITUDINAL STUDY;METABOLIC STRESS;METASTATIC COLORECTAL;MOUSE MODEL","8;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;HIPPO PATHWAY;HEPATOCELLULAR CARCINOMA;CELL LINES;D-IBS PATIENTS;LIVER CANCER;CANCER CELLS;FATTY ACIDS;LIVER TUMORS;CANCER CELL;CARCINOMA HCC;COLORECTAL CANCER;MEDITERRANEAN DIET;COEFFICIENT SE;PROTEIN EXPRESSION;CELL PROLIFERATION;HCC PATIENTS;ISCD MICE;LIVER DISEASE;AFP LEVELS;FATTY LIVER;GENE EXPRESSION;AKTRAS LIVER;CALVISI DF;CELL CYCLE;DISEASE PROGRESSION;FATTY ACID;GROWTH FACTOR;GUAN KL","50;32;25;21;19;12;12;11;11;11;10;10;10;10;9;9;8;8;8;8;7;7;7;6;6;6;6;6;6;6",48,0.48,9.62,8,2.5,1,1,2.75,1,1,1,8.75,1,1,10,2,1,3,9.5,5.75,4,0,0,82.75,82.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2019,87,13.0804597701149,3.47126436781609,0.288079470198675,0.367816091954023,0.367816091954023,0.344827586206897,0.701149425287356,0,46,18,5,5,0.53,0.21,0.06,0.06,22.93,0.943008627740152,0.390804597701149,0.873563218390805,4.82212581344903,0.443762512347182,0.445816186556927,0.402439024390244,0.391281233386497,"NICOLA VERONESE;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;VITO GUERRA;GIANLUIGI GIANNELLI;MARIA NOTARNICOLA;VALERIA TUTINO;BRENDON STUBBS;ALBERTO R. OSELLA;A. PANARESE;ELISA STASI;LEE SMITH;ROSA REDDAVIDE;ROSSELLA DONGHIA;VALENTINA DE NUNZIO;ELISABETTA CAVALCANTI;ROSA INGUAGGIATO;STEFANIA DE SANTIS;ANNA MARIA CISTERNINO;RAFFAELE COZZOLONGO","16;12;10;9;9;9;8;7;7;6;6;6;6;6;5;5;5;5;5;5","NICOLA VERONESE;MARIA GABRIELLA CARUSO;ELISABETTA CAVALCANTI;GIANLUIGI GIANNELLI;ALBERTO R. OSELLA;STEFANIA DE SANTIS;RAFFAELE ARMENTANO;GIOACCHINO LEANDRO;VITO GUERRA;MARIA NOTARNICOLA;VALERIA TUTINO;ELISA STASI;MARIA LUCIA CARUSO;FRANCESCO RUSSO;BRENDON STUBBS;LEE SMITH;DIONIGI LORUSSO;A. PANARESE;VALENTINA DE NUNZIO;FABIO FUCILLI","1.57;1.06;0.92;0.91;0.84;0.82;0.81;0.77;0.75;0.71;0.66;0.64;0.63;0.62;0.6;0.57;0.53;0.52;0.5;0.5","NICOLA VERONESE;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;VITO GUERRA;GIANLUIGI GIANNELLI;MARIA NOTARNICOLA;VALERIA TUTINO;ALBERTO R. OSELLA;A. PANARESE;ELISA STASI;ROSA REDDAVIDE;ROSSELLA DONGHIA;VALENTINA DE NUNZIO;ELISABETTA CAVALCANTI;ROSA INGUAGGIATO;STEFANIA DE SANTIS;ANNA MARIA CISTERNINO;RAFFAELE COZZOLONGO;MAURO MASTRONARDI;ORNELLA ROTOLO","16;12;10;9;9;9;8;7;6;6;6;6;5;5;5;5;5;5;5;5","NICOLA VERONESE;MARIA GABRIELLA CARUSO;ELISABETTA CAVALCANTI;GIANLUIGI GIANNELLI;ALBERTO R. OSELLA;STEFANIA DE SANTIS;RAFFAELE ARMENTANO;GIOACCHINO LEANDRO;VITO GUERRA;MARIA NOTARNICOLA;VALERIA TUTINO;ELISA STASI;MARIA LUCIA CARUSO;FRANCESCO RUSSO;DIONIGI LORUSSO;A. PANARESE;VALENTINA DE NUNZIO;FABIO FUCILLI;MAURO MASTRONARDI;G LANTONE","1.57;1.06;0.92;0.91;0.84;0.82;0.81;0.77;0.75;0.71;0.66;0.64;0.63;0.62;0.53;0.52;0.5;0.5;0.45;0.4","NICOLA VERONESE;GIANLUIGI GIANNELLI;BRENDON STUBBS;LEE SMITH;ANN CLEVERLY;IVELINA GUEORGUIEVA;KARIM A. BENHADJI;MICHAEL LAHN;ROBIN KATE KELLEY;SANDRINE FAIVRE;DAVY VANCAMPFORT;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;GRAZIA SERINO;MARCELLO CHIEPPA;MAURO MASTRONARDI;MARIA NOTARNICOLA;A. PANARESE;GIULIO VERNA;MARINA LISO","521;450;329;312;277;277;277;277;277;277;243;219;214;206;206;206;205;203;201;201","NICOLA VERONESE;GIANLUIGI GIANNELLI;GRAZIA SERINO;MAURO MASTRONARDI;A. PANARESE;GIULIO VERNA;MARINA LISO;MARIA GABRIELLA CARUSO;MARCELLO CHIEPPA;GIOACCHINO LEANDRO;MARIA NOTARNICOLA;VALERIA TUTINO;VANESSA GALLEGGIANTE;DIONIGI LORUSSO;MANUELA DICARLO;VALENTINA DE NUNZIO;CARLA MARIA LEONE;ANTONIO LIPPOLIS;ANTONIO CIGLIANO;ELISABETTA CAVALCANTI","465;450;206;206;203;201;201;171;167;166;157;122;121;109;107;99;94;88;77;75","NICOLA VERONESE;MARIA GABRIELLA CARUSO;GIOACCHINO LEANDRO;GIANLUIGI GIANNELLI;MARIA NOTARNICOLA;VITO GUERRA;ALBERTO R. OSELLA;VALERIA TUTINO;A. PANARESE;ELISABETTA CAVALCANTI;ROSSELLA DONGHIA;ELISA STASI;RAFFAELE COZZOLONGO;ROSA REDDAVIDE;VALENTINA DE NUNZIO;MAURO MASTRONARDI;ANNA MARIA CISTERNINO;CARLA MARIA LEONE;CATERINA BONFIGLIO;DIONIGI LORUSSO","14;11;9;9;8;8;7;7;6;6;5;5;5;5;5;5;4;4;4;4","MEDICINE;BIOLOGY;SOCIOLOGY;CHEMISTRY;MATERIALS SCIENCE;ECONOMICS;MATHEMATICS;COMPUTER SCIENCE;PSYCHOLOGY;GEOGRAPHY;PHILOSOPHY;PHYSICS;ENGINEERING;POLITICAL SCIENCE","78;33;11;10;6;5;5;4;4;3;3;3;2;1","INTERNAL MEDICINE;PATHOLOGY;GASTROENTEROLOGY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;SURGERY;BIOCHEMISTRY;GENETICS;ONCOLOGY;CELL BIOLOGY;DEMOGRAPHY;GERONTOLOGY;IMMUNOLOGY;PSYCHIATRY;ENDOCRINOLOGY;GENERAL SURGERY;NURSING;RADIOLOGY;ORGANIC CHEMISTRY;PALEONTOLOGY;PHYSICAL THERAPY;STATISTICS","59;26;19;15;14;14;12;12;12;10;9;8;8;6;5;5;5;5;4;4;4;4","DISEASE;CANCER;COHORT;GENE;POPULATION;RANDOMIZED CONTROLLED TRIAL;COHORT STUDY;CONFIDENCE INTERVAL;OBESITY;SIGNAL TRANSDUCTION;CONFOUNDING;ADVERSE EFFECT;ALTERNATIVE MEDICINE;CROSS-SECTIONAL STUDY;ENDOSCOPY;META-ANALYSIS;QUALITY OF LIFE (HEALTHCARE);ANXIETY;BIOPSY;CIRRHOSIS;CLINICAL TRIAL;HEPATOCELLULAR CARCINOMA;INFLAMMATION;ODDS RATIO;RECEPTOR;STEM CELL;VIRUS","20;19;12;11;11;10;8;8;7;7;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","COLORECTAL CANCER;FATTY LIVER;HAZARD RATIO;OVERWEIGHT;OSTEOARTHRITIS;SORAFENIB;CARCINOGENESIS;CLINICAL ENDPOINT;DEMENTIA;FINE-NEEDLE ASPIRATION;HEPATITIS C VIRUS;METABOLIC SYNDROME;MITOCHONDRIAL DNA;ULCERATIVE COLITIS;ADALIMUMAB;CAUSE OF DEATH;CROHN'S DISEASE;CYCLOPHOSPHAMIDE;DEPRESSIVE SYMPTOMS;GENE EXPRESSION;INFLAMMATORY BOWEL DISEASE;METASTASIS;MICRORNA;PERFORATION;PHENOTYPE;PI3K/AKT/MTOR PATHWAY;POLYUNSATURATED FATTY ACID;PREVALENCE;QUARTILE;SAMPLING (SIGNAL PROCESSING);THERAPEUTIC ENDOSCOPY;WNT SIGNALING PATHWAY","11;5;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","REGORAFENIB;COLONOSCOPY;EICOSAPENTAENOIC ACID;FRIZZLED;MICROVESICLES;VINCRISTINE;ADENOMATOUS POLYPOSIS COLI;ALCOHOLIC FATTY LIVER;AMPHIPHILE;AP SITE;ARTICULAR CARTILAGE;ASPIRATION BIOPSY;ASTROVIRUS;AZOXYMETHANE;BASE EXCISION REPAIR;CANNABINOID RECEPTOR;COLECTOMY;DBM;DNA GLYCOSYLASE;FAMILIAL ADENOMATOUS POLYPOSIS;FOOD INSECURITY;FOVEOLAR CELL;GENE DELIVERY;GENETIC HETEROGENEITY;GERD;GLYCEMIC INDEX;HEPACIVIRUS;HOMEOBOX;IMMUNE CHECKPOINT;KRAS;MACULAR HOLE;NATIONAL DEATH INDEX;NONALCOHOLIC FATTY LIVER DISEASE;NUCLEOTIDE EXCISION REPAIR;OSTEOCALCIN;PTEN;RIBAVIRIN;SAPOVIRUS;SOD1;TFAM;TRANSIENT ELASTOGRAPHY","4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;;FEMALE;MIDDLE AGED;AGED;ADULT;ITALY;NON-ALCOHOLIC FATTY LIVER DISEASE;OBESITY;LIVER;AGED, 80 AND OVER;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;ANIMALS;BIOMARKERS;LIVER CIRRHOSIS;CARDIOVASCULAR DISEASES;INFLAMMATION;INTESTINAL MUCOSA","46;37;36;34;27;21;19;14;14;14;12;11;11;11;10;10;10;8;8;8","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GASTRIC CANCER RESEARCH AND TREATMENT;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;GLIOMAS;HEPATITIS C INFECTION AND TREATMENT;PANCREATIC CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;FRAILTY IN OLDER ADULTS AND GERIATRIC CARE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEPATOCELLULAR CARCINOMA;LIPID METABOLISM IN CANCER PATHOGENESIS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ATRIAL FIBRILLATION;BULLYING BEHAVIORS AND PSYCHOLOGICAL IMPACT;CANCER IMMUNOTHERAPY;CANCER STEM CELLS AND TUMOR METASTASIS;CLINICAL AND MOLECULAR ASPECTS OF NOCARDIOSIS","6;4;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1","CROSS-SECTIONAL STUDY;DIET QUALITY;HEALTHY EATING INDEX;NAFLD;REGORAFENIB;CLINICAL ENDPOINT;DEPRESSION (ECONOMICS);ENDOSCOPIC SUBMUCOSAL DISSECTION;GLIOBLASTOMA;LYMPH NODE DISSECTION;MEDITERRANEAN DIET;TREATMENT;ASSOCIATION (PSYCHOLOGY);BLOOD PRESSURE;CANCER;CANCER PROGRESSION;DIETARY PATTERNS;DISCONTINUATION;EUS-GUIDED FINE NEEDLE ASPIRATION;EXTRACELLULAR VESICLES","5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","FATTY LIVER;CLINICAL TRIAL;COLORECTAL CANCER;GASTRIC CANCER;LIVER DISEASE;RANDOMIZED CONTROLLED;ADVANCED HEPATOCELLULAR;ANALYZING REGORAFENIB;ENDOSCOPIC SUBMUCOSAL;GLIOBLASTOMA PATIENTS;HEALTH-RELATED QUALITY;HEPATOCELLULAR CARCINOMA;HRQOL EVALUATION;II CLINICAL;LIFE HRQOL;LONGITUDINAL STUDY;METASTATIC COLORECTAL;NON-ALCOHOLIC FATTY;PHASE II;RANDOMIZED PHASE;REGOMA TRIAL;REGORAFENIB ACTIVITY;RELAPSED GLIOBLASTOMA;SUBMUCOSAL DISSECTION;TRIAL ANALYZING;BLOOD PRESSURE;CACO- CELLS;CONTROLLED TRIALS;CURRENT PRACTICES;CÓRDOBA ARGENTINA","5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;HUMAN HB;HR CI;CALVISI DF;FOOD INSECURITY;GENE EXPRESSION;GUAN KL;HB DEVELOPMENT;HIPPO PATHWAY;DEPRESSIVE SYMPTOMS;GROWTH FACTOR;PROTEIN INTAKE;CB RECEPTOR;COLORECTAL CANCER;GASTRIC CANCER;HB FORMATION;HEPATOCELLULAR CARCINOMA;POTENTIAL CONFOUNDERS;WINNIE MICE;CELL LINES;CHRONIC DISEASES;DF RANGANATHAN;DIETARY PROTEIN;DIETARY VITAMIN;FISHER SCIENTIFIC;HUMAN HEPATOBLASTOMA;INCREASED RISK;LOGISTIC REGRESSION;MACULAR HOLE","42;23;13;12;10;8;8;8;8;8;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5",42,0.48,6.95,10,2.75,3.25,1,8,0,1,1,10.75,1,0,9,1.75,5.5,1,3.25,7,3,0,0,55.75,55.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2020,98,13.5102040816327,4.08163265306122,0.245,0.438775510204082,0.448979591836735,0.530612244897959,0.755102040816326,2,45,29,11,1,0.46,0.3,0.11,0.01,18.18,0.721615391861158,0.285714285714286,0.908163265306122,5.46938775510204,0.550796875975107,0.462783171521036,0.45727956254272,0.422142214221422,"GIANLUIGI GIANNELLI;RODOLFO SARDONE;FRANCESCO PANZA;LUISA LAMPIGNANO;ROBERTA ZUPO;FABIO CASTELLANA;MADIA LOZUPONE;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;VITO GUERRA;ILARIA BORTONE;MARIA NOTARNICOLA;CATERINA BONFIGLIO;MARCELLO CHIEPPA;MARIA GABRIELLA CARUSO;ALBERTO R. OSELLA;VINCENZO TRIGGIANI;GIANCARLO LOGROSCINO;ANNA MARIA CISTERNINO;GRAZIA SERINO","30;19;17;16;16;14;14;12;12;10;9;9;8;8;8;7;7;6;6;6","GIANLUIGI GIANNELLI;FRANCESCO PANZA;MADIA LOZUPONE;RODOLFO SARDONE;MARCELLO CHIEPPA;LUISA LAMPIGNANO;ROBERTA ZUPO;FABIO MARINO;ROSSELLA DONGHIA;FABIO CASTELLANA;GIOVANNI DE PERGOLA;VITO GUERRA;VINCENZO TRIGGIANI;MARIA NOTARNICOLA;ILARIA BORTONE;MARIA GABRIELLA CARUSO;CATERINA BONFIGLIO;ALBERTO R. OSELLA;BRIAN I. CARR;GRAZIA SERINO","2.91;2.54;2.2;1.8;1.63;1.44;1.44;1.33;1.32;1.21;1.2;1.08;0.76;0.73;0.67;0.64;0.64;0.6;0.58;0.58","GIANLUIGI GIANNELLI;RODOLFO SARDONE;FRANCESCO PANZA;LUISA LAMPIGNANO;ROBERTA ZUPO;FABIO CASTELLANA;MADIA LOZUPONE;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;VITO GUERRA;ILARIA BORTONE;MARIA NOTARNICOLA;CATERINA BONFIGLIO;MARCELLO CHIEPPA;MARIA GABRIELLA CARUSO;ALBERTO R. OSELLA;ANNA MARIA CISTERNINO;GRAZIA SERINO;RAFFAELE COZZOLONGO;PAOLO SORINO","30;19;17;16;16;14;14;12;12;10;9;9;8;8;8;7;6;6;6;5","GIANLUIGI GIANNELLI;FRANCESCO PANZA;MADIA LOZUPONE;RODOLFO SARDONE;MARCELLO CHIEPPA;LUISA LAMPIGNANO;ROBERTA ZUPO;FABIO MARINO;ROSSELLA DONGHIA;FABIO CASTELLANA;GIOVANNI DE PERGOLA;VITO GUERRA;MARIA NOTARNICOLA;ILARIA BORTONE;MARIA GABRIELLA CARUSO;CATERINA BONFIGLIO;ALBERTO R. OSELLA;GRAZIA SERINO;ISABELLA GIGANTE;ANTONELLA ORLANDO","2.91;2.54;2.2;1.8;1.63;1.44;1.44;1.33;1.32;1.21;1.2;1.08;0.73;0.67;0.64;0.64;0.6;0.58;0.57;0.57","GIANLUIGI GIANNELLI;RODOLFO SARDONE;LUISA LAMPIGNANO;ROBERTA ZUPO;FRANCESCO PANZA;MARCELLO CHIEPPA;FABIO CASTELLANA;MADIA LOZUPONE;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;VITO GUERRA;CATERINA BONFIGLIO;ILARIA BORTONE;MARIA NOTARNICOLA;ALBERTO R. OSELLA;MARIA DE ANGELIS;MARCO CASTELLANA;CAMILLA LAZZI;DANILO ERCOLINI;ERASMO NEVIANI","597;326;320;320;299;279;276;243;240;219;200;186;177;172;170;168;144;138;138;138","GIANLUIGI GIANNELLI;RODOLFO SARDONE;LUISA LAMPIGNANO;ROBERTA ZUPO;FRANCESCO PANZA;FABIO CASTELLANA;MARCELLO CHIEPPA;ROSSELLA DONGHIA;VITO GUERRA;CATERINA BONFIGLIO;MARIA NOTARNICOLA;ALBERTO R. OSELLA;ILARIA BORTONE;MARCO CASTELLANA;GRAZIA SERINO;IVAN LOLLI;MARINA LISO;ANGELO CAMPANELLA;ANTONELLA BIANCO;ANTONELLA MIRIZZI","597;326;320;320;299;276;234;219;192;186;172;170;163;144;130;130;130;129;129;129","GIANLUIGI GIANNELLI;RODOLFO SARDONE;FRANCESCO PANZA;LUISA LAMPIGNANO;ROBERTA ZUPO;FABIO CASTELLANA;ROSSELLA DONGHIA;MARIA NOTARNICOLA;VITO GUERRA;MARIA GABRIELLA CARUSO;CATERINA BONFIGLIO;ALBERTO R. OSELLA;ILARIA BORTONE;MARCELLO CHIEPPA;ANNA MARIA CISTERNINO;GRAZIA SERINO;RAFFAELE COZZOLONGO;CHIARA GRISETA;MARINA LISO;VALERIA TUTINO","30;19;17;16;16;14;12;9;9;8;8;7;7;7;6;6;6;5;5;5","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;SOCIOLOGY;ECONOMICS;COMPUTER SCIENCE;PHYSICS;GEOGRAPHY;MATHEMATICS;ENGINEERING;GEOLOGY;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE","86;42;16;7;7;5;4;3;2;2;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;PATHOLOGY;CANCER RESEARCH;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;ONCOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;PSYCHIATRY;CELL BIOLOGY;GERONTOLOGY;VIROLOGY;PHYSICAL THERAPY;BIOINFORMATICS;INTENSIVE CARE MEDICINE;SURGERY;DEMOGRAPHY;PHARMACOLOGY","67;22;21;18;17;17;17;13;12;12;11;10;10;9;8;7;7;7;6;6","DISEASE;CANCER;GENE;POPULATION;OBESITY;BODY MASS INDEX;COHORT;MEDITERRANEAN DIET;HEPATOCELLULAR CARCINOMA;INFLAMMATION;CELL;CIRRHOSIS;COGNITION;COHORT STUDY;CONFIDENCE INTERVAL;RECEPTOR;IN VITRO;INSULIN;VIRUS;ANTIBIOTICS;DIABETES MELLITUS;HEARING LOSS;IMMUNOHISTOCHEMISTRY;PROPORTIONAL HAZARDS MODEL;PROSPECTIVE COHORT STUDY;SIGNAL TRANSDUCTION","21;18;18;15;11;10;9;8;7;7;6;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4","COLORECTAL CANCER;OVERWEIGHT;INFECTIOUS DISEASE (MEDICAL SPECIALTY);DEMENTIA;FATTY LIVER;WAIST;HAZARD RATIO;INSULIN RESISTANCE;MICRORNA;PRESBYCUSIS;2019-20 CORONAVIRUS OUTBREAK;DOWNREGULATION AND UPREGULATION;GENE EXPRESSION;GENOTYPE;WEIGHT LOSS;ALCOHOLIC LIVER DISEASE;ANTIBIOTIC RESISTANCE;CARCINOGENESIS;CELL MIGRATION;CLARITHROMYCIN;CYCLOPHOSPHAMIDE;DNA REPAIR;EPIGENETICS;GLIADIN;GLYCEMIC;HEPATITIS C VIRUS;HOMOLOGOUS RECOMBINATION;IMMUNOTHERAPY;INNATE IMMUNE SYSTEM;LATE LIFE DEPRESSION;LEVOFLOXACIN;PERIPHERAL BLOOD MONONUCLEAR CELL;PHENOTYPE;PI3K/AKT/MTOR PATHWAY;POLYMERASE;POLYUNSATURATED FATTY ACID;PORTAL VEIN THROMBOSIS;PROGRESSION-FREE SURVIVAL;PROTEIN KINASE B;RNA;SORAFENIB;T CELL;THYROID FUNCTION;TRIIODOTHYRONINE;TYPE 2 DIABETES;WNT SIGNALING PATHWAY","10;8;6;5;5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);REGORAFENIB;COGNITIVE DECLINE;LACTOBACILLUS RHAMNOSUS;POLY ADP RIBOSE POLYMERASE;RIBOSOME;SYNTHETIC LETHALITY;VINCRISTINE;5-HT RECEPTOR;ADENOMATOUS POLYPOSIS COLI;AMPK;ANTIBODY-DRUG CONJUGATE;ANTIGEN-PRESENTING CELL;ANUS NEOPLASMS;BRAIN-DERIVED NEUROTROPHIC FACTOR;CD11C;COXSACKIEVIRUS;DEMENTIA WITH LEWY BODIES;DNA MISMATCH REPAIR;DNA VIRUS;EICOSAPENTAENOIC ACID;EPITHELIAL–MESENCHYMAL TRANSITION;FAMILIAL ADENOMATOUS POLYPOSIS;FECAL BACTERIOTHERAPY;FOLINIC ACID;FRIZZLED;GASTRIC BYPASS;GENE EXPRESSION PROFILING;GENE SIGNATURE;GENETIC HETEROGENEITY;GENOTYPING;GLYCEMIC INDEX;HEPACIVIRUS;HES1;IN SITU HYBRIDIZATION;INNATE LYMPHOID CELL;IRINOTECAN;KRAS;LEVODOPA;MICROVESICLES;MODEL FOR END-STAGE LIVER DISEASE;NATURAL KILLER T CELL;OFLOXACIN;OSTEOCALCIN;OXALIPLATIN;PHYLOGENETIC RELATIONSHIP;PORTOSYSTEMIC SHUNT;RAD51;RIBAVIRIN;SEROPREVALENCE;SEROTONERGIC;SOMATIZATION DISORDER;SOMATOSTATIN RECEPTOR 2;STEATOHEPATITIS;TOLL-LIKE RECEPTOR;TRANSCRIPTOME;TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;TRK RECEPTOR;TROPOMYOSIN RECEPTOR KINASE B;ZONISAMIDE","6;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;ITALY;MALE;MIDDLE AGED;ADULT;AGED;BIOMARKERS;OBESITY;MICRORNAS;AGED, 80 AND OVER;DIET, MEDITERRANEAN;GENE EXPRESSION REGULATION, NEOPLASTIC;STOMACH NEOPLASMS;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CELL LINE, TUMOR;COHORT STUDIES","50;45;25;24;23;21;19;16;13;10;9;8;8;8;8;7;7;6;6;6","ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATOCELLULAR CARCINOMA;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;HEPATITIS C INFECTION AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EFFECTS OF KETOGENIC DIET ON HEALTH;FRAILTY IN OLDER ADULTS AND GERIATRIC CARE;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;IMPACT OF HEARING LOSS ON COGNITIVE FUNCTION;LIPID METABOLISM IN CANCER PATHOGENESIS;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;MICRORNA REGULATION IN CANCER AND DEVELOPMENT;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;CHOLANGIOCARCINOMA;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;CLASSIFICATION AND MANAGEMENT OF ODONTOGENIC TUMORS","6;4;4;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","DIETARY PATTERNS;MEDITERRANEAN DIET;DIET QUALITY;HEALTHY EATING INDEX;PANDEMIC;PRESBYCUSIS;2019-20 CORONAVIRUS OUTBREAK;AGE-RELATED HEARING LOSS;AGING;AUDITORY PROCESSING;DEPRESSION (ECONOMICS);HEARING LOSS;LIVER DISEASE;LOW-CARBOHYDRATE DIET;NAFLD;NEUROENDOCRINE TUMORS;PANCREATIC NEUROENDOCRINE TUMORS;REGORAFENIB;TREATMENT;TUMOR MICROENVIRONMENT","8;8;6;6;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","SOUTHERN ITALY;MEDITERRANEAN DIET;CELL LINES;COLORECTAL CANCER;HEPATOCELLULAR CARCINOMA;APULIA STUDY;HEARING LOSS;LIVER DISEASE;AGE-RELATED CENTRAL;AGE-RELATED HEARING;AUDITORY PROCESSING;AUTUMN ROYAL;BONE MARROW;CANCER CELL;CANCERS CELL;CENTRAL AUDITORY;COLON CANCER;COVID- PANDEMIC;DENDRITIC CELLS;DIGESTIVE ENDOSCOPY;EGNATIA GRAPE;FATTY LIVER;GRAPE SKIN;HOMOLOGOUS RECOMBINATION-PROFICIENT;HUMAN COLON;INFECTED PATIENTS;LACTOBACILLUS RHAMNOSUS;LATE-LIFE DEPRESSION;NON-ALCOHOLIC FATTY;ON-TREATMENT SERUM","7;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SERUM ALBUMIN;PHYSICAL FRAILTY;PUBMED SCOPUS;CELL LINES;DEMENTIA INCIDENCE;ON-TREATMENT SERUM;CROSSREF PUBMED;GENE EXPRESSION;AGE-RELATED CAPD;BLOOD PRESSURE;LIVER DISEASE;LIVER FIBROSIS;PHYSICAL ACTIVITY;SERUM LEVELS;ALZHEIMERS DIS;BODY WEIGHT;CANCER CELLS;COGNITIVE IMPAIRMENT;DIS -CROSSREF;PERIPHERAL ARHL;PROSPECTIVE STUDY;SKELETAL MUSCLE;SOUTHERN ITALY;AGERELATED CAPD;AUTUMN ROYAL;BARI ITALY;BODY MASS;CONFIDENCE INTERVAL;HEALTHY DIET;HEARING LOSS","21;14;13;12;10;10;9;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5",61,0.62,5.9,7,2,1,0,1,1.25,1,0,9,1,1,6,1,1,1,3,5,4,0,0,56,56,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0.25,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"SERINO GRAZIA","1","ENTE OSPEDALIERO SPECIALIZZATO IN GASTROENTEROLOGIA ""SAVERIO DE BELLIS""","1","34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY","2;1","DIGESTIVE DISEASES","1","5.1 PHARMACEUTICALS","1","A61P29/00;A61P37/00;C12N15/113","1;1;1","A61P29/00;A61P37/00;C12N15/113;C12N2310/141;C12N2320/30","1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,0,0,5,1,1,0,8,0,0,"GASTROENTEROLOGY HOSPITAL ""SAVERIO DE BELLIS""","1","ITALIAN ASSOCIATION FOR CANCER RESEARCH","1","ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","1",NA,NA,"31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1;1","CANCER;CLINICAL RESEARCH;COLO-RECTAL CANCER;DIGESTIVE DISEASES;GENETICS","1;1;1;1;1","CANCER","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1","COLON AND RECTAL CANCER","1","1.2 CANCER INITIATION: ALTERATIONS IN CHROMOSOMES;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1;1","A01 CLINICAL MEDICINE","1",NA,NA,12,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS","9;3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3507 STRATEGY, MANAGEMENT AND ORGANISATIONAL BEHAVIOUR;4014 MANUFACTURING ENGINEERING","10;4;2;1;1;1;1;1;1","CANCER;BIOTECHNOLOGY;GENETICS;CLINICAL RESEARCH;DIGESTIVE DISEASES;LIVER CANCER;LIVER DISEASE;RARE DISEASES","4;3;3;1;1;1;1;1",NA,NA,"4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","3","BIOMEDICAL","3","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","1;1","LIVER CANCER","1",NA,NA
"IRCCS_DEBELLIS",2021,94,12.6702127659574,4.87234042553191,0.205240174672489,0.436170212765957,0.425531914893617,0.478723404255319,0.75531914893617,0,35,27,7,1,0.37,0.29,0.07,0.01,12.71,0.824395553240368,0.393617021276596,0.893617021276596,6.12238325281804,0.516568248017807,0.426969696969697,0.399470899470899,0.387628865979382,"GIANLUIGI GIANNELLI;RODOLFO SARDONE;FRANCESCO PANZA;ROBERTA ZUPO;FABIO CASTELLANA;GIOVANNI DE PERGOLA;LUISA LAMPIGNANO;MADIA LOZUPONE;ROSSELLA DONGHIA;VITO GUERRA;ILARIA BORTONE;MARIA NOTARNICOLA;CHIARA GRISETA;FRANCESCO RUSSO;ANTONELLA ORLANDO;MARCELLO CHIEPPA;MARIA GABRIELLA CARUSO;BENEDETTA D’ATTOMA;RAFFAELE ARMENTANO;FRANCESCO DITURI","22;21;20;18;17;16;16;16;16;15;13;11;9;9;8;8;8;7;7;6","GIANLUIGI GIANNELLI;FRANCESCO PANZA;RODOLFO SARDONE;ROBERTA ZUPO;MADIA LOZUPONE;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;FABIO CASTELLANA;VITO GUERRA;LUISA LAMPIGNANO;FRANCESCO RUSSO;ANTONELLA ORLANDO;MARIA NOTARNICOLA;ILARIA BORTONE;MARCELLO CHIEPPA;BENEDETTA D’ATTOMA;RAFFAELE ARMENTANO;GIUSEPPE RIEZZO;FRANCESCO DITURI;ENDRIT SHAHINI","1.91;1.85;1.81;1.47;1.4;1.4;1.29;1.27;1.21;1.2;1.1;0.99;0.99;0.95;0.87;0.85;0.77;0.75;0.7;0.68","GIANLUIGI GIANNELLI;RODOLFO SARDONE;FRANCESCO PANZA;ROBERTA ZUPO;FABIO CASTELLANA;GIOVANNI DE PERGOLA;LUISA LAMPIGNANO;MADIA LOZUPONE;ROSSELLA DONGHIA;VITO GUERRA;ILARIA BORTONE;MARIA NOTARNICOLA;CHIARA GRISETA;FRANCESCO RUSSO;ANTONELLA ORLANDO;MARCELLO CHIEPPA;MARIA GABRIELLA CARUSO;BENEDETTA D’ATTOMA;RAFFAELE ARMENTANO;FRANCESCO DITURI","22;21;20;18;17;16;16;16;16;15;13;11;9;9;8;8;8;7;7;6","GIANLUIGI GIANNELLI;FRANCESCO PANZA;RODOLFO SARDONE;ROBERTA ZUPO;MADIA LOZUPONE;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;FABIO CASTELLANA;VITO GUERRA;LUISA LAMPIGNANO;FRANCESCO RUSSO;ANTONELLA ORLANDO;MARIA NOTARNICOLA;ILARIA BORTONE;MARCELLO CHIEPPA;BENEDETTA D’ATTOMA;RAFFAELE ARMENTANO;GIUSEPPE RIEZZO;FRANCESCO DITURI;ENDRIT SHAHINI","1.91;1.85;1.81;1.47;1.4;1.4;1.29;1.27;1.21;1.2;1.1;0.99;0.99;0.95;0.87;0.85;0.77;0.75;0.7;0.68","GIANLUIGI GIANNELLI;ROBERTA ZUPO;RODOLFO SARDONE;FABIO CASTELLANA;LUISA LAMPIGNANO;FRANCESCO PANZA;GIOVANNI DE PERGOLA;MADIA LOZUPONE;ILARIA BORTONE;CHIARA GRISETA;ROSSELLA DONGHIA;VITO GUERRA;MARIA NOTARNICOLA;FRANCESCO RUSSO;ANTONELLA ORLANDO;BENEDETTA D’ATTOMA;MARCELLO CHIEPPA;VITTORIO DIBELLO;GIUSEPPE RIEZZO;VINCENZO SOLFRIZZI","448;354;344;337;327;309;278;275;255;224;223;222;158;140;136;112;107;103;102;96","GIANLUIGI GIANNELLI;ROBERTA ZUPO;RODOLFO SARDONE;FABIO CASTELLANA;LUISA LAMPIGNANO;FRANCESCO PANZA;GIOVANNI DE PERGOLA;ILARIA BORTONE;CHIARA GRISETA;ROSSELLA DONGHIA;VITO GUERRA;MARIA NOTARNICOLA;FRANCESCO RUSSO;ANTONELLA ORLANDO;BENEDETTA D’ATTOMA;MARCELLO CHIEPPA;GIUSEPPE RIEZZO;MARCO CASTELLANA;FRANCESCO DITURI;MARINA LISO","448;354;344;337;327;305;265;255;224;223;222;158;140;136;112;107;102;89;87;86","GIANLUIGI GIANNELLI;RODOLFO SARDONE;FRANCESCO PANZA;ROBERTA ZUPO;FABIO CASTELLANA;ROSSELLA DONGHIA;LUISA LAMPIGNANO;VITO GUERRA;GIOVANNI DE PERGOLA;ILARIA BORTONE;MARIA NOTARNICOLA;FRANCESCO RUSSO;CHIARA GRISETA;ANTONELLA ORLANDO;MARCELLO CHIEPPA;MARIA GABRIELLA CARUSO;BENEDETTA D’ATTOMA;RAFFAELE ARMENTANO;FRANCESCO DITURI;GIUSEPPE RIEZZO","24;21;19;18;17;16;16;15;14;12;11;9;9;8;8;8;7;7;6;6","MEDICINE;BIOLOGY;CHEMISTRY;SOCIOLOGY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;ECONOMICS;ENGINEERING;MATHEMATICS;GEOGRAPHY;MATERIALS SCIENCE;ART","83;36;13;11;7;6;5;4;3;3;2;2;1","INTERNAL MEDICINE;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;GENETICS;BIOCHEMISTRY;ENDOCRINOLOGY;PATHOLOGY;SURGERY;GERONTOLOGY;ONCOLOGY;CANCER RESEARCH;DEMOGRAPHY;IMMUNOLOGY;PSYCHIATRY;BIOINFORMATICS;CELL BIOLOGY;INTENSIVE CARE MEDICINE;PEDIATRICS;PHYSIOLOGY;ARTIFICIAL INTELLIGENCE;AUDIOLOGY;GENERAL SURGERY;NURSING;OPTICS","63;24;21;18;16;15;15;13;12;12;11;10;10;10;6;6;6;6;5;4;4;4;4;4","DISEASE;POPULATION;CANCER;GENE;HEPATOCELLULAR CARCINOMA;CONFIDENCE INTERVAL;DIABETES MELLITUS;BODY MASS INDEX;ADVERSE EFFECT;CARCINOMA;COHORT;IMMUNE SYSTEM;OBESITY;PROPORTIONAL HAZARDS MODEL;RETROSPECTIVE COHORT STUDY;CLINICAL TRIAL;COGNITION;ENZYME;INFLAMMATION;IRRITABLE BOWEL SYNDROME","25;21;18;17;11;10;8;7;6;6;6;6;6;6;6;5;5;5;5;5","COLORECTAL CANCER;FATTY LIVER;INFECTIOUS DISEASE (MEDICAL SPECIALTY);DEMENTIA;HAZARD RATIO;OVERWEIGHT;DYSBIOSIS;ULCERATIVE COLITIS;ADALIMUMAB;CLINICAL ENDPOINT;GENOTYPE;HCCS;INNATE IMMUNE SYSTEM;MITOCHONDRIAL BIOGENESIS;MUTATION;TYPE 2 DIABETES;AGONIST;CANCER CELL;CARCINOGENESIS;CHEMOKINE;DIAMINE OXIDASE;DOWNREGULATION AND UPREGULATION;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;EPIGENETICS;GENE EXPRESSION;GERMLINE;KETOGENIC DIET;MAPK/ERK PATHWAY;MICRORNA;NEUROPSYCHOLOGY;OFFSPRING;POLYPHENOL;PORTAL VEIN THROMBOSIS;TRANSFORMING GROWTH FACTOR BETA;TUMOR MICROENVIRONMENT;WEIGHT LOSS;WNT SIGNALING PATHWAY","9;6;6;5;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);TFAM;CANCER-ASSOCIATED FIBROBLASTS;COGNITIVE DECLINE;COLONOSCOPY;GERMLINE MUTATION;USTEKINUMAB;ADENOMATOUS POLYPOSIS COLI;ALLOSTERIC ENZYME;ALPHA (FINANCE);ALTERNATIVE SPLICING;AMPLICON;ANAEROBIC GLYCOLYSIS;ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY;BIFIDOBACTERIUM;BILIARY TRACT CANCER;CANNABINOID RECEPTOR;CD86;CHRONIC GASTRITIS;CLADE;COLECTOMY;DNA METHYLATION;DUODENITIS;ENDOCRINE DISEASE;EPITHELIAL–MESENCHYMAL TRANSITION;EXCITOTOXICITY;FAMILIAL ADENOMATOUS POLYPOSIS;FISTULOTOMY;FRIZZLED;GENE EXPRESSION PROFILING;GENE SIGNATURE;GENOMICS;GERIATRIC DEPRESSION SCALE;GLUT1;HAPLOTYPE;INSULITIS;KRAS;MANAGEMENT OF OBESITY;MECONIUM;METHYLTRANSFERASE;MICROVESICLES;MITOCHONDRIAL FUSION;MOLECULAR EPIDEMIOLOGY;NONALCOHOLIC FATTY LIVER DISEASE;NRF1;OBETICHOLIC ACID;PROBAND;REGORAFENIB;RNA SPLICING;SINGLE-NUCLEOTIDE POLYMORPHISM;SOD2;SUPERPARAMAGNETISM;SYNBIOTICS;TOLL-LIKE RECEPTOR;TRAMETINIB;TRANSCRIPTOME;VINCRISTINE;WEIGHT CHANGE;WEIGHT MANAGEMENT","6;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;MALE;FEMALE;AGED;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;ITALY;MIDDLE AGED;ADULT;COLITIS, ULCERATIVE;COVID-19;RETROSPECTIVE STUDIES;ANIMALS;DEPRESSION;DIABETES MELLITUS, TYPE 1;IRRITABLE BOWEL SYNDROME;PROGNOSIS;PROSPECTIVE STUDIES;CARDIOVASCULAR DISEASES","48;42;23;20;18;16;16;15;14;10;8;7;7;6;6;6;6;6;6;5","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATOCELLULAR CARCINOMA;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;DIVERSITY AND FUNCTION OF GUT MICROBIOME;EFFECTS OF KETOGENIC DIET ON HEALTH;FRAILTY IN OLDER ADULTS AND GERIATRIC CARE;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;ANORECTAL SURGICAL PROCEDURES;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;CORONAVIRUS DISEASE 2019;DIAGNOSIS AND MANAGEMENT OF LIVER DISEASES;EFFECTS OF PHYSICAL ACTIVITY ON HEALTH OUTCOMES;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;METABOLIC REPROGRAMMING IN CANCER BIOLOGY;PANCREATIC CANCER RESEARCH AND TREATMENT;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS;3D BIOPRINTING TECHNOLOGY;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS","8;6;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1","DIETARY PATTERNS;NAFLD;INTESTINAL PERMEABILITY;COGNITIVE DECLINE;DYSBIOSIS;HEPATOCELLULAR CARCINOMA;LIPID DYSREGULATION;LIVER BIOPSY;LOW-CARBOHYDRATE DIET;AUDITORY PROCESSING;CLINICAL ENDPOINT;CROSS-SECTIONAL STUDY;DEPRESSION (ECONOMICS);DIET QUALITY;IRRITABLE BOWEL SYNDROME;KETOGENIC DIET;METABOLISM;OBESITY-ASSOCIATED MICROBIOME;PANDEMIC;PORTAL VEIN THROMBOSIS","6;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","SOUTHERN ITALY;APULIA STUDY;HEPATOCELLULAR CARCINOMA;FATTY LIVER;BOWEL SYNDROME;IRRITABLE BOWEL;LIVER DISEASE;ULCERATIVE COLITIS;ALL-CAUSE MORTALITY;COLORECTAL CANCER;DENDRITIC CELLS;INTESTINAL BARRIER;KETOGENIC DIET;PROPENSITY SCORE;AGE-RELATED CENTRAL;BARRIER FUNCTION;CLINICAL MANAGEMENT;CLINICAL PHENOTYPES;CLINICAL TRIALS;COMPETING RISK;DIGESTIVE SYSTEM;GASTRIC CANCER;HEARING LOSS;INCIDENT LATE-ONSET;LATE-ONSET DEPRESSION;LOW-FODMAP DIET;MITOCHONDRIAL BIOGENESIS;PHASE II;PHYSICAL ACTIVITY;PROCESSED MEAT","10;8;7;5;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HEPATOCELLULAR CARCINOMA;AGE-RELATED CAPD;FATTY LIVER;CARCINOMA HCC;LIVER DISEASE;LIVER FIBROSIS;MAXIMUM TUMOR;PORTAL VEIN;SERUM LEVELS;TUMOR DIAMETER;CLINICAL TRIALS;COGNITIVE FRAILTY;GENE EXPRESSION;NEUROLOGICAL CONDITIONS;VEIN THROMBOSIS;INTESTINAL BARRIER;LIVER FRAILTY;OXIDATIVE STRESS;PHYSICAL FRAILTY;SIGNIFICANTLY LOWER;ADVERSE EVENTS;APULIA STUDY;COLORECTAL CANCER;DISEASE NAFLD;FIBROSIS RISK;GI SYMPTOMS;GUT MICROBIOTA;HCC PATIENTS;IL- IL-;REGRESSION MODELS","16;14;14;9;9;9;9;9;9;9;8;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6",56,0.6,5.09,6,1,1,0,2.25,0,1,0,6.5,1,1,5.25,1,1,1,2,4,2,0,0,36.5,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_DEBELLIS",2022,116,14.1724137931034,4.17241379310345,0.239669421487603,0.396551724137931,0.405172413793103,0.482758620689655,0.75,2,43,27,9,1,0.37,0.23,0.08,0.01,7.55,0.845960139876571,0.310344827586207,0.905172413793103,5.48652694610779,0.505690250997708,0.387608806963646,0.457658779576588,0.418055555555555,"GIANLUIGI GIANNELLI;RODOLFO SARDONE;FABIO CASTELLANA;ROBERTA ZUPO;ROSSELLA DONGHIA;GIOVANNI DE PERGOLA;FRANCESCO PANZA;LUISA LAMPIGNANO;RAFFAELE ARMENTANO;MADIA LOZUPONE;ILARIA BORTONE;FRANCESCO RUSSO;NUNZIA LABARILE;GIANLUIGI GIANNELLI;GIUSEPPE RIEZZO;GRAZIA SERINO;GIUSEPPE LISCO;CRISTIANO SIMONE;VINCENZO TRIGGIANI;SERENA MANCARELLA","22;17;15;15;15;14;13;12;12;11;11;9;8;8;8;8;7;7;7;6","GIANLUIGI GIANNELLI;MARIA NOTARNICOLA;RAFFAELE ARMENTANO;ROSSELLA DONGHIA;GIOVANNI DE PERGOLA;RODOLFO SARDONE;ROBERTA ZUPO;FRANCESCO RUSSO;FABIO CASTELLANA;D’ALESSANDRO;ILARIA BORTONE;FRANCESCO PANZA;GRAZIA SERINO;SIMONA ARESTA;GIUSEPPE RIEZZO;ALESSANDRO RIZZO;ANGELA DALIA RICCI;GIUSEPPE LISCO;VINCENZO TRIGGIANI;LUISA LAMPIGNANO","2.1;1.49;1.47;1.35;1.21;1.21;1.13;1.08;1;1;0.96;0.91;0.88;0.85;0.83;0.81;0.81;0.78;0.78;0.77","GIANLUIGI GIANNELLI;RODOLFO SARDONE;FABIO CASTELLANA;ROBERTA ZUPO;ROSSELLA DONGHIA;GIOVANNI DE PERGOLA;FRANCESCO PANZA;LUISA LAMPIGNANO;RAFFAELE ARMENTANO;MADIA LOZUPONE;ILARIA BORTONE;FRANCESCO RUSSO;NUNZIA LABARILE;GIANLUIGI GIANNELLI;GIUSEPPE RIEZZO;GRAZIA SERINO;CRISTIANO SIMONE;SERENA MANCARELLA;CHIARA GRISETA;SARAH TIRELLI","22;17;15;15;15;14;13;12;12;11;11;9;8;8;8;8;7;6;6;6","GIANLUIGI GIANNELLI;MARIA NOTARNICOLA;RAFFAELE ARMENTANO;ROSSELLA DONGHIA;GIOVANNI DE PERGOLA;RODOLFO SARDONE;ROBERTA ZUPO;FRANCESCO RUSSO;FABIO CASTELLANA;D’ALESSANDRO;ILARIA BORTONE;FRANCESCO PANZA;GRAZIA SERINO;SIMONA ARESTA;GIUSEPPE RIEZZO;ANGELA DALIA RICCI;LUISA LAMPIGNANO;ANTONELLA ORLANDO;MADIA LOZUPONE;GIANLUIGI GIANNELLI","2.1;1.49;1.47;1.35;1.21;1.21;1.13;1.08;1;1;0.96;0.91;0.88;0.85;0.83;0.81;0.77;0.72;0.7;0.69","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;MARIA DE ANGELIS;GIOVANNI DE PERGOLA;GIUSY RITA CAPONIO;RAFFAELE ARMENTANO;RODOLFO SARDONE;FRANCESCO MARIA CALABRESE;FABIO CASTELLANA;ROBERTA ZUPO;FRANCESCO PANZA;MADIA LOZUPONE;LUISA LAMPIGNANO;GIUSEPPE LISCO;GRAZIA SERINO;VINCENZO TRIGGIANI;GIUSEPPE GAMBACORTA;MIRELLA NOVIELLO;GIUSEPPINA PIAZZOLLA;ILARIA BORTONE","317;147;144;142;127;125;118;112;108;103;96;94;93;88;88;88;83;83;82;81","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;GIOVANNI DE PERGOLA;GIUSY RITA CAPONIO;RAFFAELE ARMENTANO;RODOLFO SARDONE;FABIO CASTELLANA;ROBERTA ZUPO;LUISA LAMPIGNANO;GRAZIA SERINO;ILARIA BORTONE;ALBERTO R. OSELLA;PASQUA LETIZIA PESOLE;TAMARA LIPPOLIS;CATERINA BONFIGLIO;SERENA MANCARELLA;ISABELLA FRANCO;MARINA LISO;ANGELA DALIA RICCI;ISABELLA GIGANTE","317;147;142;127;125;118;108;103;93;88;74;70;70;70;63;59;57;57;55;55","GIANLUIGI GIANNELLI;RODOLFO SARDONE;ROBERTA ZUPO;FABIO CASTELLANA;ROSSELLA DONGHIA;GIOVANNI DE PERGOLA;RAFFAELE ARMENTANO;LUISA LAMPIGNANO;ILARIA BORTONE;FRANCESCO RUSSO;GIUSEPPE RIEZZO;GRAZIA SERINO;NUNZIA LABARILE;CRISTIANO SIMONE;FRANCESCO PANZA;PAOLA SANESE;VALENTINA GROSSI;ANNAMARIA SILA;BENEDETTA D’ATTOMA;RAFFAELE COZZOLONGO","30;17;15;15;15;14;12;12;10;9;8;8;8;7;6;6;6;6;6;6","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;SOCIOLOGY;MATHEMATICS;PSYCHOLOGY;ECONOMICS;ENGINEERING;BUSINESS;MATERIALS SCIENCE;PHYSICS;POLITICAL SCIENCE;ENVIRONMENTAL SCIENCE;HISTORY","103;44;15;10;6;5;5;4;4;3;3;2;2;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;IMMUNOLOGY;PATHOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;GENETICS;CANCER RESEARCH;CELL BIOLOGY;SURGERY;GERONTOLOGY;ONCOLOGY;PSYCHIATRY;FOOD SCIENCE;PHARMACOLOGY;PHYSICAL THERAPY;DEMOGRAPHY;GENERAL SURGERY;RADIOLOGY;STATISTICS","85;35;22;22;20;19;17;17;15;12;10;8;8;8;7;7;7;5;5;5;5","DISEASE;CANCER;GENE;POPULATION;INFLAMMATION;DIABETES MELLITUS;OBESITY;COHORT;CONFIDENCE INTERVAL;PROSPECTIVE COHORT STUDY;SIGNAL TRANSDUCTION;ADVERSE EFFECT;BIOPSY;BODY MASS INDEX;COLITIS;ENDOSCOPY;ANTIBODY;DIARRHEA;FIBROSIS;IMMUNE SYSTEM;IRRITABLE BOWEL SYNDROME;MEDITERRANEAN DIET;RECEPTOR","35;30;19;17;9;8;8;7;7;7;7;6;6;6;6;6;5;5;5;5;5;5;5","INFLAMMATORY BOWEL DISEASE;COLORECTAL CANCER;ULCERATIVE COLITIS;DOWNREGULATION AND UPREGULATION;FATTY LIVER;INFECTIOUS DISEASE (MEDICAL SPECIALTY);BREAST CANCER;CARCINOGENESIS;GENE EXPRESSION;INFLIXIMAB;MUTATION;TYPE 2 DIABETES;CLINICAL ENDPOINT;GERMLINE;GLYCEMIC;NOTCH SIGNALING PATHWAY;OVERWEIGHT;SEROLOGY;TUMOR MICROENVIRONMENT;TUMOR PROGRESSION","18;14;12;6;6;6;4;4;4;4;4;4;3;3;3;3;3;3;3;3","COLONOSCOPY;CORONAVIRUS DISEASE 2019 (COVID-19);GERMLINE MUTATION;ANGIOPOIETIN 2;BRAIN-DERIVED NEUROTROPHIC FACTOR;GLYCEMIC INDEX;HES1;INFLAMMATORY BOWEL DISEASES;LIRAGLUTIDE;OBETICHOLIC ACID;ABTS;ACRYLAMIDE;ADENOMATOUS POLYPOSIS COLI;ANGIOPOIETIN;ANTIBODY TITER;ARID1A;ATROPHIC GASTRITIS;BILIARY TRACT CANCER;CD90;CETUXIMAB;DNA MISMATCH REPAIR;DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;EXENATIDE;FAMILIAL ADENOMATOUS POLYPOSIS;FEBRILE NEUTROPENIA;FINE NEEDLE BIOPSY;FOAM CELL;FOVEAL AVASCULAR ZONE;FRIZZLED;GENE EXPRESSION PROFILING;GENETICALLY MODIFIED MOUSE;GENOMICS;GLYCATED HEMOGLOBIN;HYDROURETER;HYPERTENSIVE RETINOPATHY;IDH1;IMMUNE CHECKPOINT;INGUINAL CANAL;IRINOTECAN;JAG1;LEISHMANIA INFANTUM;LYMPHANGIOGENESIS;MESOPOROUS SILICA;MILAN CRITERIA;MOLECULAR MEDICINE;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NONALCOHOLIC FATTY LIVER DISEASE;ONCOGENE;OSTEOPOROTIC FRACTURE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PTEN;RAPID UREASE TEST;SANGER SEQUENCING;SEROTONERGIC;SEROTONIN TRANSPORTER;SPIRILLACEAE;STEATOHEPATITIS;SUICIDAL IDEATION;SYSTEMIC THERAPY;TOXICOGENOMICS;TRANSCRIPTOME;TRANSIENT ELASTOGRAPHY;TRK RECEPTOR;TROPOMYOSIN RECEPTOR KINASE B;TROUGH LEVEL;TUMOR PROMOTION;UREA BREATH TEST;VEDOLIZUMAB;WEIGHT CHANGE","7;6;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;ANIMALS;FEMALE;MALE;COLITIS, ULCERATIVE;COVID-19;NON-ALCOHOLIC FATTY LIVER DISEASE;INFLAMMATORY BOWEL DISEASES;PROSPECTIVE STUDIES;INFLAMMATION;IRRITABLE BOWEL SYNDROME;CHOLANGIOCARCINOMA;DIABETES MELLITUS, TYPE 2;MICE;BILE DUCT NEOPLASMS;DIET;INTESTINAL MUCOSA;OBESITY;AGED","58;52;13;13;12;11;11;11;10;10;9;9;8;8;8;7;7;7;7;6","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;CHOLANGIOCARCINOMA;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GLOBAL BURDEN OF LEISHMANIASIS INCIDENCE AND TREATMENT;ANTIOXIDANTS AND FREE RADICALS IN HEALTH AND DISEASE;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;CORONAVIRUS DISEASE 2019 RESEARCH;DETECTION AND MANAGEMENT OF RETINAL DISEASES;DIAGNOSIS AND MANAGEMENT OF LIVER DISEASES;DIVERSITY AND FUNCTION OF GUT MICROBIOME;EFFECTS OF KETOGENIC DIET ON HEALTH;HEPATOCELLULAR CARCINOMA;MECHANISMS OF ALZHEIMER'S DISEASE;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;;3D BIOPRINTING TECHNOLOGY","9;8;6;5;5;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1","DIAGNOSIS;LIVER BIOPSY;CHROMOENDOSCOPY;DIETARY PATTERNS;MEDITERRANEAN DIET;ULCERATIVE COLITIS;COLONOSCOPY;DIET QUALITY;INTESTINAL PERMEABILITY;INTRAHEPATIC CHOLANGIOCARCINOMA;LIVER FIBROSIS;LOW-CARBOHYDRATE DIET;METABOLIC SYNDROME;CLINICAL ENDPOINT;CONCOMITANT;HEALTHY EATING INDEX;HELICOBACTER PYLORI;IRRITABLE BOWEL SYNDROME;NAFLD;OBESITY-ASSOCIATED MICROBIOME","7;6;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3","INFLAMMATORY BOWEL;ULCERATIVE COLITIS;APULIA STUDY;BOWEL DISEASE;COLORECTAL CANCER;INTRAHEPATIC CHOLANGIOCARCINOMA;LIVER FIBROSIS;SOUTHERN ITALY;ARTIFICIAL INTELLIGENCE;BILIARY CHOLANGITIS;CHROMOENDOSCOPY ARTIFICIAL;DETECT ENDOSCOPIC;FATTY LIVER;GLYCEMIC INDEX;HEPATOCELLULAR CARCINOMA;INTELLIGENCE SYSTEM;IRRITABLE BOWEL;LEARNING APPROACH;LIVER DISEASE;MACHINE LEARNING;MEDITERRANEAN DIET;PRIMARY BILIARY;RANDOMIZED CONTROLLED;VIRTUAL CHROMOENDOSCOPY;ALL-CAUSE MORTALITY;ALZHEIMERS DISEASE;BILIARY TRACT;BODY COMPOSITION;BOWEL DISEASES;BOWEL SYNDROME","8;7;6;6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","INFLAMMATORY BOWEL;STATISTICALLY SIGNIFICANT;BOWEL DISEASE;LIVER FIBROSIS;IBD PATIENTS;ULCERATIVE COLITIS;FATTY LIVER;LIVER DISEASE;COLORECTAL CANCER;DISEASE IBD;COLITIS UC;IBS-D PATIENTS;ACTIVE FORM;BODY COMPOSITION;ERADICATION RATE;LOGISTIC REGRESSION;BOWEL SYNDROME;CANL ACTIVE;CLINICAL TRIALS;DIRECT EFFECT;ENDOTHELIAL ANGIOPOIETIN-;FEMALE PATIENTS;SIGNIFICANT DIRECT;UC PATIENTS;ADIPOSE TISSUE;ANGIOPOIETIN- EXPRESSION;ANTIOXIDANT ACTIVITY;BETA CI;CHOLANGIOCARCINOMA ICCA;DE BELLIS","17;15;14;14;13;13;12;11;10;10;8;8;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5",66,0.57,5.18,4,1,1,0,2.5,0,1,1,5.75,1,0,4,1,0,1,3,4,2,0,0,19,19,1,0,0,2,1,0,0,0,0,0,0,0,2,1,0,0,4,2.48,2,0,3,3,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"SUSARREY ARCE ARTURO;ARTURO SUSARREY ARCE;BERENSCHOT ERWIN;BERENSCHOT JOHAN WILLEM;ERWIN BERENSCHOT;KROL SILKE;KROL SILKE INGE;NIELS TAS;SILKE KROL;TAS NIELS","2;1;1;1;1;1;1;1;1;1","ENTE OSPEDALIERO SPECIALIZZATO IN GASTROENTEROLOGIA SAVERIO DE BELLIS IRCCS;UNIV TWENTE;ENTE OSPEDALIERO SPECIALIZZATO IN GASTROENTEROLOGIA ""SAVERIO DE BELLIS"" IRCCS;TWENTE UNIVERSITEIT","2;2;1;1","40 ENGINEERING;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;4003 BIOMEDICAL ENGINEERING","6;3;3;3","REGENERATIVE MEDICINE;STEM CELL RESEARCH","3;3",NA,NA,"C12M1/12;C12N5/00","3;3","C12M21/08;C12M25/14;C12N2513/00;C12N2533/30;C12N5/0062;C12N5/0068","3;3;3;3;3;3",4,6,658.5,2.74,1,0.25,28.25,0,0,0,0,1,0,1,2,0,3,1,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"United States;Australia;Finland;Spain","4;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4206 PUBLIC HEALTH","4;4;3;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;NUTRITION;PREVENTION;AUTOIMMUNE DISEASE;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;CANCER;CARDIOVASCULAR;COLO-RECTAL CANCER;INFLAMMATORY BOWEL DISEASE;OBESITY;PATIENT SAFETY","4;3;3;2;2;1;1;1;1;1;1;1;1;1;1","ORAL AND GASTROINTESTINAL;CANCER;CARDIOVASCULAR;METABOLIC AND ENDOCRINE;STROKE","3;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELLBEING;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","2;1;1;1","COLON AND RECTAL CANCER","1","2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;2.3 INTERACTIONS OF GENES AND/OR GENETIC POLYMORPHISMS WITH EXOGENOUS AND/OR ENDOGENOUS FACTORS;3.2 NUTRITIONAL SCIENCE IN CANCER PREVENTION","1;1;1",1,0,0,2,1,1,0,1,0,0,"GASTROENTEROLOGY HOSPITAL ""SAVERIO DE BELLIS""","1","ITALIAN ASSOCIATION FOR CANCER RESEARCH","1","ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","1",NA,NA,"31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1;1","CANCER;CLINICAL RESEARCH;COLO-RECTAL CANCER;DIGESTIVE DISEASES;GENETICS;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","1;1;1;1;1;1;1","CANCER","1","5.1 PHARMACEUTICALS","1","COLON AND RECTAL CANCER","1","1.3 CANCER INITIATION: ONCOGENES AND TUMOR SUPPRESSOR GENES;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1;1","A01 CLINICAL MEDICINE","1",NA,NA,2,"SPRINGER NATURE","2","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3203 DENTISTRY","2;2;2",NA,NA,NA,NA,NA,NA,NA,NA,"BASIC SCIENCE","2","LIVER CANCER","2",NA,NA
"IRCCS_DEBELLIS",2023,107,13.8971962616822,4.89719626168224,0.204198473282443,0.429906542056075,0.495327102803738,0.476635514018692,0.85981308411215,0,53,19,4,0,0.5,0.18,0.04,0,3.6,0.820912029711291,0.233644859813084,0.794392523364486,5.05327868852459,0.483246723990377,0.388301387970919,0.467633928571429,0.360371855632519,"GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;GIOVANNI DE PERGOLA;PASQUA LETIZIA PESOLE;CATERINA BONFIGLIO;RODOLFO SARDONE;SARA DE NUCCI;FRANCESCO DITURI;FABIO CASTELLANA;SERGIO COLETTA;ROBERTA RINALDI;MADIA LOZUPONE;FRANCESCO PANZA;GRAZIA SERINO;MARIA NOTARNICOLA;RAFFAELE ARMENTANO;ROBERTA ZUPO;CRISTIANO SIMONE;BENEDETTA D’ATTOMA;ANGELO CAMPANELLA","32;23;12;12;12;12;10;9;9;9;9;8;8;8;8;8;7;7;7;7","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;PASQUA LETIZIA PESOLE;VITO GUERRA;CATERINA BONFIGLIO;RODOLFO SARDONE;GIOVANNI DE PERGOLA;FRANCESCO DITURI;MARIA NOTARNICOLA;RAFFAELE ARMENTANO;SERGIO COLETTA;GRAZIA SERINO;SARA DE NUCCI;ANGELO CAMPANELLA;FABIO CASTELLANA;ROBERTA RINALDI;BRIAN I. CARR;RAFFAELE COZZOLONGO;ENDRIT SHAHINI;MARINA LISO","3.2;2.59;1.31;1.26;1.25;1.04;1.01;0.98;0.9;0.87;0.83;0.82;0.8;0.79;0.75;0.72;0.7;0.69;0.66;0.64","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;GIOVANNI DE PERGOLA;PASQUA LETIZIA PESOLE;CATERINA BONFIGLIO;RODOLFO SARDONE;SARA DE NUCCI;FRANCESCO DITURI;FABIO CASTELLANA;SERGIO COLETTA;ROBERTA RINALDI;MADIA LOZUPONE;FRANCESCO PANZA;GRAZIA SERINO;MARIA NOTARNICOLA;RAFFAELE ARMENTANO;ROBERTA ZUPO;CRISTIANO SIMONE;BENEDETTA D’ATTOMA;ANGELO CAMPANELLA","32;23;12;12;12;12;10;9;9;9;9;8;8;8;8;8;7;7;7;7","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;PASQUA LETIZIA PESOLE;VITO GUERRA;CATERINA BONFIGLIO;RODOLFO SARDONE;GIOVANNI DE PERGOLA;FRANCESCO DITURI;MARIA NOTARNICOLA;RAFFAELE ARMENTANO;SERGIO COLETTA;GRAZIA SERINO;SARA DE NUCCI;ANGELO CAMPANELLA;FABIO CASTELLANA;ROBERTA RINALDI;RAFFAELE COZZOLONGO;ENDRIT SHAHINI;MARINA LISO;MADIA LOZUPONE","3.2;2.59;1.31;1.26;1.25;1.04;1.01;0.98;0.9;0.87;0.83;0.82;0.8;0.79;0.75;0.72;0.69;0.66;0.64;0.64","GIANLUIGI GIANNELLI;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;SARA DE NUCCI;GIUSEPPINA PIAZZOLLA;ROBERTA RINALDI;FABIO CASTELLANA;CATERINA BONFIGLIO;VINCENZO TRIGGIANI;ROBERTA ZUPO;RODOLFO SARDONE;LUISA LAMPIGNANO;MARTINA DI CHITO;PASQUA LETIZIA PESOLE;ENDRIT SHAHINI;FRANCESCO PANZA;MADIA LOZUPONE;GRAZIA SERINO;SERGIO COLETTA;ANNAMARIA SILA","166;99;73;71;68;60;59;57;57;55;55;52;51;51;48;46;46;43;43;42","GIANLUIGI GIANNELLI;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;SARA DE NUCCI;ROBERTA RINALDI;CATERINA BONFIGLIO;FABIO CASTELLANA;MARTINA DI CHITO;PASQUA LETIZIA PESOLE;LUISA LAMPIGNANO;ENDRIT SHAHINI;GRAZIA SERINO;SERGIO COLETTA;ANNAMARIA SILA;RAFFAELE COZZOLONGO;ROBERTA ZUPO;VITO GIANNUZZI;ANTONIA IGNAZZI;BENEDETTA D’ATTOMA;FRANCESCO RUSSO","166;99;73;71;60;57;53;51;51;49;48;43;43;42;41;37;37;36;36;36","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;CATERINA BONFIGLIO;GIOVANNI DE PERGOLA;PASQUA LETIZIA PESOLE;SARA DE NUCCI;ROBERTA RINALDI;FRANCESCO DITURI;SERGIO COLETTA;GRAZIA SERINO;RAFFAELE ARMENTANO;RODOLFO SARDONE;MARIA NOTARNICOLA;ANGELO CAMPANELLA;RAFFAELE COZZOLONGO;BENEDETTA D’ATTOMA;ENDRIT SHAHINI;FABIO CASTELLANA;FRANCESCO RUSSO;GIUSEPPE RIEZZO","33;23;12;12;12;10;9;9;9;8;8;8;8;7;7;7;7;7;7;7","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;SOCIOLOGY;MATHEMATICS;PSYCHOLOGY;ENGINEERING;BUSINESS;PHILOSOPHY;PHYSICS;ART;ENVIRONMENTAL SCIENCE;MATERIALS SCIENCE;POLITICAL SCIENCE","95;46;12;9;5;5;4;4;3;2;2;2;1;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;CANCER RESEARCH;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;GENETICS;CELL BIOLOGY;ONCOLOGY;SURGERY;PSYCHIATRY;IMMUNOLOGY;PATHOLOGY;ENDOCRINOLOGY;FOOD SCIENCE;PHYSICAL THERAPY;GERONTOLOGY;PHYSIOLOGY;BIOINFORMATICS;DEMOGRAPHY;MACHINE LEARNING;NURSING","81;25;24;21;19;17;16;15;15;13;11;11;10;10;10;9;8;5;5;5;5","CANCER;DISEASE;POPULATION;GENE;COHORT;HEPATOCELLULAR CARCINOMA;OBESITY;SIGNAL TRANSDUCTION;CONFIDENCE INTERVAL;ANXIETY;CELL;LIVER DISEASE;RECEPTOR;BODY MASS INDEX;CIRRHOSIS;COGNITION;IRRITABLE BOWEL SYNDROME;LOGISTIC REGRESSION;PROPORTIONAL HAZARDS MODEL;PROSPECTIVE COHORT STUDY;QUALITY OF LIFE (HEALTHCARE);STEATOSIS","30;27;16;15;14;10;9;9;7;6;6;6;6;5;5;5;5;5;5;5;5;5","COLORECTAL CANCER;FATTY LIVER;INFLAMMATORY BOWEL DISEASE;DOWNREGULATION AND UPREGULATION;HAZARD RATIO;MICRORNA;ULCERATIVE COLITIS;BREAST CANCER;MUTATION;OVERWEIGHT;TYPE 2 DIABETES;WNT SIGNALING PATHWAY;CELL CYCLE;CELL MIGRATION;CLINICAL ENDPOINT;DEMENTIA;DNA REPAIR;GLYCEMIC;KETOGENIC DIET;NEUROPSYCHOLOGY","11;11;7;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3","DNA MISMATCH REPAIR;EPITHELIAL–MESENCHYMAL TRANSITION;GERMLINE MUTATION;IRINOTECAN;KRAS;REGORAFENIB;CATENIN;CHROMATIN REMODELING;CORONAVIRUS DISEASE 2019 (COVID-19);LIVER STEATOSIS;LOW CALORIE DIET;MICROSATELLITE;MICROVESICLES;NOX4;TRANSIENT ELASTOGRAPHY;VASCULAR ENDOTHELIAL GROWTH FACTOR A;VEDOLIZUMAB;ABTS;ADENOMATOUS POLYPOSIS COLI;ADHERENS JUNCTION;ADJUVANT CHEMOTHERAPY;AMPK;ARID1A;AUTOTAXIN;BETA-CATENIN;BILIARY TRACT CANCER;BROMODOMAIN;C-MET;CALIFORNIA VERBAL LEARNING TEST;CALPROTECTIN;CANNABINOID RECEPTOR;CASPASE 1;CETUXIMAB;COGNITIVE DECLINE;DASATINIB;DESMOGLEIN;DNA METHYLATION;ESOPHAGEAL VARICES;FAMILIAL ADENOMATOUS POLYPOSIS;FAMILY PLANNING;FINE NEEDLE BIOPSY;FUCOSYLATION;GENOME INSTABILITY;GLUCAGON-LIKE PEPTIDE-1;GLYCEMIC INDEX;GOLIMUMAB;HBSAG;HEMIMEGALENCEPHALY;LIRAGLUTIDE;MACULAR HOLE;MEMORY SPAN;METASTATIC BREAST CANCER;MILAN CRITERIA;MINI–MENTAL STATE EXAMINATION;MULTICENTER TRIAL;NECROPTOSIS;NONALCOHOLIC FATTY LIVER DISEASE;ONCOGENE;OXALIPLATIN;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PACED AUDITORY SERIAL ADDITION TEST;PDGFRA;PENETRANCE;PROANTHOCYANIDIN;REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS;TGF ALPHA;TRAIL MAKING TEST;TROLOX;VASCULAR DEMENTIA;VERBAL FLUENCY TEST;VINCRISTINE","3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;OBESITY;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;NON-ALCOHOLIC FATTY LIVER DISEASE;FEMALE;INFLAMMATORY BOWEL DISEASES;ITALY;PROSPECTIVE STUDIES;DIABETES MELLITUS, TYPE 2;FRAILTY;IRRITABLE BOWEL SYNDROME;MALE;OVERWEIGHT;ABDOMINAL PAIN;ADULT;COLITIS, ULCERATIVE;FATTY LIVER;LIVER CIRRHOSIS","55;50;16;15;15;15;9;8;8;8;7;7;7;7;7;6;6;6;6;6","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;CHOLANGIOCARCINOMA;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;EFFECTS OF KETOGENIC DIET ON HEALTH;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;FRAILTY IN OLDER ADULTS AND GERIATRIC CARE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;VITREORETINAL SURGERY TECHNIQUES;WNT SIGNALING IN DEVELOPMENT AND DISEASE;ADVANCES IN METABOLOMICS RESEARCH;ANTIOXIDANTS AND FREE RADICALS IN HEALTH AND DISEASE;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;GLIOMAS;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS IN IMMUNITY;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS;","14;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;1","LOW-CARBOHYDRATE DIET;NAFLD;LIVER DISEASE;DIETARY PATTERNS;FRAILTY;INTESTINAL PERMEABILITY;IRRITABLE BOWEL SYNDROME;STEATOSIS;CALORIE;CLINICAL ENDPOINT;HEALTHY EATING INDEX;KETOGENIC DIET;MEDITERRANEAN DIET;AGING;CANCER GENOMICS;DEPRESSION (ECONOMICS);FOLFIRI;FUNCTIONAL DECLINE;HEPATOCELLULAR CARCINOMA;INTRAOCULAR PRESSURE","7;7;6;5;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3","HEPATOCELLULAR CARCINOMA;COLORECTAL CANCER;LIVER DISEASE;KETOGENIC DIET;BOWEL DISEASE;GASTRIC CANCER;INFLAMMATORY BOWEL;SOUTHERN ITALY;ALZHEIMERS DISEASE;BOWEL SYNDROME;CANCER CELL;COHORT STUDY;IRRITABLE BOWEL;LOW-CALORIE KETOGENIC;MACHINE LEARNING;METASTATIC COLORECTAL;MULTIPLE SCLEROSIS;PHYSICAL ACTIVITY;PILOT STUDY;PRELIMINARY RESULTS;ULCERATIVE COLITIS;ADVANCED CHRONIC;AEROBIC EXERCISE;BIOPSYCHOSOCIAL FRAILTY;CANCER PATIENTS;CANCER PROGRESSION;CHRONIC LIVER;COGNITIVE IMPAIRMENT;COLON CANCER;COMPENSATED ADVANCED","9;6;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","LIVER DISEASE;STATISTICALLY SIGNIFICANT;PHYSICAL ACTIVITY;FATTY LIVER;BIOPSYCHOSOCIAL FRAILTY;CELL LINES;COLORECTAL CANCER;HEPATOCELLULAR CARCINOMA;HCC CELLS;SOUTHERN ITALY;VISUAL ACUITY;AEROBIC EXERCISE;CARCINOMA HCC;DISEASE NAFLD;INFLAMMATORY BOWEL;MO CI;NUTRITIONAL FRAILTY;BOWEL DISEASE;CTDNA VAF;DISEASE PROGRESSION;EVOO CONSUMPTION;IBS SYMPTOMS;NAFLD PATIENTS;OBESE PATIENTS;SERUM LEVELS;TUMOR TISSUE;ABDOMINAL BLOATING;ALCOHOL CONSUMPTION;BACTERIAL DNA;BLOOD PARAMETERS","36;18;14;13;11;10;10;10;9;9;9;8;8;8;8;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6",50,0.47,4.99,8,1,0,0,1,0,1,0,8.75,1,0,7.25,1,0,1.5,3.5,5.5,2,0,0,11.25,11.25,2,0,0,1,3,0,0,0,0,0,0,0,4,0,0,0,4,3.05,2,0,4,4,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BERENSCHOT JOHAN WILLEM;KROL SILKE INGE;TAS NIELS ROELOF;SUSARREY ARCE ARTURO;USARREY ARCE ARTURO","4;4;4;3;1","ENTE OSPEDALIERO SPECIALIZZATO IN GASTROENTEROLOGIA ""SAVERIO DE BELLIS"" IRCCS;ENTE OSPEDALIERO SPECIALIZZATO IN GASTROENTEROLOGIA SAVERIO DE BELLIS IRCCS;TWENTE UNIVERSITEIT;UNIV TWENTE;UNIVERSITEIT TWENTE","2;2;2;1;1","40 ENGINEERING;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;4003 BIOMEDICAL ENGINEERING","8;4;4;4","REGENERATIVE MEDICINE;STEM CELL RESEARCH","4;4",NA,NA,"C12M1/12;C12N5/00;C12M3/00","4;4;1","C12M21/08;C12M25/14;C12N2513/00;C12N2533/30;C12N5/0062;C12N5/0068","3;3;3;3;3;3",1,3,90,0.69,0,0,4,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;4206 PUBLIC HEALTH","1;1;1","CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;DIGESTIVE DISEASES;LIVER DISEASE;NUTRITION;OBESITY;PREVENTION","1;1;1;1;1;1;1","CARDIOVASCULAR;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;STROKE","1;1;1;1","6.7 PHYSICAL","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"FRONTIERS","2","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3204 IMMUNOLOGY;3210 NUTRITION AND DIETETICS;4206 PUBLIC HEALTH","4;2;1;1;1","CLINICAL RESEARCH;NUTRITION;AGING;BEHAVIORAL AND SOCIAL SCIENCE;BIODEFENSE;EMERGING INFECTIOUS DISEASES;IMMUNIZATION;INFECTIOUS DISEASES;LUNG;PNEUMONIA;PNEUMONIA & INFLUENZA;PREVENTION;VACCINE RELATED","2;2;1;1;1;1;1;1;1;1;1;1;1",NA,NA,NA,NA,"POPULATION & SOCIETY","1","PUBLIC HEALTH","2",NA,NA,"3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_DEBELLIS",2024,83,17.6024096385542,5.13253012048193,0.194835680751174,0.457831325301205,0.433734939759036,0.349397590361446,0.831325301204819,0,42,15,1,2,0.51,0.18,0.01,0.02,0.55,0.579903987261493,0.204819277108434,0.831325301204819,4.21895861148197,0.541042631688811,0.36026936026936,0.411290322580645,0.310588235294118,"GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;CATERINA BONFIGLIO;GIOVANNI DE PERGOLA;FRANCESCO RUSSO;SERGIO COLETTA;ROSSELLA TATOLI;ANGELO CAMPANELLA;GIUSEPPE RIEZZO;GRAZIA SERINO;CLAUDIO LOTESORIERE;RAFFAELE COZZOLONGO;MARIA NOTARNICOLA;ENDRIT SHAHINI;FATIMA MAQOUD;VALENTINA DE NUNZIO;MARTINA DI CHITO;VALENTINA ARRÈ;ISABELLA FRANCO;LEONARDO VINCENTI","30;18;14;12;12;10;8;8;7;7;7;7;7;7;6;6;6;5;5;5","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;CATERINA BONFIGLIO;FRANCESCO RUSSO;ANGELO CAMPANELLA;ROSSELLA TATOLI;GIOVANNI DE PERGOLA;FRANCESCO CUCCARO;FATIMA MAQOUD;SERGIO COLETTA;GRAZIA SERINO;ENDRIT SHAHINI;GIUSEPPE RIEZZO;ISABELLA FRANCO;ANTONELLA BIANCO;MARIA NOTARNICOLA;CLAUDIO LOTESORIERE;DAVIDE GUIDO;ANTONELLA ORLANDO;RITANNA CURCI","3.27;2.02;1.86;1.22;1.18;1.11;0.92;0.72;0.71;0.67;0.66;0.59;0.57;0.57;0.57;0.55;0.54;0.52;0.5;0.5","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;CATERINA BONFIGLIO;GIOVANNI DE PERGOLA;FRANCESCO RUSSO;SERGIO COLETTA;ROSSELLA TATOLI;ANGELO CAMPANELLA;GIUSEPPE RIEZZO;GRAZIA SERINO;CLAUDIO LOTESORIERE;RAFFAELE COZZOLONGO;MARIA NOTARNICOLA;ENDRIT SHAHINI;FATIMA MAQOUD;VALENTINA DE NUNZIO;MARTINA DI CHITO;VALENTINA ARRÈ;ISABELLA FRANCO;LEONARDO VINCENTI","30;18;14;12;12;10;8;8;7;7;7;7;7;7;6;6;6;5;5;5","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;CATERINA BONFIGLIO;FRANCESCO RUSSO;ANGELO CAMPANELLA;ROSSELLA TATOLI;GIOVANNI DE PERGOLA;FATIMA MAQOUD;SERGIO COLETTA;GRAZIA SERINO;ENDRIT SHAHINI;GIUSEPPE RIEZZO;ISABELLA FRANCO;ANTONELLA BIANCO;MARIA NOTARNICOLA;CLAUDIO LOTESORIERE;DAVIDE GUIDO;ANTONELLA ORLANDO;RITANNA CURCI;VALENTINA DE NUNZIO","3.27;2.02;1.86;1.22;1.18;1.11;0.92;0.71;0.67;0.66;0.59;0.57;0.57;0.57;0.55;0.54;0.52;0.5;0.5;0.49","GIANLUIGI GIANNELLI;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;FRANCESCO RUSSO;GIUSEPPE RIEZZO;MARIA NOTARNICOLA;ALFREDO DI LEO;BENEDETTA D’ATTOMA;CATERINA BONFIGLIO;ENZO IERARDI;FRANCESCA CELIBERTO;GIUSEPPE LOSURDO;ANGELO CAMPANELLA;FEDERICA RIZZI;GIUSEPPE LISCO;M. LUCIA CURRI;MARIA PRINCIPIA SCAVO;NICOLETTA DEPALO;VALENTINA ARRÈ;VALENTINA DE NUNZIO","22;13;11;9;9;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6","GIANLUIGI GIANNELLI;GIOVANNI DE PERGOLA;ROSSELLA DONGHIA;FRANCESCO RUSSO;GIUSEPPE RIEZZO;MARIA NOTARNICOLA;BENEDETTA D’ATTOMA;CATERINA BONFIGLIO;ANGELO CAMPANELLA;MARIA PRINCIPIA SCAVO;VALENTINA ARRÈ;VALENTINA DE NUNZIO;ENDRIT SHAHINI;M. ZAPPIMBULSO;MARTINA DI CHITO;RAFFAELE COZZOLONGO;ROBERTA RINALDI;SARA DE NUCCI;SERGIO COLETTA;LIVIANNA CARRIERI","22;13;11;9;9;8;7;7;6;6;6;6;5;5;5;5;5;5;5;4","GIANLUIGI GIANNELLI;ROSSELLA DONGHIA;CATERINA BONFIGLIO;FRANCESCO RUSSO;GIOVANNI DE PERGOLA;SERGIO COLETTA;ROSSELLA TATOLI;ANGELO CAMPANELLA;ENDRIT SHAHINI;RAFFAELE COZZOLONGO;GRAZIA SERINO;MARIA NOTARNICOLA;GIUSEPPE RIEZZO;MARTINA DI CHITO;VALENTINA DE NUNZIO;FATIMA MAQOUD;ANTONELLA BIANCO;ANTONELLA ORLANDO;BENEDETTA D’ATTOMA;ISABELLA FRANCO","32;18;14;12;12;10;8;8;7;7;7;7;7;6;6;6;5;5;5;5","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;SOCIOLOGY;HISTORY;PHYSICS;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY","75;40;11;6;3;3;3;2;2;1;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;BIOCHEMISTRY;GENETICS;CANCER RESEARCH;ENDOCRINOLOGY;ONCOLOGY;CELL BIOLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;FOOD SCIENCE;PATHOLOGY;BIOINFORMATICS;MICROBIOLOGY;PHYSICAL THERAPY;PHYSIOLOGY;COMPUTATIONAL BIOLOGY;SURGERY;DEMOGRAPHY;GERONTOLOGY;VIROLOGY","71;22;17;16;15;15;13;12;10;9;7;7;5;5;5;5;4;4;3;3;3","DISEASE;CANCER;GENE;COHORT;COHORT STUDY;OBESITY;POPULATION;STEATOSIS;DIABETES MELLITUS;RANDOMIZED CONTROLLED TRIAL;CONFIDENCE INTERVAL;PROSPECTIVE COHORT STUDY;RECEPTOR;CELL;HEPATOCELLULAR CARCINOMA;INFLAMMATION;BODY MASS INDEX;ENZYME;FIBROSIS;IRRITABLE BOWEL SYNDROME;LIVER DISEASE;PROPORTIONAL HAZARDS MODEL","22;20;16;12;11;9;8;8;7;7;6;6;6;5;5;5;4;4;4;4;4;4","FATTY LIVER;COLORECTAL CANCER;TYPE 2 DIABETES;METABOLIC SYNDROME;MICRORNA;OVERWEIGHT;AGONIST;GENE EXPRESSION;GENOTYPE;HAZARD RATIO;METASTASIS;AMOXICILLIN;BACTEROIDES;BREATH TEST;CANCER CELL;CLARITHROMYCIN;GERMLINE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLAMMATORY BOWEL DISEASE;INTERIM ANALYSIS;LOWER RISK;METABOLOME;METRONIDAZOLE;MUTATION;QUARTILE;TRANSCRIPTION FACTOR;TUMOR MICROENVIRONMENT;TUMOR PROGRESSION;VIABILITY ASSAY","11;10;7;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","IRINOTECAN;KRAS;MICROVESICLES;OBETICHOLIC ACID;TRANSCRIPTOME;CORONAVIRUS DISEASE 2019 (COVID-19);GERMLINE MUTATION;LIRAGLUTIDE;NONALCOHOLIC FATTY LIVER DISEASE;ADENOMATOUS POLYPOSIS COLI;ANGIOPOIETIN;AUTOTAXIN;BILIARY TRACT CANCER;BONE METASTASIS;CELL CYCLE CHECKPOINT;COLONOSCOPY;CREB;CYANOACRYLATE;DIRECT BILIRUBIN;DIROFILARIA;DIROFILARIA REPENS;DNA DAMAGE REPAIR;EICOSAPENTAENOIC ACID;FAMILIAL ADENOMATOUS POLYPOSIS;FUSOBACTERIUM;FUSOBACTERIUM NUCLEATUM;GASTROINTESTINAL CANCER;GENE SIGNATURE;GLYCATED HEMOGLOBIN;HEARTBURN;HEPATITIS E VIRUS;INTERMEDIATE FILAMENT;LEISHMANIA INFANTUM;LIVER STEATOSIS;LOW SODIUM DIET;LYMPHANGIOGENESIS;LYMPHATIC VESSEL;MANAGEMENT OF OBESITY;PAX5;RNA SPLICING;SH-SY5Y;SINGLE-NUCLEOTIDE POLYMORPHISM;STEATOHEPATITIS;TARGET LESION;TRANSIENT ELASTOGRAPHY;UREA BREATH TEST;VEDOLIZUMAB;WEIGHT MANAGEMENT","3;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;NON-ALCOHOLIC FATTY LIVER DISEASE;ITALY;ANIMALS;FATTY LIVER;CELL LINE, TUMOR;DIET;PROSPECTIVE STUDIES;RISK FACTORS;COHORT STUDIES;DIET, KETOGENIC;MICE;OBESITY;BILE DUCT NEOPLASMS","43;40;27;25;23;21;13;8;7;6;6;5;5;5;5;4;4;4;4;3","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;CHOLANGIOCARCINOMA;EFFECTS OF KETOGENIC DIET ON HEALTH;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;BREATH ANALYSIS TECHNOLOGY;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF LIVER DISEASES;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPATOCELLULAR CARCINOMA;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;BIOLOGY AND PATHOLOGY OF KERATINS AND RELATED DISORDERS;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;CHEMISTRY AND HEALTH EFFECTS OF OLIVE OIL;COLORECTAL CANCER RESEARCH AND TREATMENT;COMPLICATIONS AND MANAGEMENT OF STOMA-RELATED ISSUES;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY","17;4;4;4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","METABOLIC SYNDROME;STEATOSIS;INTESTINAL PERMEABILITY;LIPID DYSREGULATION;LIVER BIOPSY;LOW-CARBOHYDRATE DIET;DIAGNOSIS;FOLFIRI;INFLAMMATION;INSULIN SIGNALING;LIVER DISEASE;METASTATIC COLORECTAL CANCER;OBESITY;OBETICHOLIC ACID;PRIMARY SCLEROSING CHOLANGITIS;BILIARY TRACT CANCER;BREATH ANALYSIS;BREATH GAS ANALYSIS;CALORIE;CELIAC DISEASE","11;8;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2","LIVER DISEASE;COLORECTAL CANCER;METABOLIC DYSFUNCTION-ASSOCIATED;STEATOTIC LIVER;DYSFUNCTION-ASSOCIATED STEATOTIC;FATTY LIVER;KETOGENIC DIET;SOUTHERN ITALY;BILIARY CHOLANGITIS;BOWEL SYNDROME;DISEASE MASLD;EXTRACELLULAR VESICLES;IRRITABLE BOWEL;ITALIAN COHORT;LOW-CALORIE KETOGENIC;METASTATIC COLORECTAL;OBESE PATIENTS;PHYSICAL ACTIVITY;PRIMARY BILIARY;TYPE DIABETES;ALL-CAUSE MORTALITY;ANTI-INFLAMMATORY EFFECTS;BILIARY TRACT;CELIAC DISEASE;CLINICAL TRIAL;COHORT STUDY;COMPETING RISK;CROSS-SECTIONAL STUDY;EXTRA VIRGIN;HELICOBACTER PYLORI","12;7;7;6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","LIVER DISEASE;PROTECTIVE ROLE;PHYSICAL ACTIVITY;LIVER STEATOSIS;STATISTICALLY SIGNIFICANT;STEATOTIC LIVER;BODY WEIGHT;METABOLIC DYSFUNCTION-ASSOCIATED;DIROFILARIA LEISHMANIA;DISEASE MASLD;BLOOD PRESSURE;CHRONIC LIVER;CRC PATIENTS;SIGNIFICANT DIFFERENCES;STUDY COHORT;WEIGHT LOSS;WHITE MEAT;BREATH SAMPLES;C-REACTIVE PROTEIN;CANCER CELL;CELL LINES;CELL VIABILITY;COHORT INCLUDED;COLORECTAL CANCER;FATTY LIVER;HEPATIC STEATOSIS;HEPATOCELLULAR CARCINOMA;LEC PODOPLANIN;NR PATIENTS;OBESE PATIENTS","26;13;10;9;9;9;8;8;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
